Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,29786,0.167134571487071,0.00350557215184799,0.160263650069449,0.174005492904693,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,24951,-0.068376541011597,0.00167592382691643,-0.0716613517123532,-0.0650917303108408,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29218,0.080032132483066,0.00199351126763561,0.0761248503985002,0.0839394145676318,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C9,Complement component C9,24951,-0.142882181499468,0.00356610066235103,-0.149871738797676,-0.13589262420126,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29566,-0.148707471229662,0.00208426509114289,-0.152792630808302,-0.144622311651022,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,28797,0.49167383547376,0.00806497464274862,0.475866485173973,0.507481185773547,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.323991486921612,0.00817522251439712,-0.340014923049831,-0.307968050793394,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,24922,0.25789858549777,0.00548498518760809,0.247148014530059,0.268649156465482,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,29500,0.138593325504634,0.00353625048715266,0.131662274549815,0.145524376459453,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24793,0.146094168774878,0.00372139100656879,0.138800242402003,0.153388095147753,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,29443,0.191444668947504,0.00280141945663467,0.1859538868125,0.196935451082508,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,29725,0.212971579267416,0.00435553020764608,0.20443474006043,0.221508418474403,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29443,-0.14273120051254,0.00202547710722078,-0.146701135642693,-0.138761265382388,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29581,-0.0893660727623495,0.00188039671563859,-0.0930516503250012,-0.0856804951996979,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,24938,0.140871450123755,0.00267307749245282,0.135632218238548,0.146110682008963,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,29347,0.132892733228681,0.00271419045403448,0.127572919938773,0.138212546518588,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PYY,Peptide YY,24111,0.305709136673321,0.00641575681884682,0.293134253308381,0.318284020038261,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,29349,0.276514574966475,0.00600777726025458,0.264739331536376,0.288289818396574,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,28916,0.165774911852739,0.00445170247570058,0.157049575000366,0.174500248705112,1.66544587825208e-296
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,29454,0.131936564024706,0.00367848245872038,0.124726738405614,0.139146389643798,8.6761599899847e-276
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,29478,-0.11341319224032,0.00316888865662828,-0.119624214007312,-0.107202170473329,1.23213093088696e-274
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,29694,0.334217107490179,0.00936193487139711,0.315867715142241,0.352566499838118,2.45231963296634e-273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,29545,-0.0657325714264932,0.00187306201528122,-0.0694037729764444,-0.062061369876542,2.29439115639954e-264
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,29400,0.23937188802292,0.00685994218613346,0.225926401338098,0.252817374707741,1.99346262098324e-261
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.0764596069797568,0.00221553234968947,0.0721171635743654,0.0808020503851481,7.70147922785712e-256
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,24966,-0.156515450269944,0.0045590256775196,-0.165451140597882,-0.147579759942006,2.01606804254029e-252
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,29489,0.184448502941038,0.00545166530314007,0.173763238946884,0.195133766935193,3.29019134069632e-246
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,29301,0.171854133599923,0.00509960996209221,0.161858898074223,0.181849369125624,2.74910712578872e-244
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,28931,0.180135713127574,0.00537510879500614,0.169600499889362,0.190670926365787,1.31741077672795e-241
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,29478,0.139117186696358,0.00416695281945635,0.130949959170224,0.147284414222493,6.55425786126469e-240
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,29434,0.118432552767369,0.00360390988062521,0.111368889401343,0.125496216133394,1.2331186005497e-232
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,24240,0.113391877285129,0.0034625236074569,0.106605331014513,0.120178423555744,3.3332668700787e-230
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28916,0.113879282470054,0.00349438189261388,0.107030293960531,0.120728270979578,8.11691367676014e-229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,28774,0.110798638165455,0.00348572863735872,0.103966610036232,0.117630666294678,5.92940694389759e-218
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.144498774610797,0.00460826497838776,0.135466575253157,0.153530973968437,2.55574827323137e-212
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,24195,0.171526110562389,0.00548783382912711,0.160769956257299,0.182282264867478,2.83807288014096e-210
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23825,0.0671979902560454,0.00217740887432807,0.0629302688623624,0.0714657116497285,4.2900799062584e-205
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,29725,0.0704120161915175,0.00229014996579591,0.0659233222585575,0.0749007101244775,2.24304601934718e-204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,0.0726339975966675,0.00236362314575513,0.0680012962309874,0.0772666989623475,3.71879749856459e-204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,29786,0.0589101361155231,0.00192108891718843,0.0551448018378338,0.0626754703932124,2.44117460077735e-203
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,29725,-0.0735359817824964,0.00241273745163133,-0.0782649471876938,-0.068807016377299,6.31263908482189e-201
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,29820,0.106499663981978,0.00354479832660771,0.0995518592618271,0.113447468702129,2.15881445361451e-195
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,29383,0.060869312340902,0.00202628002169274,0.0568978034983842,0.0648408211834197,2.67532628529931e-195
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,24922,0.186665839039113,0.00620553759823955,0.174502985346563,0.198828692731662,2.70723313397577e-195
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,29443,0.0836369457202141,0.00279791152399887,0.0781530391331763,0.0891208523072519,1.92187476169916e-193
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,29559,0.0660079521775888,0.00221148576475696,0.0616734400786652,0.0703424642765125,6.88595721619538e-193
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29628,0.0955617737877807,0.00320245324770172,0.0892849654222853,0.101838582153276,8.45763030632536e-193
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,27442,0.0822437004960489,0.00275906157114088,0.0768359398166128,0.087651461175485,3.52366935697896e-192
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28935,0.159202402512225,0.00534933309289012,0.148717709650161,0.16968709537429,9.71702372467784e-192
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,29820,0.0895021163598246,0.00301671539757569,0.0835893541805762,0.0954148785390729,1.15663138025437e-190
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FURIN,Furin,29566,0.0671010448175497,0.00227082804406019,0.0626502218511918,0.0715518677839077,3.81616442005605e-189
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,29034,-0.10728957179328,0.00363614822213338,-0.114416422308662,-0.100162721277899,1.45958950963318e-188
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,29674,0.231703529043556,0.00803683662267455,0.215951329263114,0.247455728823998,2.76595495459528e-180
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.163338351689385,0.00567632657375547,0.152212751604824,0.174463951773945,1.49073130590967e-179
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.0638955299710699,0.00222750040440607,0.059529629178434,0.0682614307637058,1.60594553204092e-178
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.286453760769262,0.0100015518430999,0.266850719156786,0.306056802381738,6.23533600197732e-178
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29349,0.134143931550961,0.00469615838104963,0.124939461124104,0.143348401977818,4.92474346689081e-177
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,29435,-0.0611528751627457,0.00215183719788756,-0.0653704760706053,-0.0569352742548861,2.76687270089236e-175
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,29694,-0.0412997320933183,0.00147139035599646,-0.0441836571910714,-0.0384158069955652,4.09743940630025e-171
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.102567157287156,0.00366322466634632,0.0953872369411174,0.109747077633195,2.88147689248499e-170
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.120037342677625,0.00430609864275223,0.111597389337831,0.12847729601742,9.10214911215344e-169
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0678828364558463,0.00243669906606741,0.0631069062863541,0.0726587666253384,1.28708699475847e-168
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,29478,0.115335044851229,0.00416631125874201,0.107169074784095,0.123501014918364,1.52854947403322e-166
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,29584,0.0642797221093434,0.00232535082599499,0.0597220344903933,0.0688374097282936,4.39423927043118e-166
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,29786,0.0490566938753142,0.00178292367282445,0.0455621634765783,0.0525512242740501,1.34543234514765e-164
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29545,-0.0548689689205984,0.00200254443496538,-0.0587939560131305,-0.0509439818280662,3.06024477086806e-163
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.158480865314039,0.00579349340071777,0.147125618248632,0.169836112379446,2.4255586124859e-162
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,29577,0.121115094911714,0.00443425508661111,0.112423954941956,0.129806234881472,3.03889924307892e-162
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MME,Neprilysin,29349,0.14791886055633,0.00545889439686008,0.137219427538484,0.158618293574176,9.96246945508962e-160
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,29349,0.0654328625377102,0.00242730783302112,0.0606753391849888,0.0701903858904316,4.00471370136556e-158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29478,0.0557935816268345,0.0020724870200768,0.051731507067484,0.059855656186185,1.0107887059527e-157
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28774,0.0964916857344611,0.00359471909129101,0.0894460363155307,0.103537335153391,8.81755281679881e-157
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,29820,0.0800948760056355,0.00299649864014906,0.0742217386709434,0.0859680133403277,1.46390700836714e-155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,29536,0.0603065689620735,0.00226273100301471,0.0558716161961647,0.0647415217279823,1.14778753823393e-154
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.0793745585283248,0.00298424118991186,0.0735254457960976,0.0852236712605521,5.10535136320633e-154
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,29683,0.0363646564503807,0.00136758905955124,0.0336841818936603,0.0390451310071012,5.61668757520085e-154
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,29426,0.152290922130051,0.0057291668766921,0.141061755051735,0.163520089208368,7.28951757562963e-154
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,24805,0.13007322310854,0.00490615913803464,0.120457151197992,0.139689295019088,9.44589312867658e-153
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,24381,0.0724259261641607,0.00274908757699908,0.0670377145132425,0.0778141378150789,7.50421717916597e-151
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.105508348074325,0.00402779525678398,0.0976138693710289,0.113402826777622,1.71470412739957e-149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.0605130867050498,0.00231130526375205,0.0559829283880957,0.0650432450220038,2.22297376213568e-149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.0837839289856747,0.00322250254143124,0.0774678240044695,0.09010003396688,2.41835762324871e-147
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0656921912843256,0.00256023689354519,0.060674126972977,0.0707102555956742,2.70877014872744e-143
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,29507,-0.0344842831987568,0.00134880656594468,-0.0371279440680084,-0.0318406223295052,1.29060724797176e-142
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,29349,0.0795328236279689,0.00311514607467828,0.0734271373215994,0.0856385099343383,3.19902698583347e-142
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0531619631630159,0.00209004180118823,-0.0572584450933449,-0.049065481232687,6.98139514271937e-141
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,29786,0.0522877854336827,0.00206560948846302,0.0482391908362951,0.0563363800310702,6.86596081250189e-140
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.136400985745553,0.00541739938866733,0.125782882943765,0.147019088547341,2.04778609479701e-138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29725,0.0631303768451791,0.0025152445391864,0.0582004975483738,0.0680602561419845,1.38380165397127e-137
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.0663689088623304,0.00264497086926642,0.0611847659585682,0.0715530517660926,1.61745613259443e-137
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0398544168203991,0.00159371732716079,0.036730730859164,0.0429781027816343,1.34784791123696e-136
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,29435,-0.0766151383875223,0.00307427039122135,-0.0826407083543161,-0.0705895684207284,1.11672183069564e-135
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29594,-0.0565275340676734,0.00226852499474422,-0.0609738430573721,-0.0520812250779748,1.18748673517616e-135
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29349,0.137922668725826,0.00553787299839117,0.127068437648979,0.148776899802673,1.66877509531955e-135
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,24329,0.063857821830239,0.00256809513665858,0.0588243553623882,0.0688912882980898,8.42512505072222e-135
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29434,0.0866875199664246,0.00349428688938208,0.0798387176632357,0.0935363222696135,1.76017288689398e-134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24938,0.0556482545899339,0.00224159961862023,0.0512547193374382,0.0600417898424295,2.05666892211358e-134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,29426,0.0777945428834806,0.0031617265763673,0.0715975587938007,0.0839915269731605,2.43339429833069e-132
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,29786,0.0575906758806807,0.00234293720205206,0.0529985189646586,0.0621828327967027,4.2413241435904e-132
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,29545,0.0304607952510033,0.00123951737906257,0.0280313411880407,0.032890249313966,5.00185552115603e-132
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,23787,-0.0726547931356425,0.00296857161147312,-0.0784731934941299,-0.0668363927771552,1.13873033580631e-130
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24579,0.0435800244044724,0.0017852051799294,0.0400810222518107,0.047079026557134,4.54954478995281e-130
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.0931543501400194,0.00382907227602311,0.0856493684790141,0.100659331801025,1.92147098857166e-129
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.0562467110994433,0.00233072613654012,0.0516784878718247,0.060814934327062,1.91661792720052e-127
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,29750,-0.0881862905812425,0.00368093663116109,-0.0954009263783182,-0.0809716547841668,1.19827012405173e-125
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0517367594682438,0.0021680699673455,0.0474873423322467,0.055986176604241,1.14565188783932e-124
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,29349,0.0912249324973954,0.00382760255205887,0.0837228314953601,0.0987270334994308,2.29308040447586e-124
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,29632,0.0786506911605282,0.0033002517251174,0.0721821977792981,0.0851191845417583,2.32646208622407e-124
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.0892866982084902,0.00376205265347111,0.0819130750076868,0.0966603214092936,2.46318402711613e-123
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.0560094140118684,0.00236337206839586,0.0513772047578125,0.0606416232659242,5.14691649128244e-123
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28553,0.162728522785566,0.00688902591624535,0.149226031989725,0.176231013581407,3.46244609304268e-122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,24240,0.0869603732157416,0.0036910062578328,0.0797260009503893,0.0941947454810939,2.29394664708537e-121
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.122620334292714,0.00520560896298527,0.112417340725263,0.132823327860166,2.36806187662889e-121
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,28797,0.122707572869167,0.00522307383907314,0.112470348144584,0.13294479759375,6.56352178466351e-121
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.0500389282006625,0.00214252170736507,0.045839585654227,0.054238270747098,1.47068943498719e-119
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,29581,0.0657777435545665,0.0028343141636185,0.0602224877938742,0.0713329993152588,4.34070905004967e-118
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29478,-0.0429239412659329,0.00185329724386846,-0.0465564038639151,-0.0392914786679507,1.27273529809092e-117
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.144510461376998,0.00626214856782925,0.132236650184053,0.156784272569944,9.01336168018647e-117
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,29694,0.0954434290021972,0.00414405812267721,0.0873210750817499,0.103565782922645,2.37228987346866e-116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REN,Renin,29478,0.119686531171991,0.00519666058837971,0.109501076418766,0.129871985925215,2.41091839023741e-116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,29544,0.0481481914093335,0.00209092537000543,0.0440499776841228,0.0522464051345441,2.63874887148621e-116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0659307995584781,0.00287338335913206,0.0602989681745793,0.0715626309423769,1.6648768752467e-115
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0594469363328253,0.00259190057971284,0.0543668111965881,0.0645270614690625,2.05484669310117e-115
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,29433,0.0465018886276991,0.00203696393189429,0.0425094393211863,0.0504943379342119,2.33243576935933e-114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,29443,-0.0417593699045517,0.00184097598209914,-0.045367682829466,-0.0381510569796374,6.10426033734228e-113
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELE,E-selectin,29820,0.0778553390579268,0.00343651013507985,0.0711197791931703,0.0845908989226832,1.1074741388301e-112
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29443,0.0661275799245803,0.00292030925393835,0.0604037737868612,0.0718513860622995,1.46560404002824e-112
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24845,-0.057085161321538,0.00251948069366113,-0.0620233434811138,-0.0521469791619622,1.62818821332459e-112
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.126017830503623,0.00560826770407061,0.115025625803644,0.137010035203601,7.34235467598404e-111
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,29693,0.0869434753148713,0.00387907070121201,0.0793404967404958,0.0945464538892469,2.39982484852306e-110
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.161237134185925,0.0072195535351379,0.147086809257055,0.175387459114796,1.43696296617985e-109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,29697,0.0402972678770239,0.00181441273521262,0.0367410189160072,0.0438535168380407,2.12573280026028e-108
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,29820,0.089509627956139,0.00403118673936277,0.081608501946988,0.0974107539652901,2.36491024281391e-108
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,24805,0.168060598528326,0.00759161108557452,0.153181040800599,0.182940156256052,1.51218769384376e-107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,29725,0.0431024126229921,0.00195179034148174,0.0392769035536879,0.0469279216922963,3.32214032163698e-107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,29702,-0.054049218463772,0.00244954555545829,-0.0588503277524702,-0.0492481091750737,4.97952717009501e-107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24888,-0.0738706352687174,0.00334702002678662,-0.0804307945212192,-0.0673104760162156,6.44503258851181e-107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0660303767753073,0.00299546445980323,0.0601592664340929,0.0719014871165216,8.38041162052936e-107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,-0.0390884231549984,0.00177590013315468,-0.0425691874159816,-0.0356076588940152,1.6188366628e-106
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,28764,0.0893582305700795,0.00406329244413936,0.0813941773795663,0.0973222837605926,2.61264612696993e-106
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,24922,0.0420013410989611,0.00194020212283879,0.0381985449381971,0.0458041372597252,5.66062436579944e-103
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.128266698030182,0.00593385963460903,0.116636333146348,0.139897062914016,8.05881033021907e-103
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,29581,-0.0637241362039652,0.00294837145742006,-0.0695029442605085,-0.0579453281474219,8.42041206227304e-103
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFM,Afamin,24966,0.0287860961389888,0.00133357234435025,0.0261722943440623,0.0313998979339153,2.11737749479735e-102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,29725,0.187988187498382,0.00873854405722767,0.170860641146216,0.205115733850549,7.12779142464653e-102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,29434,0.111553480373203,0.00518588870820546,0.10138913850512,0.121717822241286,7.49850347800214e-102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,24381,0.0423525268331916,0.00196838885809153,0.0384944846713322,0.046210568995051,9.69220822546884e-102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,24951,-0.0758434786534722,0.00353789321784489,-0.0827777493604482,-0.0689092079464962,4.88535993674458e-101
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,29443,-0.0548273687713348,0.00256233916934603,-0.059849553543253,-0.0498051839994166,8.29746413390934e-101
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,29604,0.086983813428443,0.00407896873620433,0.0789890347054825,0.0949785921514035,3.78481927280195e-100
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,24240,0.093005459891677,0.00439182270933813,0.0843974873813743,0.10161343240198,1.22130593657419e-98
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29115,0.0521184299566775,0.00247059629584914,0.0472760612168132,0.0569607986965418,4.75052005938192e-98
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0418620349109511,0.00198489897241721,0.0379716329250134,0.0457524368968889,5.1587949791228e-98
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.104735015316087,0.00496356294166173,0.0950064319504304,0.114463598681744,5.63994960528788e-98
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,29820,-0.0236367536782767,0.00112124355146723,-0.0258343910391525,-0.021439116317401,6.19457811438515e-98
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,29434,0.068666282777666,0.00326741403944254,0.0622621512603586,0.0750704142949733,2.46142630321309e-97
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29349,0.0514415582669816,0.00245424521885095,0.0466312376380337,0.0562518788959294,7.77110024643793e-97
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29566,0.031474925074208,0.00150708117205561,0.028521045976979,0.034428804171437,3.65821594979346e-96
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,29786,0.046758925751056,0.00224062613299665,0.0423672985303825,0.0511505529717294,5.02941938296034e-96
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.067588828663299,0.00323894053639353,0.0612405052119677,0.0739371521146304,7.29213743238605e-96
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,24867,0.0632244243501468,0.00303240112219705,0.0572809181506406,0.069167930549653,1.01451396365635e-95
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OCLN,Occludin,24867,0.0627113624150632,0.00300944025896605,0.0568128595074897,0.0686098653226366,1.28233190782372e-95
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0868838643621918,0.00417321608101059,-0.0950633678809726,-0.0787043608434111,1.97918888252764e-95
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.0807845048769982,0.00390274491050329,0.0731351248524117,0.0884338849015846,2.20723928086004e-94
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELN,Elastin,24922,0.0495206097698896,0.00240574124686126,0.0448053569260415,0.0542358626137376,2.27123129552074e-93
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.0807536713360327,0.00392917698834245,0.0730524844388815,0.0884548582331839,4.56874385760382e-93
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,29594,0.0750195662939825,0.00366205132652938,0.0678419456939849,0.0821971868939801,1.27155026513353e-92
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.0920909632209168,0.00451524968403778,0.0832410738402028,0.100940852601631,1.0290422519677e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,29443,0.0781088173369416,0.0038347786418343,0.0705926511989463,0.0856249834749368,1.36351739617347e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MENT,Protein MENT,24381,-0.0316919224050079,0.00155592008705062,-0.0347415257756271,-0.0286423190343887,1.83606508392789e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.0541260707074184,0.00266047156284956,0.0489115464442332,0.0593405949706035,2.23428450933571e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0474211466916298,0.00233156048687106,-0.0519910052458971,-0.0428512881373625,2.43540425367036e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.0776613222845556,0.00385270939656788,0.0701100118672825,0.0852126327018286,1.26660959544938e-89
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,29478,0.0362375266143405,0.00180252169505519,0.0327045840920324,0.0397704691366487,2.717947723056e-89
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,29725,-0.0228315833107096,0.00113572789928554,-0.0250576099933092,-0.0206055566281099,2.72786046332546e-89
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,29443,0.0322707675845195,0.00160655591200687,0.029121917996986,0.0354196171720529,3.80666650776141e-89
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.0681084313601603,0.00339316428144643,0.0614578293685253,0.0747590333517953,6.75577509114489e-89
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,29530,0.038804284178027,0.00193970642540926,0.0350024595842248,0.0426061087718291,1.91495714429519e-88
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0515387893591093,0.00258513315793468,0.0464719283695574,0.0566056503486613,7.46064449281179e-88
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POSTN,Periostin,24938,-0.0517073442276816,0.0025957769495853,-0.0567950670488688,-0.0466196214064944,1.3183662208305e-87
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,29725,0.0361523351479472,0.00181715346259916,0.0325907143612528,0.0397139559346415,1.67056712853873e-87
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,29433,0.0407972177598283,0.0020546668833757,0.036770070668412,0.0448243648512447,3.65456988175028e-87
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.057782574988793,0.00291671046799796,0.052065822471517,0.063499327506069,8.82086873123554e-87
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.0680155193680154,0.00343534172651785,0.0612822495840404,0.0747487891519904,1.12257433906704e-86
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24609,0.0430213492799461,0.00218636862283138,0.0387360667791966,0.0473066317806956,1.54343814671313e-85
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,29434,-0.0460769439641072,0.00234464642864162,-0.0506724509642448,-0.0414814369639696,1.96598379518256e-85
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.053159059605855,0.00270961534822787,0.0478482135233284,0.0584699056883816,3.76886732769188e-85
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0512284530048684,0.00261924031597595,0.0460947419855555,0.0563621640241813,1.18931148001898e-84
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29378,0.0907064314284738,0.00463948081307186,0.0816130490348529,0.0997998138220946,1.39777681195885e-84
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,28477,0.0536884909419075,0.00274920048501804,0.0483000579912721,0.0590769238925428,2.23304857414267e-84
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.0734176156540007,0.00376787004236776,0.0660325903709599,0.0808026409370415,5.14159142009457e-84
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,29694,0.04924243249813,0.00253166980144857,0.0442803596872908,0.0542045053089692,9.58510650496874e-84
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.109807042701432,0.00564827042732117,0.0987364326638823,0.120877652738981,1.20004262221923e-83
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,29443,0.0497276429668213,0.00256016172793024,0.044709725980078,0.0547455599535646,1.62607924293466e-83
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,29786,0.0600225573121285,0.00310162160718335,0.0539433789620491,0.0661017356622078,6.34507897241186e-83
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,29169,0.0406902185086763,0.00210362354912304,0.0365671163523952,0.0448133206649575,7.73774389663261e-83
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,24922,0.0350384994793827,0.00181220571922709,0.0314865762696976,0.0385904226890678,1.10743963078314e-82
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,29192,-0.0373715058044898,0.00193997046118907,-0.0411738479084204,-0.0335691637005592,3.4960345683847e-82
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,29604,0.0786812531618707,0.00408465058140741,0.0706753380223122,0.0866871683014293,3.52551499012558e-82
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.0393370879070975,0.00204276405554285,0.0353332703582336,0.0433409054559615,3.96799232546175e-82
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,29218,0.0475747342573752,0.00248060240426729,0.0427127535450114,0.0524367149697391,1.76930567364166e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,24381,0.0357280994964047,0.00187121848696516,0.032060511261953,0.0393956877308564,1.11151517108888e-80
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0257786533367214,0.00135367759434322,-0.0284318614216342,-0.0231254452518087,2.27822589299454e-80
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.0680608881059856,0.0035942091863665,0.0610162381007073,0.075105538111264,2.08681318417435e-79
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,29527,-0.05042298161405,0.00266524363381721,-0.0556468591363318,-0.0451991040917683,2.36108414545457e-79
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAST,Gastrin,24845,0.168758847280448,0.00893171617143618,0.151252683584433,0.186265010976463,4.55813619228076e-79
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,29545,0.0426910531235121,0.00226121156760983,0.0382590784509969,0.0471230277960274,4.89660140258169e-79
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,29487,0.0408217846622445,0.00216328901111601,0.0365817382004571,0.0450618311240319,5.85917963596754e-79
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29443,-0.034802363643053,0.00184470855482581,-0.0384179924105116,-0.0311867348755944,6.34679216036069e-79
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.0503915248540339,0.0026782938673795,-0.0556409808340978,-0.0451420688739701,1.65316299493184e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.0393358196714563,0.00209078425708073,0.0352378825275781,0.0434337568153345,1.67669754492496e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSN,Gelsolin,24845,-0.0246626494676947,0.00131091389941191,-0.0272320407105421,-0.0220932582248474,2.06339110690848e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.0315935103523729,0.00168718166534608,-0.0349003864164512,-0.0282866342882946,8.56726297061527e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29542,-0.0397077321752664,0.00212071583434706,-0.0438643352105867,-0.0355511291399462,8.95588306914373e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.0872551045947495,0.00467246508266706,0.078097073032722,0.0964131361567769,2.81509660962923e-77
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0350436105133566,0.00188828385038853,0.0313425741665951,0.0387446468601181,2.29581757583281e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,29218,-0.0431708940696915,0.00232830839818375,-0.0477343785301316,-0.0386074096092513,2.61024867779413e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0458297119828331,0.00247276318170992,0.0409830961466817,0.0506763278189846,2.99353696437635e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,29820,0.0770822393389563,0.00416232346414146,0.0689240853492391,0.0852403933286736,3.88172203131378e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,24914,-0.047395392646669,0.00257120229325808,-0.0524349491414549,-0.0423558361518832,2.26084024040471e-75
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,-0.0321614990215999,0.00174835654508873,-0.0355882778499738,-0.028734720193226,3.79254500108763e-75
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,28916,0.0674761710954275,0.00366875583784755,0.0602854096532463,0.0746669325376088,4.08067156903987e-75
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,29701,0.0300251644739981,0.00163446104188961,0.0268216208318945,0.0332287081161017,5.94241671694246e-75
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,28762,0.0399208714767843,0.0021771897183777,0.035653579628764,0.0441881633248046,1.14008323948742e-74
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,29497,0.0623922250807196,0.00340558375304926,0.055717280924743,0.0690671692366961,1.47206431009927e-74
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,29434,0.050127235951332,0.002748485566794,0.0447402042404157,0.0555142676622482,6.57387661380526e-74
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,24922,0.102011662840798,0.00560148090115353,0.0910327602745372,0.112990565407059,1.25671658034918e-73
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29218,0.0730213903639956,0.00403811932993754,0.0651066764773181,0.0809361042506732,1.08182770057348e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,24381,0.0790154650933681,0.00437654929622253,0.070437428472772,0.0875935017139643,2.16497424631084e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,29478,0.0784938049054478,0.00435089800436411,0.0699660448168942,0.0870215649940015,2.28563601921505e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,24914,0.0349485036021192,0.00193632309001946,0.0311533103456811,0.0387436968585574,2.32926873867938e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0342379228351253,0.00189996793777017,0.0305139856770958,0.0379618599931548,3.30635073793983e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PXN,Paxillin,28774,0.0634702701001349,0.00352731273628894,0.0565567371370085,0.0703838030632612,5.39952000563095e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,29725,0.0564893197560285,0.0031545795076958,0.0503063439209448,0.0626722955911123,2.46459747992923e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.0890403284775393,0.00497657562447985,0.0792862402535588,0.0987944167015199,3.28204659244442e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.0547868036686638,0.00306973897716069,0.0487701152734288,0.0608034920638987,8.61225163306176e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,29694,-0.0455971258869062,0.00255882748336001,-0.0506124277542918,-0.0405818240195206,1.16458680574392e-70
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.0757347948817785,0.00425941011530467,-0.0840832387077757,-0.0673863510557814,2.31368805482295e-70
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24229,0.150348810921331,0.00845518514257635,0.133776648041881,0.166920973800781,2.73622423220444e-70
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29173,0.0344443369969565,0.00194549653705206,0.0306311637843345,0.0382575102095785,8.95835967159651e-70
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,0.0496869447435482,0.00281081786810878,0.044177741722055,0.0551961477650414,1.44552781186471e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.0761263647979004,0.00430982753086019,0.0676791028374145,0.0845736267583864,1.82058994314046e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,29566,0.0484879836224433,0.00274657180345749,0.0431047028876666,0.0538712643572199,2.15496183248837e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTR,Transthyretin,24707,0.0307371864152606,0.00174193360644191,0.0273229965466344,0.0341513762838867,2.9379735708086e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,29434,0.0675437711432498,0.00383316488990607,0.0600307679590339,0.0750567743274657,3.86206235511623e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,29351,0.0385212102510388,0.0021871028944166,0.0342344885779822,0.0428079319240953,4.45185688369462e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29434,0.076767578682607,0.00436599464931343,0.0682102291699527,0.0853249281952614,7.47900943063777e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGRN,Agrin,29581,0.0414225782090542,0.0023567767874764,0.0368032957056004,0.0460418607125079,8.43519567927655e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,29480,-0.0631870718258727,0.00359671541701552,-0.0702366340432232,-0.0561375096085223,9.71699462273989e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,24653,0.0328882584156937,0.00187541145563699,0.0292124519626452,0.0365640648687422,1.96397363038681e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29581,0.0323677017144968,0.00185104146717458,0.0287396604388346,0.035995742990159,4.02209496127326e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0479863368265033,0.00274744994024609,0.042601334943621,0.0533713387093857,6.65446528646036e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,29468,-0.0460454923433012,0.00264582188311519,-0.051231303234207,-0.0408596814523954,1.70233131211771e-67
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,24381,0.0625481197577449,0.00359310213777486,0.0555056395677062,0.0695905999477837,1.84314960079859e-67
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.0465164152221533,0.00267514993198678,0.0412731213554592,0.0517597090888474,2.59437054118708e-67
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,29434,0.0646150737992931,0.00371846097860917,0.0573268902812191,0.0719032573173671,2.68170112512671e-67
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,24194,0.0329155018909807,0.00189337192921839,0.0292044929097127,0.0366265108722488,2.77116255636568e-67
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,29478,0.0421244818786075,0.00242652990912325,0.0373684832567259,0.0468804805004891,3.58298739924264e-67
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,29163,0.0737037560401486,0.00425210334028293,0.065369633493194,0.0820378785871031,5.7014671141752e-67
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,29566,0.0314179567502514,0.00181740827020815,0.0278558365406434,0.0349800769598594,1.24964751197182e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0521482793025328,0.00301946509596529,0.0462301277144408,0.0580664308906247,1.66878521645139e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,24905,-0.0408422855801912,0.00236610786478519,-0.0454798569951702,-0.0362047141652123,2.23885222750463e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.0647774766948631,0.00376522081070463,0.057397643905882,0.0721573094838441,5.27210220977379e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,24240,0.0710047146854391,0.00413832063544613,0.0628936062399647,0.0791158231309135,1.34123100995051e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,24938,0.0437745903079681,0.00255677162946584,0.038763317914215,0.0487858627017211,2.4462271813272e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,24805,0.114674825500073,0.00671297840856274,0.10151738781929,0.127832263180856,4.72008798576083e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,29786,0.0897773298009099,0.00526009673202735,0.0794675402061363,0.100087119395683,5.27323609215496e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0596375973333607,0.00349392172192471,0.0527895107583883,0.0664856839083331,5.2820168164708e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,24892,-0.0856291759133332,0.00503644642980586,-0.0955006109157527,-0.0757577409109138,1.83958287990544e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,24828,0.0359370976335007,0.00211504417301988,0.0317916110543818,0.0400825842126197,2.20882031956293e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,29683,0.0669786025579084,0.00395266448728119,0.0592313801628372,0.0747258249529795,4.18618267385063e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,29683,0.0398378640685087,0.00235534820752147,0.0352213815817667,0.0444543465552508,7.09872013114767e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,24229,0.0519228316195825,0.00307124951955813,0.0459031825612486,0.0579424806779164,9.42326551036699e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29478,0.0893067495984692,0.00528740154526984,0.0789434425697403,0.0996700566271981,1.05512177606602e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29434,0.042575679813008,0.00252226022744008,0.0376320497672254,0.0475193098587905,1.25990360243552e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29820,0.0404306688277549,0.00239940956599713,0.0357278260784005,0.0451335115771093,2.05499498626356e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,29725,0.0640031903283736,0.0038004944119226,0.0565542212810053,0.0714521593757418,2.41466002893271e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,29628,-0.0320869779150711,0.00190539432650009,-0.0358215507950113,-0.0283524050351309,2.44775567141103e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.0868363092501639,0.00515466045045196,0.0767331747672781,0.0969394437330498,2.51075933653022e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,29218,0.0599297576811232,0.00356866954861265,0.0529351653658424,0.066924349996404,5.39947539158526e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0411963806169505,0.00245532330167425,0.0363839469456689,0.046008814288232,6.99333712813971e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,24938,-0.0681761790640549,0.00406181956552245,-0.0761373454124789,-0.0602150127156309,7.00611751005126e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,29595,0.0781804478084692,0.00466056586865666,0.0690457387059022,0.0873151569110363,7.27932307434884e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24951,-0.0304998506870067,0.00182072433725173,-0.0340684703880201,-0.0269312309859933,1.21572951018355e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29434,0.0751744056521952,0.00449216911859322,0.0663697541797525,0.0839790571246379,1.43036686550438e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.0777448376430541,0.00464662067709477,0.0686374611159483,0.0868522141701598,1.5274181983046e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.0499921860287568,0.00299280661056704,0.0441262850720454,0.0558580869854682,2.37644271363305e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MLN,Promotilin,29434,0.101471736885764,0.00609423669087891,0.0895270329716417,0.113416440799887,5.77532799394865e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,0.0442415675800653,0.00267014569507736,0.0390080820177136,0.0494750531424169,2.21674410010175e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,24922,0.0642346376032477,0.00388040204651289,0.0566290495920825,0.071840225614413,3.20404139923142e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.0432278298840806,0.00261433607968045,-0.0483519286002543,-0.0381037311679069,3.87112116796269e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.068499838713295,0.00415246934364879,0.0603609987997433,0.0766386786268466,7.35322244937691e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24867,0.0656497053239137,0.00397863521888508,0.057851580294899,0.0734478303529285,7.662689744455e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24845,0.0534283656383412,0.00324724009666146,0.0470637750488847,0.0597929562277976,1.65656286302319e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,29725,0.0429757411857727,0.00261425564954021,0.0378518001126739,0.0480996822588715,1.86078504848338e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,24240,0.0361515942078441,0.00219813246930539,0.0318432545680056,0.0404599338476827,1.89036712152779e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.0310357676655981,0.00189115367867225,0.0273291064554005,0.0347424288757957,2.94751916847804e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,29434,0.0524762343064615,0.0032025011080098,0.0461993321347623,0.0587531364781607,4.44547924380076e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29694,0.0747649615665517,0.00456595202872771,0.0658156955902454,0.083714227542858,5.33861683505306e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.0469715425631443,0.00288944590122638,0.0413082285967406,0.052634856529548,3.64340849213679e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29349,0.0662163069574013,0.00408042667938972,0.0582186706657975,0.0742139432490052,5.79856974263896e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0774119967518305,0.00479254256906744,0.0680186133164583,0.0868053801872027,2.1995248375696e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.0576380710595864,0.00357282588551303,0.0506353323239808,0.0646408097951919,2.67711820797286e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,29652,0.0411485488294453,0.00255242621989552,0.0361457934384501,0.0461513042204405,3.1965993400842e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0316971476245135,0.00196644211564246,0.0278429210778543,0.0355513741711727,3.33081269242068e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASPN,Asporin,24922,-0.0305208580581479,0.00189321865633838,-0.0342315666245711,-0.0268101494917247,3.57128851643079e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0221491911179207,0.0013877851287501,0.0194291322655705,0.0248692499702709,4.21591802440096e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.0759203548603763,0.00476440736980113,0.0665821164155661,0.0852585933051865,6.95746842690447e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,29349,0.124186934612482,0.00779751907131011,0.108903797232714,0.13947007199225,7.1919393769459e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29454,0.102450269365904,0.00644834645469376,0.0898115103147045,0.115089028417104,1.32326418555151e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEP,Leptin,29478,0.0731206264568061,0.00460785175083151,0.0640892370251764,0.0821520158884359,1.78975818384905e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29349,0.134543319185471,0.00850870329427278,0.117866260728697,0.151220377642246,4.35651518366649e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24381,0.0822475522062643,0.0052017429005703,0.0720521361211465,0.092442968291382,4.92299898929117e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0303072301480054,0.00191804448788747,0.0265478629517459,0.0340665973442648,5.26183321495849e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,29725,-0.0498856626010693,0.0031629074728444,-0.0560849612478443,-0.0436863639542942,8.16042988644302e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0678061962351968,0.00430089105761331,0.0593764497622747,0.0762359427081189,9.99553901438485e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,29192,0.0398985756102971,0.0025408324689511,0.0349185439711529,0.0448786072494412,2.4336463155393e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28797,0.118534077530695,0.00755144877925437,0.103733237923357,0.133334917138034,2.69574254004028e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,29434,0.0353076277786884,0.0022496675315423,0.0308982794168655,0.0397169761405113,2.76138173772674e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,29786,0.0444183473712652,0.002831563474465,0.0388684829613138,0.0499682117812166,3.09725903567116e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0300613114919773,0.00191675377187754,0.0263044740990974,0.0338181488848573,3.2915901467682e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,24805,0.115186170822949,0.0073442874363486,0.100791367447705,0.129580974198192,3.59802289756192e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29349,0.0726490767826733,0.00464197098236427,0.0635508136572393,0.0817473399081072,5.50513696146243e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,29453,0.0341817890484516,0.00218620448418686,0.0298968282594453,0.0384667498374578,6.96978787167576e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,24381,0.0491809977461122,0.00315133953847797,0.0430043722506954,0.055357623241529,1.21178177996496e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.0362673169956986,0.00232500772141544,0.0317103018617243,0.0408243321296728,1.22720662185708e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,24229,0.0893933490189227,0.0057499405622041,0.0781234655170027,0.100663232520843,3.05875330153613e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24938,0.0248850721043462,0.00160134665572496,0.0217464326591253,0.0280237115495671,3.33711888906623e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.0778633201073121,0.00504454741354223,0.0679760071767693,0.0877506330378549,1.54633754918875e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,29536,0.0609184231187673,0.00395845030677431,0.0531598605174896,0.0686769857200449,3.10195442691821e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,29443,0.0340029654834455,0.00220987311526988,0.0296716141775166,0.0383343167893745,3.23401113402035e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.0629816599398657,0.00409197397381927,0.0549613909511799,0.0710019289285515,3.29138424628255e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,24381,-0.0549493982615623,0.00357015010306752,-0.0619468924635746,-0.0479519040595499,3.33152539569491e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,-0.0355930337403272,0.00231476379737564,-0.0401299707831834,-0.0310560966974709,3.78427093582969e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29333,-0.0664540043607433,0.00432199875771249,-0.0749251219258598,-0.0579828867956268,3.83943311203982e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,29786,0.0365352046306995,0.0023763000479683,0.0318776565366816,0.0411927527247173,3.86640469440845e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,29218,0.040255312359776,0.00261890198992655,0.0351222644595199,0.045388360260032,4.13322691792118e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,29349,0.0818982897369293,0.00532926152311289,0.071452937151628,0.0923436423222305,4.34501559493244e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0292974074661458,0.00190743616231223,0.0255588325880138,0.0330359823442777,4.9092614265188e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24229,0.0901454954618517,0.00587149790440621,0.0786373595692155,0.101653631354488,6.00239842270059e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,29478,-0.0391493895224381,0.00256120508132902,-0.044169351481843,-0.0341294275630332,1.51954802507877e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,24793,0.0467661273155434,0.00305887252975707,0.0407707371572195,0.0527615174738672,1.58071291003027e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,24240,0.063371699284181,0.00414833389717356,0.0552409648457208,0.0715024337226412,1.92853213536101e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,29218,0.0925898974591885,0.0060690832966664,0.0806944941977223,0.104485300720655,2.39162050844538e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_E,,29434,0.0303444975813598,0.00198981989589912,0.0264444505853975,0.034244544577322,2.615931789042e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,24805,0.105084347219561,0.00689002248780732,0.0915799031434582,0.118588791295663,2.77291366826019e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,29786,0.0568820868321028,0.00373427400302005,0.0495629097861835,0.0642012638780221,3.39062040460747e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,29820,-0.0285006012573205,0.0018713426822874,-0.0321684329146038,-0.0248327696000372,3.51499071325104e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29434,0.064210144388486,0.0042167849578769,0.0559452458710473,0.0724750429059247,3.68665320524204e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,29511,-0.0386491096462107,0.00254048390764658,-0.043628458105198,-0.0336697611872234,4.55252836977408e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,0.0288226410057253,0.00189885289670775,0.0251008893281781,0.0325443926832725,7.66214097396012e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,29694,0.0451450348460861,0.00297638532213268,0.0393113196147061,0.0509787500774662,9.04666029098464e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0317655317485158,0.00209850851139287,0.0276524550661858,0.0358786084308459,1.43568212730914e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,28990,-0.0311740651839672,0.00206035448033251,-0.0352123599654189,-0.0271357704025154,1.60589348579213e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD248,Endosialin,24938,-0.0417534937900396,0.0027642676229506,-0.0471714583310228,-0.0363355292490565,2.54440787002955e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,29566,0.0430654945444774,0.00285420020397019,0.0374712621446958,0.048659726944259,2.99506548733415e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,24820,0.112955271708625,0.00750582236618802,0.0982438598708965,0.127666683546354,5.88369925660791e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29594,-0.0312075461030699,0.00207574327017673,-0.0352760029126163,-0.0271390892935235,6.74104847955538e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.0736693862353364,0.00490079554425181,0.0640638269686029,0.0832749455020699,7.05777670884783e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.100280965368831,0.00667750337421261,0.0871930587553739,0.113368871982287,8.68300150496105e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,0.0376124992187941,0.00250675456661908,0.0326992602682207,0.0425257381693675,1.05759752118385e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,29566,0.0336789375987819,0.00224765482163998,0.0292735341483676,0.0380843410491963,1.43261991347931e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.0612932135620307,0.00409722591093764,0.0532626507765929,0.0693237763474684,2.23467711943473e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,29581,0.0415905874701564,0.00278612820925026,0.0361297761800259,0.0470513987602869,3.31566868083163e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29443,0.0544383288957263,0.00364675988730154,0.0472906795166153,0.0615859782748373,3.31598448733978e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,29265,0.0235382066078337,0.00157977884295522,0.0204418400756414,0.0266345731400259,5.05429524404689e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,24867,0.0542238792725653,0.00364150197217266,0.0470865354071069,0.0613612231380237,6.23667421515566e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,24922,0.0932772393132721,0.00627700602130329,0.0809743075115177,0.105580171115027,9.76948859240018e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,29495,0.0474325562387841,0.00319382392089706,0.0411726613538258,0.0536924511237423,1.03190037041929e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,29218,-0.0261779015298364,0.00176618306054272,-0.0296396203285001,-0.0227161827311726,1.6050387008836e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.0880088873095335,0.00594003807521291,0.0763664126821162,0.0996513619369508,1.87244373003122e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,24938,0.114849646957612,0.00775215466402703,0.0996554238161187,0.130043870099105,1.8975626804221e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29566,0.0926064731157048,0.00625775704762505,0.0803412693023597,0.10487167692905,2.24555997584763e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,29736,0.0509082015822587,0.00344474039046215,0.0441565104169528,0.0576598927475645,3.01503834095955e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24381,0.0231644237488283,0.00157339590359622,0.0200805677777797,0.0262482797198769,7.49007399790481e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,29820,0.0569532539987278,0.00387006999827497,0.0493679168021089,0.0645385911953467,7.51713985993856e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.0871212066722547,0.00593392840142142,0.0754907070054687,0.0987517063390407,1.26679046351251e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.0440558486906481,0.00300220688829063,-0.0499401741916977,-0.0381715231895984,1.39227248053828e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29278,0.0276993371900321,0.0018882519031589,0.0239983634598406,0.0314003109202235,1.50839815627522e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,29639,0.0581006663178154,0.00396286488471082,0.0503334511437822,0.0658678814918486,1.68806533497573e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.105357386287355,0.00718921811478155,0.0912665187823829,0.119448253792327,1.86081613466996e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0501283335171586,0.00342667652423522,0.0434120475296576,0.0568446195046596,2.70454946817683e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.0800574338857336,0.0054768373505039,0.0693228326787459,0.0907920350927212,3.44780422280193e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.0310704230041332,0.00212556641032314,0.0269043128398998,0.0352365331683665,3.48638262124247e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,29725,0.0647214534026408,0.00444781483678925,0.0560037363225338,0.0734391704827477,8.37207721799218e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.030475957152625,0.00209511508450722,0.0263695315869908,0.0345823827182591,9.0651027136549e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28797,0.0638038061590276,0.0043863889834075,0.0552064837515489,0.0724011285665063,9.16932272250191e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0365062865257026,0.00251114982595642,0.031584432866828,0.0414281401845771,1.11328844805095e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24229,0.0796211538929998,0.00547823343450986,0.0688838163613604,0.0903584914246391,1.16995157122584e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29301,0.025671021685448,0.00177329974438443,0.0221953541864545,0.0291466891844415,2.48894511774363e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,29786,0.0486918019369603,0.00337274184755813,0.0420812279157464,0.0553023759581743,4.37662455965095e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.0694865334890606,0.00481454192918438,0.0600500313078592,0.0789230356702619,4.70150030363339e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,29478,-0.0509300156985655,0.0035343621365358,-0.0578573654861757,-0.0440026659109554,6.47016242857529e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,24845,0.0374774803488083,0.00260428654344297,0.03237307872366,0.0425818819739565,9.13325457188252e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,29478,0.0671277844027159,0.00466992581664317,0.0579747298020953,0.0762808390033366,1.07682531596377e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24644,0.0314890896104327,0.00219150824460871,0.0271937334509996,0.0357844457698657,1.2562896275187e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0491549836375178,0.00342394647103592,0.0424440485542874,0.0558659187207482,1.39922793254717e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29404,0.019564592123586,0.00136578042464866,0.0168876624912746,0.0222415217558974,2.19398439336031e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EZR,Ezrin,29694,0.0235566916401662,0.00164623605929498,0.0203300689639481,0.0267833143163844,2.72514970882221e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,29434,0.0592980223010589,0.00414874220011338,0.0511664875888367,0.0674295570132811,3.45520280089602e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0382596263071661,0.00267785650298565,0.0330110275613142,0.043508225053018,4.02774092150172e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.0582322972359003,0.00409808572541994,0.0502000492140773,0.0662645452577234,1.13790034722282e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,29218,0.0515527525614847,0.00362901773980784,0.0444398777914613,0.0586656273315081,1.19893927977913e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,24919,0.054824906520963,0.00386213106022854,0.0472551296429151,0.062394683399011,1.47103083203465e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,24938,0.0246619297467,0.00174090730171286,0.0212497514353428,0.0280741080580572,2.22743405679386e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,24951,0.0237978226091434,0.00168143739456788,0.0205022053157903,0.0270934399024964,2.67081499358481e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,29725,0.0388917336824594,0.00275044799794473,0.0335008556064877,0.044282611758431,3.01306673722176e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,24922,0.0436457732065822,0.00308605489888167,0.0375971056047741,0.0496944408083903,3.09243726744186e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0198223761218042,0.00140593260006932,0.0170667482256683,0.02257800401794,5.37336520150885e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29566,-0.0409029521995041,0.00290274642180527,-0.0465923351862425,-0.0352135692127658,6.02279521997333e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29434,0.0551946687348995,0.00391704997657261,0.0475172507808172,0.0628720866889818,6.05261074176798e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASN,Vasorin,29065,-0.0265969760551106,0.00189207540634357,-0.030305443851544,-0.0228885082586772,9.77798297997748e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.028991927086601,0.00206205027554085,0.0249503085465409,0.0330335456266611,9.97185978453088e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,29434,0.0709468722610768,0.00504916599787353,0.0610505069052447,0.0808432376169089,1.0567028963384e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,29349,0.0503682165958875,0.00358797941779315,0.0433357769370129,0.0574006562547621,1.2720686549359e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,24229,0.0442362892550351,0.00316336014730366,0.0380361033663199,0.0504364751437503,2.90425366929589e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,29349,0.0694718555856314,0.00497711575381124,0.0597167087081614,0.0792270024631014,3.8796237537354e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.085422121919449,0.0061270999618776,0.0734130059941689,0.0974312378447291,4.89631373946452e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.0257897716124692,0.0018501764318611,0.0221634258060214,0.0294161174189169,5.05477365256195e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,28774,0.0616804081358984,0.00442735317873726,0.0530027959055734,0.0703580203662234,5.65413548567249e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.0810608470334304,0.00582242874320942,0.06964888669674,0.0924728073701209,6.85903829142247e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,24793,0.0950209590477694,0.00682575745343281,0.0816424744390411,0.108399443656498,6.91716874056109e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,29400,0.0875529074808248,0.00629782009787289,0.0752091800889939,0.0998966348726557,8.46812379963551e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,-0.0274882968700102,0.00198307883108293,-0.0313751313789327,-0.0236014623610876,1.48157721852437e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,29293,0.067564932952632,0.00487622773762808,0.058007526586881,0.0771223393183831,1.60637535267567e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27939,0.0380205817592554,0.00274500385210513,0.0326403742091293,0.0434007893093814,1.75161688929021e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.0774498602150444,0.00559343799335702,0.0664867217480646,0.0884129986820242,1.93719262895572e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,29581,0.063427584201851,0.00458274867595651,0.0544453967969762,0.0724097716067257,1.9835685971715e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFI,Complement factor I,24966,0.0189266738142879,0.00137121014213742,0.0162391019356986,0.0216142456928773,3.5287363703188e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.0547987918390818,0.00397198038453578,0.0470137102853916,0.0625838733927719,3.6483015645835e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANG,Angiogenin,29435,0.0319260231190811,0.00231567201142593,0.0273873059766863,0.0364647402614759,4.16014288813372e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,29674,0.0267310087482535,0.00194047650300288,0.0229276748023678,0.0305343426941391,4.85822601072549e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0385589523720351,0.00280012348076192,0.0330707103497417,0.0440471943943285,5.21198333485535e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,24557,0.0225831444183124,0.0016447741934647,0.0193593869991216,0.0258069018375033,9.62893266601484e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29820,0.0384563464057794,0.00280299883302238,0.0329624686930555,0.0439502241185033,1.04339640089584e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.0655651719134295,0.00477768622209648,0.0562009069181204,0.0749294369087386,1.06528062294875e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.0485636642696842,0.00354663477337669,0.0416122601138659,0.0555150684255025,1.52285541123528e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,29594,0.0289264049923881,0.00212260748250763,0.0247660943266731,0.033086715658103,3.67193986392243e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.0596973390045444,0.00439605073962199,0.0510810795548853,0.0683135984542035,7.10739910459374e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,28931,0.0441599314624138,0.00325558485072674,0.0377789851549893,0.0505408777698382,8.74617738619835e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.0459043857889496,0.00339563773274463,0.0392489358327701,0.0525598357451291,1.62582343938047e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,28797,0.0437091354360089,0.00323333842882597,0.03737179211551,0.0500464787565078,1.63389342751967e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.0784255603385324,0.00580237730863059,0.0670529008136164,0.0897982198634483,1.67307441545628e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0467565000229408,0.00345833501882395,0.0399781633860458,0.0535348366598357,1.68952893966416e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28797,0.0563717348616164,0.00417576340798979,0.0481872385819564,0.0645562311412764,2.09800099788961e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,28797,0.0583815034608565,0.00432533148889103,0.0499038537426301,0.0668591531790829,2.16014747493686e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,29786,-0.00822457818428516,0.00061048544071124,-0.00942112964807919,-0.00702802672049113,3.01217823263457e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28931,0.078677298052716,0.0058411103349314,0.0672287217962504,0.0901258743091815,3.14576702859757e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29434,0.0792538157586497,0.00588739351899055,0.0677145244614283,0.0907931070558712,3.48464724412803e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,28424,0.0846136913081291,0.0062957821351436,0.0722739583232477,0.0969534242930106,4.72197932804509e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,29319,0.0727585732172186,0.00541980368122614,0.0621357580020154,0.0833813884324218,5.73738174186e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GH1,Somatotropin,29433,-0.163409674532228,0.0121857981827873,-0.187293838970491,-0.139525510093965,6.98285972440465e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.0447829505432603,0.0033434510384069,0.0382297865079827,0.0513361145785378,8.64975515717465e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28774,0.046826354888365,0.00349879576166745,0.0399687151954968,0.0536839945812332,9.99030720609774e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0265844666856648,0.00198621349821989,0.0226914882291538,0.0304774451421758,1.03764649424398e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.073239140584856,0.00547385537611333,0.0625103840476739,0.0839678971220382,1.09865462861545e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,29349,0.0640526073377816,0.00478972116396642,0.0546647538564074,0.0734404608191558,1.14535942504609e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24101,0.0671239296019554,0.00501875701938479,0.0572871658439612,0.0769606933599496,1.1886005143898e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29286,0.0421264706504229,0.00315289609217559,0.0359467943097588,0.0483061469910871,1.34049321710532e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0179692942647837,0.00134502253012149,0.0153330501057456,0.0206055384238218,1.37395243194863e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,29218,0.0611687692956968,0.00458312768140334,0.0521858390401462,0.0701516995512473,1.63180045612814e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,29443,-0.0262562669688271,0.00196743848577502,-0.0301124464009462,-0.0224000875367081,1.65259268160535e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.0682061374065475,0.0051170543175969,0.0581767109440576,0.0782355638690374,2.17740549017675e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,29581,0.0608014654923299,0.00456402880580485,0.0518559690329524,0.0697469619517074,2.25822474874436e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28931,-0.0360583252836082,0.00271242526403359,-0.0413746788011141,-0.0307419717661024,3.30252370868943e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.0558366193137476,0.00420665558997377,0.047591574357399,0.0640816642700962,4.30793945278013e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,29443,0.0506821595742285,0.00381837474807693,0.0431981450679977,0.0581661740804593,4.31706680374396e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,28765,0.0360373301412483,0.00271562642235242,0.0307147023534375,0.041359957929059,4.51276953094638e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREH,Trehalase,24938,0.0683218069258693,0.00515175971545164,0.0582243578835841,0.0784192559681545,5.26590377521287e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,29786,0.0686807551930587,0.00518872361434444,0.0585108569089436,0.0788506534771738,6.99835809860573e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24229,-0.0295660007194,0.00223373826988271,-0.0339441277283701,-0.0251878737104298,7.4686555674651e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.0383069470699957,0.00290318363742885,0.0326167071406352,0.0439971869993563,1.21836223796592e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0254416916577836,0.00192880111433295,0.021661241473691,0.0292221418418761,1.29058478949326e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0211662523051684,0.00160872463555205,0.0180131520194864,0.0243193525908505,2.00050587895101e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.0879165375774529,0.0066840075840248,0.0748158827127643,0.101017192442141,2.10585260664294e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,29725,-0.0307495987540782,0.00233957540425279,-0.0353351665464136,-0.0261640309617427,2.39662056041553e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29434,0.0386538068866387,0.00294436989320775,0.0328828418959515,0.0444247718773259,2.93342155245992e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,28347,0.028444629758466,0.00216796764510412,0.0241954131740619,0.0326938463428701,3.27384275373388e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,24922,0.0616786641870565,0.00471074936245838,0.0524455954366381,0.0709117329374749,4.84825996412016e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24381,0.0364674413000807,0.00278688117856374,0.0310051541900958,0.0419297284100657,5.40262910104304e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.0950344850141721,0.00727750507032457,0.0807705750763359,0.109298394952008,7.27540466245657e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.0978272040008282,0.0075072653592742,0.0831129638966508,0.112541444105006,1.09351697030266e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,24240,0.0460229465773181,0.00353197011927488,0.0391002851435393,0.0529456080110968,1.10896440725281e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,29434,0.0814940707075786,0.00628407753405339,0.069177278740834,0.0938108626743232,2.35700149148201e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,29434,-0.041140111160693,0.00317955285170472,-0.0473720347500343,-0.0349081875713518,3.44890663420474e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.034305409084923,0.00265351303395405,0.0291045235383731,0.039506294631473,4.13619117062409e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,28797,0.0659403447405124,0.00510318333511192,0.0559381054036931,0.0759425840773318,4.35037777465103e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,29566,-0.0355571326182232,0.00275297399985684,-0.0409529616579426,-0.0301613035785038,4.64229257970119e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0262540708810054,0.00203296984294565,0.0222694499888319,0.0302386917731788,4.96230880033164e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.049870821722508,0.00386698852056378,0.042291524222203,0.057450119222813,5.96563574791341e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,0.0396536579142151,0.00307547330803235,0.0336257302304717,0.0456815855979585,6.18684107315074e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,29566,0.0473950405290893,0.00367874086947871,0.0401847084249111,0.0546053726332676,7.05211691846336e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.0863308099184222,0.00672002225259931,0.0731595663033276,0.0995020535335168,1.18138847849243e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0308034527692224,0.00240039153629143,-0.0355082201803536,-0.0260986853580913,1.35721131129595e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,29443,0.0394317878804076,0.00307334691764766,0.0334080279218182,0.0454555478389971,1.40021254100853e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,24752,0.0383723935019018,0.00299198078470049,0.0325081111638888,0.0442366758399147,1.56303952401458e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0450216831913702,0.0035194467023735,0.0381235676547181,0.0519197987280223,2.37776007611362e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,29343,0.0270925351385222,0.00211891057154083,0.0229394704183021,0.0312455998587422,2.46810870481065e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,28795,0.0435099566898423,0.00341501312149631,0.0368165309717096,0.0502033824079751,4.41929153328295e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAYN,Layilin,29163,0.0305741282092997,0.00240037248720518,0.0258693981343776,0.0352788582842218,4.61010467472327e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28774,0.074287386517055,0.00583754695045949,0.0628457944941544,0.0857289785399556,5.35068249478697e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.0371611128714025,0.00292027433769118,0.0314373751695278,0.0428848505732772,5.35590124895816e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29443,0.0307229877041862,0.00241574433559158,0.0259881288064267,0.0354578466019457,5.89156387475204e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24111,0.0545018743143579,0.0042942738106892,0.046085097645407,0.0629186509833087,8.61735913701591e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,24111,0.0591069542706415,0.0046576286873008,0.0499780020435319,0.068235906497751,8.77200667698425e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,29786,0.036483969304283,0.00288101542423345,0.0308371790727854,0.0421307595357805,1.17014689002834e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29478,0.0754411964660365,0.00596889588274859,0.0637421605358493,0.0871402323962238,1.59985784656015e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0469619502920392,0.00371645121329751,0.0396777059139761,0.0542461946701023,1.65951232745399e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,29434,0.0823654535072693,0.00652404622089844,0.0695783229143084,0.0951525841002303,1.91386423420472e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,29489,-0.0238186438140647,0.00188907274575555,-0.0275212263957456,-0.0201160612323839,2.3491133807808e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,24966,0.0269959422599635,0.00214347200916598,0.0227947371219982,0.0311971473979288,2.91937551536913e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,28774,0.0530927984261086,0.00421928969335419,0.0448229906271344,0.0613626062250828,3.24855958689134e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,29434,0.0337998388401677,0.00269683052515801,0.028514051010858,0.0390856266694774,6.07400251082083e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,24805,0.0730014568842822,0.00582625818765847,0.0615819908364716,0.0844209229320928,6.59590769553991e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,24445,0.111051409862155,0.00886800739383558,0.0936701153702375,0.128432704354073,7.22963047771351e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.0382194699110222,0.00305650897167957,0.0322287123265302,0.0442102274955142,9.10274672494975e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29820,0.057492782027756,0.00459922178521031,0.0484783073287437,0.0665072567267682,9.11646705995392e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,29566,0.0709650600266,0.00567911502577358,0.0598339945760838,0.0820961254771162,9.69182203376276e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,29454,0.0225827022733334,0.00181160887258854,0.0190319488830599,0.026133455663607,1.41531989677724e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDK,Midkine,29455,0.0434967976893642,0.0034894175391628,0.0366575393126051,0.0503360560661233,1.41892643700659e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,0.0258485920314711,0.00208056779450994,0.0217706791542317,0.0299265049087106,2.47302437516873e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28774,0.0484701605163336,0.00390550522473822,0.0408153702758467,0.0561249507568205,2.81457751779123e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0318496180314473,0.00256754998196852,0.026817220066789,0.0368820159961056,3.15418369807563e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29409,0.0392595479968579,0.0031721632553749,0.0330421080163231,0.0454769879773927,4.29689575855214e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,29478,0.0306578934435232,0.00247937533143372,0.0257983177939131,0.0355174690931333,4.92796399828611e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.0519665065616117,0.0042052814294113,0.0437241549599655,0.0602088581632578,5.44921345533796e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,29786,0.0318942841494689,0.00258506873162799,0.026827549435478,0.0369610188634597,6.89149364135168e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.0616597062618814,0.00499995864469143,0.0518597873182862,0.0714596252054767,7.74591076153211e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,23389,0.0207705875773455,0.0016857801797952,0.0174664584249469,0.0240747167297441,8.94737886861643e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,29349,0.0258285223553576,0.00209891877200084,0.021714641562236,0.0299424031484793,1.02898384126379e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29433,0.0629542077767464,0.0051225555079865,0.0529139989810929,0.0729944165724,1.25272417287361e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.0369844295121687,0.00301109878799413,-0.0428861831366372,-0.0310826758877002,1.36375306454051e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,29335,0.0387197436868169,0.00315580035802607,0.0325343749850858,0.044905112388548,1.60739258013159e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.0585081955149132,0.00476784979524412,0.0491632099162347,0.0678531811135917,1.62427528733042e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,29786,0.0792527750554754,0.00646784794415775,0.0665757930849262,0.0919297570260245,1.95167134823122e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24195,0.102066155167712,0.00832924328539069,0.0857408383283459,0.118391472007077,2.0243727811913e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.0201344818228968,0.00164467984573441,-0.0233580543205362,-0.0169109093252573,2.24105790864474e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.0724716598183282,0.00591996119815901,0.0608685358699365,0.0840747837667199,2.24905047842508e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29542,0.0430768124968137,0.00352563940754071,0.0361665592580339,0.0499870657355934,3.00861866527199e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29694,0.0802810897600249,0.00657613910077691,0.0673918571225022,0.0931703223975477,3.40592220323323e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.117395508089136,0.00963111270810306,0.0985185271812543,0.136272488997018,4.4433140315321e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.0645843807825045,0.00530220117944334,0.0541920664707956,0.0749766950942135,4.92464307559999e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,28705,0.0582132810228886,0.00478033823291915,0.048843818086367,0.0675827439594101,4.96212394991427e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,28835,0.0323276063433447,0.00265689562859139,0.0271200909113056,0.0375351217753839,5.61518849004717e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,29218,0.0349098661996017,0.00287203456455972,0.0292806784530646,0.0405390539461387,6.50926245124234e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0529161875423707,0.00435822142948485,0.0443740735405803,0.061458301544161,7.91205914534902e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,29725,0.0320196579477077,0.00263970658561261,0.026845833039907,0.0371934828555084,8.80425559875197e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,24381,0.0258229378228147,0.00213169969338058,0.0216448064237887,0.0300010692218406,1.11593983133924e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.0678891779968094,0.00561450242908047,0.0568847532358117,0.0788936027578071,1.40057641198062e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,29434,0.0695049288437507,0.00575037432001105,0.0582341951765291,0.0807756625109724,1.48555442051326e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24381,0.0344237536038128,0.00285447177115274,0.0288289889323534,0.0400185182752722,2.14936709093437e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0365497835850692,0.00303115706251336,0.030608715742543,0.0424908514275954,2.18921858378512e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.017759357575209,0.00147469035851347,-0.0206497506778954,-0.0148689644725226,2.54450180146205e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,24845,0.0523154392556946,0.00434497829036847,0.0437992818065724,0.0608315967048168,2.69683027798093e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29434,-0.0434875276762036,0.00361468209961761,-0.0505723045914541,-0.0364027507609531,2.93008489677801e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.0264715797594409,0.00220322838693117,0.0221532521210558,0.030789907397826,3.54758149622596e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0331105407924023,0.00276312854734596,-0.0385262727452004,-0.0276948088396042,5.20789249114631e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.0431415139019032,0.0036019553399456,-0.0502013463681966,-0.0360816814356099,5.57946313871124e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,28931,0.0362963793365887,0.00303228977506709,0.0303530913774572,0.0422396672957202,6.1084783107119e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29349,-0.0197410340202854,0.00164961723543778,-0.0229742838017435,-0.0165077842388274,6.30994300984683e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0431704738443585,0.00361349487730436,0.0360880238848419,0.050252923803875,8.32287827602082e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,29081,0.0296487335248914,0.00248619424651713,0.0247757928017178,0.034521674248065,1.04101711287472e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,29218,0.0280133289286676,0.00235160859384985,0.0234041760847219,0.0326224817726133,1.21396836674851e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.0216934363942717,0.00182173120761973,-0.0252640295612064,-0.0181228432273371,1.31600428724918e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,29169,0.03744314115589,0.00315012420081362,0.0312688977222953,0.0436173845894847,1.65902176083894e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,28797,0.0330636031212937,0.00278897740403539,0.0275972074093844,0.0385299988332031,2.40831955284687e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0466079224158685,0.00393347893130332,0.0388983037105139,0.054317541121223,2.58639202461116e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0306292818364991,0.00258899716278216,0.0255548473974461,0.0357037162755521,3.22031291394379e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.0623052326763594,0.00527077344996328,0.0519745167144313,0.0726359486382874,3.60223110994346e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.0218548205224874,0.00185108071899607,0.0182267023132551,0.0254829387317197,4.26482848532415e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.0915717509289719,0.0077714994501424,0.0763396120066928,0.106803889851251,5.82827742075611e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.0673820439535828,0.00572362602335617,0.0561637369478047,0.0786003509593609,6.5929017721119e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28774,0.063789527599559,0.00542644486259353,0.0531536956688756,0.0744253595302423,7.84393771568629e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,29478,0.0431651314559327,0.00367392872155394,0.0359642311616869,0.0503660317501784,8.4114296304466e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28797,0.0450022218942355,0.00383066516887041,0.0374941181632495,0.0525103256252215,8.55923873659418e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29536,0.0418714325977607,0.00357122256365593,0.034871836372995,0.0488710288225263,1.11999263017734e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.030243112076919,0.00258084758047652,0.025184650819185,0.035301573334653,1.20801227866325e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.0241581741648052,0.00206584110259822,0.0201091256037127,0.0282072227258977,1.60467458488938e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0310139854538868,0.00265798355540123,0.0258043376853004,0.0362236332224732,2.17039539035425e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,29227,0.0579208412854869,0.00497438500354532,0.0481710466785381,0.0676706358924357,2.89269331156624e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,24240,0.0592173786165609,0.00508642590239807,0.0492479838478607,0.0691867733852611,3.04430821567059e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.0828838777823339,0.00712169452917904,0.068925356505143,0.0968423990595248,3.08447020450218e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,24951,0.0221106941326442,0.00189988077529485,0.0183869278130663,0.0258344604522221,3.18346677087186e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.033792593235788,0.00290474128505476,-0.0394858861544953,-0.0280993003170806,3.25699586566404e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,24966,0.0243401380819283,0.00209271409123111,0.0202384184631153,0.0284418577007413,3.45543174008003e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.0577320150913393,0.00496974275933634,0.0479913192830401,0.0674727108996385,4.08176773061061e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.0788289323570043,0.00678925558744391,0.0655219914056143,0.0921358733083944,4.23664122548901e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,29443,-0.0205206505636062,0.00177410953029008,-0.0239979052429747,-0.0170433958842376,7.08570965103875e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0323888911072861,0.00280095622350738,0.0268990169092116,0.0378787653053605,7.56693434249024e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,29694,0.047034093029801,0.00406837028561979,0.0390600872699862,0.0550080987896158,7.57020413815884e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.0328238605212487,0.00284031027397869,0.0272568523842505,0.0383908686582469,8.0065618384372e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,24381,-0.0170748317413841,0.00147809124421432,-0.0199718905800442,-0.0141777729027241,8.68119949528955e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,29581,0.0376014003566451,0.00325592956548206,0.0312197784083003,0.04398302230499,8.73755455655481e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,29434,0.0725285812890252,0.00628443739316681,0.0602110839984182,0.0848460785796321,9.54945366173437e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29593,-0.0192112753203049,0.00166584674177479,-0.0224763349341835,-0.0159462157064263,1.05330529980716e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.034884800585451,0.0030252877609147,0.0289552365740582,0.0408143645968438,1.07220168676508e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,29474,-0.0172171474501446,0.00149465792065715,-0.0201466769746326,-0.0142876179256566,1.22932770150922e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,29434,0.0674593781115977,0.00586606998021523,0.0559618809503759,0.0789568752728196,1.53456096061409e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.045471876310526,0.00395595620977606,0.037718202139365,0.0532255504816871,1.63264600399176e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,24381,0.0339747530387278,0.00295529615320367,0.0281823725784486,0.039767133499007,1.65196290752825e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.0298703651551832,0.00259993483468537,0.0247744928791999,0.0349662374311666,1.74732345913323e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,29333,0.027026692094661,0.0023530641591427,0.0224146863427413,0.0316386978465807,1.80804936520315e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,29082,0.0371231977186103,0.00323277949308653,0.0307869499121607,0.0434594455250599,1.86060604957884e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,24229,0.0736959374648456,0.0064170972206323,0.0611184269124063,0.0862734480172849,1.897022101082e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,29383,0.0227460358711215,0.00198402759630985,0.0188573417823542,0.0266347299598888,2.30624048273662e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.02082841453206,0.0018180530778899,0.0172650304993958,0.0243917985647242,2.52986251211618e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0172616280159203,0.00150814789077242,0.0143056581500064,0.0202175978818343,2.95684569951977e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0361488262557597,0.00316113231808953,0.0299530069123043,0.0423446455992152,3.22313004428091e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RETN,Resistin,29362,0.0331557678105413,0.00289970858454697,0.0274723389848292,0.0388391966362533,3.2703207761042e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0310014511844286,0.00271217280488399,0.025685592486856,0.0363173098820012,3.40387644827689e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,24793,0.0167301436221483,0.00146506375326949,0.0138586186657401,0.0196016685785565,3.97965687617414e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29678,0.0213186775999342,0.00186732804262882,0.0176587146363818,0.0249786405634867,3.99028413087045e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0249722611257574,0.00218873942004155,0.0206823318624759,0.0292621903890388,4.33260037227378e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,29218,0.0407670431199406,0.00357467638424374,0.0337606774068228,0.0477734088330583,4.60262016620639e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29030,0.0228939922115584,0.00200805642665118,0.0189582016153221,0.0268297828077947,4.78588527792683e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,24867,0.0821680845786937,0.00721530794979358,0.0680260809970982,0.0963100881602891,5.69335436479049e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.0583767038109497,0.00513642381325368,0.0483093131369725,0.0684440944849269,7.41457691906226e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24805,0.0667465691695582,0.00587653390323785,0.055228562719212,0.0782645756199044,8.00640222781877e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,24804,0.0459810802239229,0.00405124369239144,0.0380406425868357,0.0539215178610101,8.79816664898313e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,29642,0.0316660822447533,0.00279886355483224,0.0261803096772821,0.0371518548122245,1.28819174087078e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.0264170959863099,0.00233526393161393,0.0218399786803465,0.0309942132922732,1.31390533049386e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,24610,-0.0844060938513204,0.00746284580395581,-0.0990332716270738,-0.069778916075567,1.3827914587077e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29454,-0.0266038636165757,0.00235442040427147,-0.0312185276089478,-0.0219891996242037,1.51761246310364e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,29030,0.0329912963921772,0.00292359530236026,0.0272610495995511,0.0387215431848033,1.80329273159179e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBIN,Erbin,29349,0.0793803601554155,0.00703559616402279,0.0655905916739308,0.0931701286369001,1.83796783412507e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COCH,Cochlin,24922,0.0359247407044261,0.00318716446990079,0.0296778983434205,0.0421715830654316,2.13320535204353e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,29694,0.044715758553112,0.00396999260848616,0.0369345730404792,0.0524969440657449,2.28117913634611e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORT1,Sortilin,29433,0.0287792943265359,0.0025585802105055,0.0237644771139451,0.0337941115391267,2.71436516397143e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0248990729621008,0.00221477950533461,0.020558105131645,0.0292400407925567,2.89780018052653e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0450642152954791,0.00400937051364597,0.037205849088733,0.0529225815022251,2.99502337362039e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,29435,0.0306105427867395,0.00272463419132044,0.0252702597717515,0.0359508258017276,3.15781590999949e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.088177267953944,0.00785452112824131,0.072782406542591,0.103572129365297,3.56221841834322e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.0487597087808432,0.00434517407638995,0.0402431675911189,0.0572762499705675,3.75569718042241e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,24240,0.0311199417157126,0.00277867279976858,0.0256737430281662,0.036566140403259,4.82910385456946e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,29434,0.062253583587153,0.00557360282299573,0.0513293220540814,0.0731778451202247,6.5851340198256e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.0270939984306722,0.00242535579733908,0.0223403010678876,0.0318476957934568,6.64292211574175e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0457163872042291,0.00409968953572216,0.0376809957142136,0.0537517786942445,8.26863700416725e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28797,0.0256565836738366,0.00230241774625664,0.0211438448911735,0.0301693224564996,8.84016235167999e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNST,Consortin,29478,0.0828754264521014,0.00744332218226693,0.0682865149748582,0.0974643379293446,9.75896216857968e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,29820,0.019079503366134,0.00171575691995544,0.0157166198030213,0.0224423869292467,1.1397521905907e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,29694,0.0263713626523965,0.00237501798402426,0.0217163274037089,0.031026397901084,1.37110860060837e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.0406115185504547,0.00367091063352387,0.0334165337087479,0.0478065033921615,2.15812050530882e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29491,0.0302292070544236,0.00273303399365635,0.0248724604268572,0.0355859536819901,2.21342016367304e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0247867756033214,0.00224178634247788,0.0203928743720648,0.0291806768345781,2.31071131371992e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24396,0.0495691916959018,0.00448703210770117,0.0407746087648075,0.0583637746269961,2.63962325066834e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,24966,-0.0231612470480405,0.00209717713988112,-0.0272717142422075,-0.0190507798538735,2.72529437462901e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELL,L-selectin,24966,-0.0176664730329111,0.00160067822103944,-0.0208038023461484,-0.0145291437196738,2.94967509960916e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28797,0.035717991123354,0.00323685734933022,0.0293737507186667,0.0420622315280412,2.95910818234852e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0289999156450975,0.00262835379794785,0.0238483422011197,0.0341514890890753,2.99294860049844e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,28774,0.0264163656478491,0.00239660461847929,0.0217190205956297,0.0311137107000685,3.39345334240167e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,29694,0.0458463233477301,0.00416044664585456,0.0376918479218551,0.054000798773605,3.4879363857633e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,24922,0.0236933209439153,0.00215674289941881,0.0194661048610544,0.0279205370267762,5.19266612512342e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,29135,0.0259278854144048,0.00236144472689825,0.0212994537496842,0.0305563170791253,5.43201854840013e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.0364518930041214,0.00332041738738595,0.0299438749248449,0.0429599110833978,5.64991477509856e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0398721319685458,0.00363249839375335,0.0327524351167892,0.0469918288203023,5.74795182813857e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,28797,0.0420780719792228,0.00384176599345416,0.0345482106320526,0.0496079333263929,7.31335155777719e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,29395,0.0623756880765117,0.00570296423763669,0.0511978781707438,0.0735534979822797,8.6377829614792e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24922,0.0257814084116287,0.00235754677281933,0.0211606167369028,0.0304022000863546,8.99927085107315e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0236537658430179,0.00216432551845801,0.0194116878268402,0.0278958438591956,9.69649138711017e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,29434,-0.0326960805018019,0.00299234105543454,-0.0385610689704536,-0.0268310920331502,9.72624896770715e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.0394259749807855,0.00360933870970053,0.0323516711097724,0.0465002788517985,1.01054502987439e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,28916,-0.0175927455781579,0.0016119950763807,-0.020752255927864,-0.0144332352284517,1.12338150274071e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,24922,0.0561435515980206,0.0051464293586911,0.0460565500549861,0.0662305531410552,1.20281043514245e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24805,0.0625515679861529,0.00573473628150611,0.0513114848744009,0.0737916510979049,1.22671682889507e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0189714465263865,0.00174343794865693,0.015554308147019,0.0223885849057541,1.62639478507727e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,29169,0.0382433312257023,0.00352307068175394,0.0313381126894645,0.04514854976194,2.12774554658069e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29349,0.102405765953157,0.00943993093199954,0.0839035013264377,0.120908030579876,2.29386268309934e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,29694,0.0390535301703899,0.00360467772467133,0.0319883618300341,0.0461186985107458,2.66855381571776e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,24966,0.0127604473794565,0.00117844670771743,0.0104506918323303,0.0150702029265826,2.91034165142045e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,24381,0.0378339239504705,0.00349679077475882,0.0309802140319433,0.0446876338689978,3.20528328317779e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,29820,-0.0223752678921475,0.00206874113462397,-0.0264300005160105,-0.0183205352682845,3.2522938680876e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.0804407276134257,0.00743605442381238,0.0658660609427535,0.095015394284098,3.26521931126064e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,-0.0212772572086512,0.00196745178838412,-0.0251334627138841,-0.0174210517034184,3.29751270138237e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0527923939334512,0.00488772860664072,0.0432124458644354,0.062372342002467,3.831560786281e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24845,0.0657571783673664,0.00608860965430631,0.053823503444926,0.0776908532898068,3.95348966498101e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29581,0.0927519259855024,0.00859250530402255,0.0759106155896182,0.109593236381387,4.10516642921574e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,24966,0.0265743693692892,0.00246642082198167,0.0217401845582051,0.0314085541803732,5.21085202538099e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.0708765242547169,0.00658453783714802,0.0579708300939067,0.083782218415527,5.72237462470748e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.0281633171089923,0.00261701851475215,0.0230339608200781,0.0332926733979065,5.85837793484919e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29497,-0.0176562180957976,0.00164411467455689,-0.0208786828579292,-0.0144337533336661,7.48228598936958e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.0491751424399853,0.00458383543636183,0.0401908249847161,0.0581594598952545,8.45664549574354e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,28870,0.0367497483988806,0.00343435714015162,0.0300184084041834,0.0434810883935778,1.13451388647217e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KAZN,Kazrin,24805,0.0768147492062704,0.00717928940996717,0.0627433419627348,0.0908861564498061,1.1701792354119e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,29594,0.0737469415759743,0.00690115818956618,0.0602206715244246,0.087273211627524,1.32133631833958e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.0694555051737525,0.00649956403937135,0.0567163596565846,0.0821946506909203,1.32309020987393e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.0171023793915535,0.00160194973534623,0.0139625579102749,0.0202422008728321,1.47616086812928e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,29353,0.0361448352922101,0.00338849055782122,0.0295033937988805,0.0427862767855397,1.62546812262527e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,29694,0.0165304872558363,0.00155097233431995,0.0134905814805692,0.0195703930311034,1.78385395482379e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28797,0.0290329935384831,0.00272421078601332,0.023693540397897,0.0343724466790692,1.80438238035364e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29443,0.0374335384179085,0.00351306326687362,0.0305479344148362,0.0443191424209808,1.83629245270893e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,29566,0.0416782072668341,0.00391145240601594,0.0340117605510429,0.0493446539826254,1.83734107761853e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,24229,0.0243435728789366,0.00228522420081841,0.0198645334453325,0.0288226123125407,1.94048648279611e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.0714056599306006,0.00670760039332479,0.058258763159684,0.0845525567015172,2.09366321978408e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28774,0.0423133646174344,0.0039773406400206,0.0345177769629941,0.0501089522718748,2.20629889504301e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.0506604022095088,0.00476775983513565,0.0413155929326429,0.0600052114863747,2.5331113281155e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NADK,NAD kinase,29478,0.0395072576223542,0.00371906308209693,0.0322178939814442,0.0467966212632642,2.60217177600283e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,29478,0.0415929508167485,0.00392133004981507,0.033907143919111,0.0492787577143861,3.08834375463098e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,28797,0.0445504415577472,0.00421380400953778,0.0362913856990532,0.0528094974164413,4.46248786947346e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.0581222519799796,0.00550734914039757,0.0473278476648004,0.0689166562951589,5.56898989693543e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24793,0.0210882876412909,0.0019996238563133,0.0171690248829169,0.025007550399665,6.00820757401973e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24883,-0.0107756227448762,0.00102246283020953,-0.0127796498920869,-0.00877159559766552,6.48379535413601e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24845,0.0215784350553512,0.00205224502474548,0.0175560348068501,0.0256008353038524,8.38819541520692e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,29446,0.0313367560552779,0.00298120178033388,0.0254936005658235,0.0371799115447323,8.50034454150254e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,28868,0.0275933414187915,0.00262895171761111,0.0224405960522737,0.0327460867853092,1.00328947495829e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0312259659994679,0.00297480929015858,0.0253953397907571,0.0370565922081787,1.01195319339164e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0457479850434047,0.00435984430817088,0.0372026901993898,0.0542932798874196,1.03235673424949e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NBN,Nibrin,28931,0.0378011236084251,0.0036064893924564,0.0307324043992105,0.0448698428176396,1.16909771194232e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,29434,0.0422366372862846,0.00403086523155977,0.0343361414324274,0.0501371331401417,1.2058869000274e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0301177097059793,0.00287386301276919,0.0244849382009517,0.035750481211007,1.20915503284536e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,24229,0.0253003434013916,0.00241496833512624,0.0205670054645442,0.030033681338239,1.25712403499718e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0454559636633898,0.00433929092288222,0.0369509534545406,0.0539609738722389,1.26691766764077e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,29349,0.0235159897170207,0.0022469823016711,0.0191119044057453,0.027920075028296,1.37904562914395e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0160348924677333,0.00153407088078628,0.0130281135413922,0.0190416713940744,1.61130829394299e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,29694,0.025900195401027,0.00248771622983824,0.021024271590544,0.0307761192115099,2.43652758817667e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,24793,0.0258566608549847,0.00248326297110302,0.0209894654316228,0.0307238562783467,2.4558766295023e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24805,0.0548532531586749,0.00528013609450774,0.0445041864134397,0.0652023199039101,3.14803371933295e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,24813,0.0532862821431279,0.00513087217298544,0.0432297726840764,0.0633427916021794,3.25420702045688e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.0539515808596179,0.00519980448349435,0.043759964071969,0.0641431976472669,3.53703680421062e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.0264159951846635,0.00254604897937325,0.0214257391850919,0.031406251184235,3.55110171716544e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,29694,0.0203512785837177,0.00196233303609663,0.0165051058329683,0.0241974513344671,3.71111839665625e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,24938,0.020104305811666,0.00193967941334033,0.016302534161519,0.0239060774618131,4.03416380397592e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,29434,0.058027921781796,0.00560218909507395,0.0470476311554511,0.069008212408141,4.24796339900502e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,29372,-0.0449681046805883,0.00434299283980404,-0.0534803706466042,-0.0364558387145724,4.42520794051781e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.0675591835530287,0.00652978698239297,0.0547608010675384,0.0803575660385189,4.79963196992403e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.0492266945400252,0.00475968742606267,0.0398977071849423,0.058555681895108,5.10765413707407e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.0478470406436145,0.00464195439471905,0.0387488100299651,0.0569452712572638,7.32954716311161e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,24101,0.0282704826714552,0.00274456618157093,0.0228911329555762,0.0336498323873342,7.89057961989548e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,24793,0.0588201566257058,0.00571254783221073,0.0476235628745728,0.0700167503768388,8.18591497231107e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.023550294535149,0.00228841344597443,0.0190650041810391,0.0280355848892588,8.51727631249453e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,24890,0.0331327890013784,0.00322032189399779,0.0268209580891427,0.0394446199136141,8.8882821798441e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,28753,-0.0327322433882144,0.00318191226534873,-0.038968791428298,-0.0264956953481309,8.9068990456897e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29820,-0.0176745188269155,0.00172030251758868,-0.0210463117613893,-0.0143027258924417,1.01414394741718e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,-0.0185850247135155,0.0018092257574396,-0.0221311071980971,-0.0150389422289339,1.05190697975412e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29673,0.0299093536144373,0.00291384696540721,0.0241982135622391,0.0356204936666354,1.11941906839164e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29349,0.0595127606285263,0.00579862142750311,0.0481474626306202,0.0708780586264324,1.13571550769881e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,29624,0.0478066821363547,0.00466574405916646,0.0386618237803885,0.056951540492321,1.35140685355394e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,23907,0.0501477598303582,0.00490322233681458,0.0405374440502017,0.0597580756105148,1.67726598905517e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.047524901040187,0.00465332777092805,0.038404378609168,0.0566454234712059,1.90157952945348e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0223470212713058,0.00218866345839372,-0.0266368016497575,-0.0180572408928541,1.95527650685825e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELP,P-selectin,29594,0.0398310829265477,0.00390532573006443,0.0321766444956214,0.047485521357474,2.19460033892094e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,29581,0.0738859238552784,0.00724930931198174,0.0596772776037942,0.0880945701067626,2.35895190709188e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,29218,0.0427598510534786,0.00419630431797019,0.034535094590257,0.0509846075167002,2.41676212231698e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,24565,0.0770036095668448,0.00755836321732445,0.0621892176608889,0.0918180014728007,2.51129981003835e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,24793,0.0277861990061355,0.00272791517693488,0.0224394852593431,0.0331329127529278,2.56050691107032e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.0776693282575263,0.00766332668574934,0.0626492079534576,0.092689448561595,4.22768064942176e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0406226018359072,0.00400897399824491,0.0327650127993471,0.0484801908724672,4.40568135444692e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28586,0.0267579619135411,0.00264355551919151,0.0215765930959257,0.0319393307311564,4.84712890233142e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,29443,-0.0202393820472029,0.00199993188893488,-0.0241592485495153,-0.0163195155448906,4.92962138543338e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,29694,0.054618738991801,0.00540837197201614,0.0440183299266493,0.0652191480569526,6.10575910875421e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.067568270944442,0.00670066539921159,0.0544349667619873,0.0807015751268967,7.12388208376137e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24381,0.0542417751259527,0.00538650813960398,0.0436842191723289,0.0647993310795765,8.35255038996458e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0220326793796997,0.00219182508332882,0.0177367022163752,0.0263286565430242,9.97324759069335e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,29443,-0.0197168300551828,0.00196366393942728,-0.0235656113764603,-0.0158680487339053,1.10072219198048e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24922,0.0502927177231569,0.00502541986943634,0.0404428947790616,0.0601425406672521,1.56251286562775e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0261668794985231,0.00261609928090932,0.0210393249079409,0.0312944340891054,1.65088453585959e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGRN,Neugrin,24845,0.0152355263722206,0.00152778173091069,0.0122410741796356,0.0182299785648055,2.22946633356457e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,29478,0.0831499553885844,0.00836482998857165,0.066754888610984,0.0995450221661848,3.02071552125865e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,24922,0.0562777669191912,0.00566092787974011,0.0451823482749006,0.0673731855634818,3.03657489659415e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BSG,Basigin,29760,0.0140263280800294,0.00141193803893269,0.0112589295237213,0.0167937266363375,3.21552716925087e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,28797,0.0669054978031087,0.00673775760447781,0.0536994928983322,0.0801115027078852,3.36142275037338e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,24951,0.0158504954601546,0.00159611352350761,0.0127221129540797,0.0189788779662296,3.3808630607045e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.0435153054936971,0.00438998799895258,0.0349109290157501,0.0521196819716442,4.05820770848571e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,24867,0.0533028915021896,0.00537738884332685,0.0427632093692689,0.0638425736351102,4.05851542231181e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.0522443306359897,0.00528623236863148,0.041883315193472,0.0626053460785074,5.44812524152678e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,24805,0.0481358676487296,0.00487309612588505,0.0385845992419949,0.0576871360554643,5.72478296656881e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29820,0.0151085404642215,0.00153108091334215,0.0121076218740709,0.0181094590543721,6.21956414419139e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,24867,0.0375626472857188,0.00381153091290895,0.0300920466964173,0.0450332478750203,7.1827420404372e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0389082707223211,0.00395366513505765,0.0311590870576081,0.0466574543870341,8.12969473320384e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,24381,0.0475516535727742,0.00483300425810169,0.0380789652268949,0.0570243419186536,8.43767445394933e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.0541639308429996,0.00551778576373309,0.0433490707460828,0.0649787909399165,1.05409479842797e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.0489325187223865,0.0049866993210023,0.039158588053222,0.058706449391551,1.07612034156705e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29079,-0.0256946644063108,0.00262034911904969,-0.0308305486796482,-0.0205587801329734,1.15249691489002e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,24801,0.0217333355528872,0.00221704028095351,0.0173879366022184,0.0260787345035561,1.20327749802846e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24938,-0.0145523390114616,0.00148507837008515,-0.0174630926168285,-0.0116415854060947,1.24885619385034e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0319038074990226,0.00325745647570683,0.0255191928066372,0.0382884221914079,1.31199990499158e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,29349,0.0496928754152708,0.00507647882043376,0.0397429769272206,0.059642773903321,1.36151423731205e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0528567482599463,0.00540144637413946,-0.0634435831532597,-0.042269913366633,1.40439192746037e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.0347946212451842,0.00355945557304114,0.0278180883220236,0.0417711541683449,1.55877622551912e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0324105930408089,0.00331566775512978,0.0259118842407545,0.0389093018408633,1.58316307312598e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29566,0.0225446350164332,0.00230718096147072,0.0180225603319506,0.0270667097009158,1.61411692211527e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,24938,0.0274791103789838,0.00281175823569607,0.0219680642370196,0.0329901565209481,1.61505008364128e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0294288620751311,0.00301164205548559,0.0235260436463794,0.0353316805038829,1.639126129151e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,29434,0.0228230400942425,0.00233733274866124,0.0182418679068665,0.0274042122816185,1.72877696350936e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29349,-0.0440954084139776,0.00452288446678087,-0.0529602619688681,-0.0352305548590871,2.00703736783833e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,29345,0.028880987845657,0.00296443778010772,0.0230706897966459,0.0346912858946682,2.14801708102587e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,28916,0.0387785288604066,0.00398262855989422,0.0309725768830139,0.0465844808377993,2.27116659455383e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TF,Serotransferrin,24966,0.0145067196760633,0.00149100928346792,0.0115843414804662,0.0174290978716604,2.47400459939368e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,29478,-0.02079379211669,0.00213775641665854,-0.0249837946933407,-0.0166037895400392,2.50114976988155e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24867,0.0423739091914097,0.00435806899143161,0.0338320939682037,0.0509157244146156,2.63416006844098e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,29786,0.0376152471008979,0.0038705673732996,0.0300289350492307,0.0452015591525651,2.71994842296524e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.0357318975235129,0.00367700139853033,0.0285249747823935,0.0429388202646324,2.78198527298684e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.034749445937881,0.00357674490489493,0.0277390259242869,0.041759865951475,2.80050082132622e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,29498,0.0435110986843175,0.0044835486525987,0.034723343325224,0.0522988540434109,3.11123854864092e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.0446578451916073,0.00461068473145514,0.0356209031179553,0.0536947872652594,3.74835600945499e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,24381,0.0200408324849103,0.00207144006161746,0.0159808099641401,0.0241008550056806,4.22716499297629e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.0515884778060042,0.00534117340219096,0.0411197779377099,0.0620571776742985,4.93965442450619e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,-0.0176425488821805,0.00182873513005348,-0.0212268697370853,-0.0140582280272757,5.43550134436794e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,28654,0.0468088704592753,0.00485338411572418,0.0372962375924559,0.0563215033260948,5.59674708469869e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,24867,-0.030870111887431,0.00320776288199256,-0.0371573271361364,-0.0245828966387255,6.94323375295467e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,29820,0.0368463804379025,0.00382949830710916,0.0293405637559685,0.0443521971198364,6.96582119978605e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29518,-0.0235821644045319,0.00245104340215217,-0.0283862094727501,-0.0187781193363136,7.00147516001211e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23906,0.0354968602493242,0.00368883007167093,0.0282667533088492,0.0427269671897992,7.01979202523478e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24805,-0.0198629503409173,0.00206592857192326,-0.0239121703418869,-0.0158137303399477,7.57910677053991e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29390,0.0151972565760479,0.00158242181491617,0.0120957098188122,0.0182988033332836,8.29550695554913e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,29443,0.0256778824735331,0.00267458154996148,0.0204357026356086,0.0309200623114576,8.54575395715671e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,0.0224263350155473,0.00233778237266728,0.0178442815651194,0.0270083884659751,9.20636128761039e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGN,Mimecan,29443,0.0277701006852713,0.0028956389169381,0.0220946484080726,0.0334455529624699,9.44882935110061e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPSE,Heparanase,24688,0.0620416634500001,0.00647057438896231,0.049359337647634,0.0747239892523663,9.77360071298899e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,29581,0.050727037123594,0.00529546014244695,0.040347935244398,0.06110613900279,1.0501617121739e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29457,0.0638621686496622,0.00666800207298825,0.0507928845866052,0.0769314527127191,1.07031071002488e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,29478,0.0280529415706204,0.00293030831678312,0.0223095372697254,0.0337963458715153,1.1127016357155e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0293012461576099,0.00306394336034966,0.0232959171713246,0.0353065751438952,1.2289344035421e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,29786,0.0304821709002396,0.00318854275618558,0.0242326270981159,0.0367317147023633,1.26601169220022e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0294541189662869,0.00308073114432292,0.023415885923414,0.0354923520091598,1.27642817485353e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,24240,-0.0426951301914266,0.00446912149250189,-0.0514546083167303,-0.0339356520661229,1.37052232343249e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,29478,0.0160002996490536,0.00167539801570053,0.0127165195382806,0.0192840797598266,1.39175621112108e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,29079,0.0249177535312786,0.00261301012586148,0.0197962536845902,0.0300392533779671,1.59563153551037e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,24111,0.0502981986430622,0.00527599231625709,0.0399572537031983,0.0606391435829261,1.66093224518938e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.0180416151591307,0.00189359764404491,0.0143301637768027,0.0217530665414588,1.72577808424719e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.0673702163608919,0.00707407567749754,0.0535050280329967,0.0812354046887871,1.79677319032944e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,24229,0.037075797606169,0.00389610678022809,0.0294394283169219,0.044712166895416,1.95981288411311e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,24793,0.0412056162161795,0.00433147297804514,0.032715929179211,0.049695303253148,2.01382958191187e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24867,0.0473999809942381,0.00498916586819965,0.0376212158925668,0.0571787460959094,2.26909408049763e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0196378262541932,0.00206755857883859,0.0155854114396696,0.0236902410687169,2.29427711120899e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.059015628986545,0.00622614447697743,0.0468123858116692,0.0712188721614208,2.79771404895633e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29349,0.0675229367498876,0.00712588667176097,0.0535561988732361,0.0814896746265391,2.84150202424012e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,24805,0.0449102547945151,0.00473941271787352,0.035621005867483,0.0541995037215472,2.87301563433649e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0425021524163761,0.0044907742784904,0.0337002348305349,0.0513040700022173,3.16783804957836e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,28774,0.0465468635147741,0.00491904543136423,0.0369055344693002,0.0561881925602479,3.22572623795319e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29434,0.0327381579477697,0.00346271027863243,0.0259512458016501,0.0395250700938892,3.47883829390758e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,29674,0.0372869925198411,0.00394482182277419,0.0295551417472037,0.0450188432924785,3.5557395043246e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.0405747973989815,0.00429191894938204,0.0321626362581927,0.0489869585397703,3.5567659729864e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0323336240981205,0.00342219028183545,0.025626131145723,0.039041117050518,3.75459528173245e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.0587649895473012,0.00622139773605483,0.0465710499846337,0.0709589291099686,3.8417533342126e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,29349,0.0877485626452891,0.00929323357534704,0.0695338248376089,0.105963300452969,3.91156883624433e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,29163,0.0518884168010804,0.00550722931891254,0.0410942473360118,0.0626825862661489,4.74747351395415e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,29694,0.0172821176269205,0.00183570904572497,0.0136841278972996,0.0208801073565415,5.08978225706262e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,24240,0.039646303035192,0.00423003984375093,0.0313554249414402,0.0479371811289439,7.67855564382723e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.0600301041456779,0.00642319788632116,0.0474406362884884,0.0726195720028673,9.75259576782016e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.0424324800322334,0.00454003214213261,0.0335340170336535,0.0513309430308133,9.81670429354318e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,24229,0.035284951863276,0.00377714095381079,0.0278817555938068,0.0426881481327451,1.02709577508974e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,28719,0.0295061323642001,0.00316424243144815,0.0233042171985617,0.0357080475298384,1.18852112573082e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.0381310553661278,0.00409404533187768,0.0301067265156476,0.0461553842166081,1.33530416463322e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.0369558086084042,0.00397307184061582,0.0291685878007972,0.0447430294160112,1.47742658822218e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24922,0.0324823598848489,0.00349495560285362,0.0256322469032558,0.039332472866442,1.60295841560291e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,29214,-0.021534538162075,0.00231776303289822,-0.0260773537065555,-0.0169917226175945,1.63000323060693e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPTC,Opticin,29349,-0.0288406029767055,0.00310946557060243,-0.0349351554950863,-0.0227460504583248,1.8925787999911e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,29453,0.0490437422888376,0.00529534774226112,0.0386648607140058,0.0594226238636694,2.14528426235507e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,24888,0.0283883860296593,0.00306518750694892,0.0223806185160394,0.0343961535432792,2.17285799995506e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,29349,0.0599836225343368,0.0064895689009525,0.0472640674884699,0.0727031775802038,2.55204500268685e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,-0.0208445772455921,0.00225814945227797,-0.0252705501720569,-0.0164186043191273,2.89305565534028e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.0460353174517165,0.00499027933283499,0.0362543699593599,0.0558162649440731,3.06093427356231e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,24845,0.0477184225863504,0.0051942878831593,0.0375376183353582,0.0578992268373426,4.35811974144561e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24229,0.0313883710757907,0.00341685239303131,0.0246913403854493,0.0380854017661321,4.38122348866835e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.0650770259755544,0.00709075006458201,0.0511791558489737,0.0789748961021352,4.74433816876637e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.0288855787928195,0.0031480919445643,-0.0350558390041655,-0.0227153185814734,4.77388362422377e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0253025711801727,0.00276258266265443,0.01988790916137,0.0307172331989753,5.63037716227294e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,24845,0.0240932707688459,0.00263209158104757,0.0189343712699927,0.0292521702676992,5.91573968439959e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24229,0.048920785780495,0.00535094311354966,0.0384329372779376,0.0594086342830523,6.57148909303234e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.0169189194249567,0.00185187220534154,0.0132892499024873,0.0205485889474261,6.87612717197788e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,29694,0.0770253318636986,0.00844492204157218,0.0604732846622172,0.0935773790651801,7.90729571913534e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.0217021195506428,0.00238039982753632,0.0170365358886717,0.026367703212614,8.20182103427369e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,29466,0.0332345742842302,0.00365046211557047,0.0260796685377121,0.0403894800307483,9.22333420739239e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,29163,-0.0303624833826311,0.0033386847997793,-0.0369063055901985,-0.0238186611750637,1.01224822325825e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0206803964454457,0.00227651281808348,-0.0251423615688893,-0.0162184313220021,1.11971763225204e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.0404892780342293,0.00445790034165167,0.0317517933645921,0.0492267627038666,1.13723739604644e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.0679408495536239,0.00748094717612498,0.053278193088419,0.0826035060188289,1.14495129184669e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0279089087935445,0.00307704966584629,0.0218778914484858,0.0339399261386033,1.26219504997962e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,24966,-0.0172025396320956,0.00189647042261367,-0.0209196216604184,-0.0134854576037728,1.26604629736725e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0351862261298512,0.00388085036002194,0.0275797594242082,0.0427926928354942,1.31745623570632e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,24922,0.0186250424459485,0.00205433928999982,0.0145985374375489,0.0226515474543482,1.32088591018344e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,29536,0.0186434549149961,0.00206193299413272,0.014602066246496,0.0226848435834962,1.63389106510374e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,24240,0.0428382536740266,0.00473852478867952,0.0335507450882148,0.0521257622598385,1.67463060426543e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29433,0.0300684423971599,0.00332694223144955,0.0235476356235188,0.036589249170801,1.69302812329323e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.0392799082139481,0.00435163101075467,0.0307507114328689,0.0478091049950272,1.88049717144459e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0338147275826875,0.0037487179879113,0.0264672403263813,0.0411622148389936,2.01011244739206e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29566,-0.0179589693298486,0.00199150757899383,-0.0218623241846765,-0.0140556144750207,2.03247187533809e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,29581,0.0263286908140286,0.00292154278118913,0.0206024669628979,0.0320549146651593,2.14376209018304e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.0258926536092471,0.00287368589836674,0.0202602292484483,0.0315250779700459,2.17780635030007e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,24951,0.0442962126649064,0.00491661443643087,0.0346596483695019,0.0539327769603109,2.21468977399769e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,29786,0.0290581020155272,0.00322617026575423,0.0227348082946489,0.0353813957364055,2.24092173754788e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0208160450004997,0.00231276643518815,0.0162830227875309,0.0253490672134684,2.3775479281712e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,24867,0.0340183933984966,0.00378760607846024,0.0265946854847145,0.0414421013122786,2.8558164255645e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24867,0.0470483363149561,0.00524389132826616,0.0367703093115544,0.0573263633183578,3.11169158552826e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,29498,0.0571904812317801,0.0063964813363354,0.0446533778125627,0.0697275846509975,4.07911430190291e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,0.023608194204257,0.00264076343613688,0.0184322978694287,0.0287840905390853,4.11494249050658e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,23498,0.0761151907535765,0.00851891429727191,0.0594181187309235,0.0928122627762294,4.37037354388159e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29786,0.0412266517806612,0.00462859470205073,0.0321546061646417,0.0502986973966806,5.53716480159453e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.034021504184249,0.00381969159622667,0.0265349086556448,0.0415080997128533,5.54094378138582e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,24111,0.0293195991208144,0.00329403652994178,0.0228632875221285,0.0357759107195003,5.92581084997289e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,24111,0.0408186630662172,0.00458615086722613,0.031829807366454,0.0498075187659804,5.94676492528501e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.0627631570235672,0.0070699362631539,0.0489060819477856,0.0766202320993489,7.29236761755534e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0348818053100967,0.00393673635640066,0.0271658020515514,0.042597808568642,8.40752228412633e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFH,Complement factor H,23693,0.0143390162566562,0.00161839260404412,0.0111669667527298,0.0175110657605827,8.54942684033287e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,24845,0.0170788636736023,0.00193088220050049,0.0132943345606214,0.0208633927865833,9.73907639062005e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,28797,0.058666597192286,0.00663358015216656,0.0456647800940396,0.0716684142905325,9.76169353444356e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,24195,0.0297752687260362,0.00336649679464105,0.0231769350085397,0.0363736024435326,9.80126401588317e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29434,0.0289421804644136,0.00328392634943069,0.0225056848195294,0.0353786761092977,1.28079908949831e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,28931,0.0689492021878467,0.00782717312892688,0.05360794285515,0.0842904615205434,1.33234923352671e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29581,0.0518323113480928,0.00588449152416227,0.0402987079607348,0.0633659147354509,1.33865999312711e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,0.0404670954926964,0.00459491451311703,0.031461063046987,0.0494731279384058,1.35546497079393e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,24793,0.0292316205622878,0.00332029169101698,0.0227238488478945,0.0357393922766811,1.40560271714046e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,28774,0.0407792130748824,0.00464702974588601,0.0316710347729459,0.049887391376819,1.79641917184022e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,29736,0.0166936092709801,0.00190238126403502,0.0129649419934714,0.0204222765484887,1.79679918305961e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.0427221316623133,0.00487119082172533,0.0331745976517316,0.0522696656728949,1.87460693149748e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,29169,0.0316231055203529,0.00360673171987967,0.0245539113493887,0.038692299691317,1.91893939196324e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0216681790711309,0.00247869894355033,0.0168099291417723,0.0265264290004896,2.44131187025511e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0459453175270744,0.00526794140102305,0.0356201523810692,0.0562704826730796,2.9097329768631e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,29760,0.0314848170737966,0.00361728036468342,0.0243949475590171,0.0385746865885761,3.36611232569064e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28916,0.043541841048746,0.00501421796811622,0.0337139738312382,0.0533697082662538,4.029862546614e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,29443,-0.0143563497156951,0.00165564248630245,-0.0176014089888479,-0.0111112904425423,4.49295784437773e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.04668576945515,0.00538423650050675,0.0361326659141568,0.0572388729961432,4.50810176170501e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.0430441894898331,0.0049722635005596,0.0332985530287363,0.0527898259509299,5.09244008719751e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0202129014178714,0.00233550495399577,0.0156353117080397,0.0247904911277031,5.19032712197004e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.0372570786747316,0.00431525002700788,0.0287991886217961,0.045714968727667,6.29354236073741e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,24732,0.0277201251249233,0.00321351485002154,0.0214216360188811,0.0340186142309655,6.72240890050912e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.0196821602898961,0.00229246770656498,0.0151889235850287,0.0241753969947634,9.58167881161285e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0432119804141149,0.00503984343450366,0.0333338872824877,0.0530900735457421,1.04697705478465e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,29820,0.0249825364233621,0.00291434798553889,0.0192704143717058,0.0306946584750183,1.06301210494396e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,24805,0.0399259877895517,0.0046587756194985,0.0307947875753347,0.0490571880037688,1.09362104309746e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.0170512504532542,0.00199408550850282,0.0131428428565887,0.0209596580499197,1.27901940188701e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,29725,0.0648929390755663,0.00758990812959103,0.0500167191415678,0.0797691590095647,1.29011365521998e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,0.0167154381789456,0.00195594917678752,0.0128817777924421,0.0205490985654492,1.34714040659107e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,24966,0.0245026925521018,0.0028679429656829,0.0188815243393633,0.0301238607648403,1.37367035029554e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,29349,0.0527652874373992,0.00617799924132089,0.0406564089244103,0.0648741659503882,1.39596039496852e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,24951,0.0376321182462679,0.00440862422919985,0.0289912147570362,0.0462730217354996,1.46712401129796e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.0658131588226208,0.0077128213138676,0.0506960290474403,0.0809302885978013,1.49401862701999e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,29640,0.0424178060120102,0.00497958400188013,0.0326578213683252,0.0521777906556953,1.69398785408533e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,24845,0.0362691814825685,0.00425734121341019,0.0279247927042846,0.0446135702608525,1.69623874910754e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,29443,0.0146166610002495,0.00171976136954703,0.0112459287159373,0.0179873932845616,1.99718098984046e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24240,0.0141070579147145,0.00165968613988182,0.0108540730805462,0.0173600427488829,2.0064317404248e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,24240,0.017856961328265,0.00210153170671649,0.0137379591831007,0.0219759634734293,2.05380519134875e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,29322,0.0491771759505668,0.00579141962176704,0.0378259934919034,0.0605283584092302,2.1369248314964e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0223859977568983,0.00263713567761224,0.0172172118287783,0.0275547836850183,2.18761860049065e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,29786,0.0512218703433111,0.0060343327415023,0.0393945781699666,0.0630491625166556,2.19071641463419e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.0546724352056221,0.00644717919985259,0.042035963973911,0.0673089064373332,2.37422601871284e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,28774,0.0479272795250122,0.00565662570833367,0.0368402931366782,0.0590142659133462,2.5089948135042e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,24195,0.0264920639254807,0.00313079477576334,0.0203557061649846,0.0326284216859769,2.78064968613838e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,29674,0.0179713698442291,0.00212729626385654,0.0138018691670703,0.0221408705213879,3.09719163675115e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,24381,-0.0166457985412571,0.00197257003171466,-0.0205120358034178,-0.0127795612790964,3.38667529815151e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,29395,0.0385736128332011,0.00457245980746921,0.0296115916105615,0.0475356340558408,3.43013191103861e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24914,-0.0109345053432664,0.00129724503988086,-0.0134771056214329,-0.00839190506509995,3.67175312285639e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,29163,0.036976512615597,0.00438870621848351,0.0283746484273693,0.0455783768038247,3.75894106206633e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,24229,0.0257970974549936,0.00306185697147574,0.0197958577909012,0.0317983371190861,3.79519287290164e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,28931,0.0408238273876454,0.00484769447740589,0.0313223462119299,0.050325308563361,3.89364423583417e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.0450186617724937,0.00535376025114181,0.0345252916802558,0.0555120318647317,4.33133493656946e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29386,0.0373608016509817,0.00444855635961198,0.0286416311861422,0.0460799721158212,4.72669333070223e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,24867,0.038634128964746,0.00460025840124999,0.029617622498296,0.047650635431196,4.77054082901285e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24805,0.0277425511422296,0.00330610825137681,0.0212625789695311,0.0342225233149281,5.06104664648396e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,24845,0.0475975820062478,0.00567261946387016,0.0364792478570623,0.0587159161554334,5.08397821422368e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,24111,0.0459061788653832,0.00547368012999128,0.0351777658106003,0.0566345919201661,5.26967381638674e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,24922,0.0577637801322775,0.0068885211398684,0.0442622786981354,0.0712652815664195,5.3144326681215e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29694,0.0264195330828593,0.00315531732425295,0.0202351111273236,0.0326039550383951,5.85990652282858e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,29434,0.0404577918633813,0.0048353948067181,0.0309804180422138,0.0499351656845487,6.1681152797658e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,24240,0.016863786444484,0.00201730077757812,0.0129098769204308,0.0208176959685371,6.62838427571172e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,24240,0.0308189372804721,0.0036871561488737,0.0235921112286796,0.0380457633322645,6.69155081374063e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,29411,0.0347797104403953,0.00416208767193518,0.0266220186034024,0.0429374022773883,6.75232185457038e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,28916,0.0326506954964997,0.00390737735143815,0.0249922358876809,0.0403091551053184,6.7656585614665e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.0594902187428005,0.00713091403599877,0.0455136272322429,0.0734668102533581,7.64253179088881e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0343004849572053,0.00411408728005992,0.0262368738882879,0.0423640960261228,7.93204343008771e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,24240,0.0442205928811034,0.00530989187713042,0.0338132048019277,0.054627980960279,8.65440120382536e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,24867,0.0380806655224288,0.00457303885321972,0.0291175093701182,0.0470438216747395,8.69824707609371e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,24845,0.0381620172982402,0.00458294760555273,0.0291794399913569,0.0471445946051236,8.7171964998059e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,29218,0.0552258447058922,0.00663370946771629,0.0422237741491683,0.0682279152626161,8.79424533633962e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0367836782961437,0.0044216900401593,0.0281171658174315,0.0454501907748559,9.33906296841452e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,24845,0.0616152752368148,0.00740861204954784,0.047094395619701,0.0761361548539286,9.50245142373263e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,24229,-0.0173778641494074,0.00209061462939855,-0.0214754688230286,-0.0132802594757862,9.87183816409408e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0293156641349832,0.00353146077541764,0.0223940010151646,0.0362373272548017,1.07301134372685e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24229,0.0557411456738177,0.00671740106371636,0.0425750395889337,0.0689072517587018,1.11315885932305e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0348703004807444,0.00420428016063012,0.0266299113659094,0.0431106895955794,1.14099448876425e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,29218,-0.0240716009319964,0.0029034111878538,-0.0297622868601899,-0.018380915003803,1.17262005517821e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24381,0.0184477340710178,0.00222624397149247,0.0140842958868926,0.022811172255143,1.22587368998477e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24195,0.045832019085265,0.00553710710448445,0.0349792891604755,0.0566847490100545,1.32494706777451e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,24195,0.0747164732794837,0.00902820216808637,0.0570211970300344,0.092411749528933,1.34003360379897e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28931,0.0338983188184308,0.00409712536279757,0.0258679531073476,0.041928684529514,1.35402703449138e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,24922,0.0367209753879107,0.00444203868443414,0.0280145795664198,0.0454273712094016,1.44518190380319e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,29694,0.0368820880874085,0.00446311431048915,0.0281343840388498,0.0456297921359673,1.4697299745593e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0280632850926466,0.00339744977954483,0.0214042835247388,0.0347222866605545,1.51531018893414e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0200719211629354,0.0024298506175015,0.0153094139526324,0.0248344283732383,1.5216209392101e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,29732,-0.0203132728355779,0.00246301913596475,-0.0251407903420688,-0.015485755329087,1.68615876261712e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0302400907819877,0.00367138774681194,0.0230441707982363,0.0374360107657391,1.84430935112226e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,24229,0.0257356115789993,0.00312767523757608,0.0196053681133501,0.0318658550446484,1.99264805163665e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,28797,0.0216522135155466,0.00263312732973636,0.0164912839492633,0.0268131430818298,2.06738426715678e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.0588634086369941,0.00715920126321151,0.0448313741610996,0.0728954431128887,2.0813548747541e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,28628,0.0634390427155352,0.00771890047730559,0.0483099977800163,0.0785680876510542,2.14390505565195e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTD,Biotinidase,24966,0.0117270166440173,0.00142834928419616,0.00892745204699284,0.0145265812410418,2.31418897677106e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29089,0.065733440634815,0.00801748708422901,0.0500191659497261,0.0814477153199038,2.52779063967645e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28916,0.0304836992740951,0.00372295105772317,0.0231867152009577,0.0377806833472325,2.76325834900779e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,24922,0.0311030519950169,0.0038027809144112,0.023649601402771,0.0385565025872629,2.99662847497735e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.0567664086885557,0.00694160236695776,0.0431608680493185,0.0703719493277929,3.0081718125375e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.0367178469956524,0.00449331182321352,0.0279109558221539,0.0455247381691509,3.16133762690746e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,29169,0.0290151021506636,0.00355092725680756,0.0220552847273208,0.0359749195740065,3.17750785233219e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,24177,0.0246281791573937,0.00301630778772318,0.0187162158934562,0.0305401424213311,3.36969817908493e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,24816,0.0476350623729801,0.00583805264320436,0.0361924791922996,0.0590776455536607,3.52489676774084e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29820,0.0401085488115482,0.00493678908030602,0.0304324422141484,0.049784655408948,4.6672355228505e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,29331,0.0160122842861338,0.00197257560310882,0.0121460361040405,0.0198785324682271,4.94561080934418e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,24793,0.0228011645295612,0.00281179878733477,0.017290038906385,0.0283122901527373,5.33350305090435e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28916,0.0421934272520756,0.00520504813397826,0.0319915329094782,0.052395321594673,5.42503340137189e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0265929718625729,0.00328081371559116,0.0201625769800142,0.0330233667451315,5.48762486957908e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,24111,0.0240755631314617,0.00297075542159808,0.0182528825051295,0.029898243757794,5.55994011623456e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29725,-0.032104185611114,0.00396279937909845,-0.0398712723941469,-0.024337098828081,5.63988009349e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,29786,0.0193605379165878,0.00239360506669675,0.0146690719858621,0.0240520038473134,6.27088386406264e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,24240,-0.0237378207786065,0.00294358251044428,-0.0295072424990773,-0.0179683990581357,7.70628886455345e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0264390707335832,0.00327965909923166,0.0200109388990892,0.0328672025680773,7.87114780468559e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,24845,0.0309341819655414,0.00384061429879685,0.0234065779398996,0.0384617859911832,8.33685906802872e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,28916,0.020151767813145,0.00250392338434333,0.015244077979832,0.0250594576464579,8.73055965023912e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.0372304586458139,0.00462866172136311,0.0281582816719422,0.0463026356196856,9.06686527805362e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,24240,0.0262796454944685,0.00326814829160546,0.0198740748429218,0.0326852161460152,9.30449158496367e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0153963394550255,0.0019161832700039,0.0116406202458178,0.0191520586642331,9.79048974425487e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29581,0.0142372860429787,0.0017756830360724,0.0107569472922768,0.0177176247936806,1.11489334325811e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,29349,0.0301063198775274,0.00376113538837498,0.0227344945163125,0.0374781452387424,1.24268775196982e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29478,-0.0141805162568966,0.00177298273188207,-0.0176555624113854,-0.0107054701024077,1.30938525408581e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.0473392158125145,0.00592128959168892,0.0357334882128042,0.0589449434122248,1.35576090563266e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,29349,-0.0161307680113497,0.00201845399514662,-0.0200869378418371,-0.0121745981808624,1.3800173383168e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,29820,-0.0166962121095436,0.00209051386776942,-0.0207936192903717,-0.0125988049287155,1.43608627112599e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,-0.0133189221029859,0.00167097561082373,-0.0165940343002004,-0.0100438099057714,1.63388130965735e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0299718780198721,0.00376147332724039,0.0225993902984809,0.0373443657412633,1.6699070640503e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,29344,0.047939053250742,0.00603608818945281,0.0361083203994145,0.0597697861020696,2.05897812900663e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,29218,0.019420170330647,0.00244749927377208,0.0146230717540537,0.0242172689072403,2.18512005376195e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.0568351115882832,0.0071722552708929,0.0427774912573331,0.0708927319192333,2.37490665671188e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24111,0.036820340528593,0.00465856798487658,0.0276895472782349,0.0459511337789511,2.82071099013348e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOST,Sclerostin,29433,0.0210313220281379,0.00266275747925297,0.0158123173688021,0.0262503266874737,2.92476566614004e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0184092147584257,0.00233069784538593,0.0138410469814693,0.0229773825353821,2.94008985843155e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.0195072742383055,0.00247524855720749,0.0146557870661788,0.0243587614104322,3.3861635076095e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,24805,0.0308787440759303,0.00391875910946451,0.0231979762213798,0.0385595119304807,3.41510882315625e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.0141919312167232,0.00180143600892712,0.010661116639226,0.0177227457942203,3.43805789211827e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,24381,0.0629921665098098,0.00800099374566295,0.0473102187683104,0.0786741142513092,3.60464579483976e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29478,0.0432537917714843,0.00549508881364975,0.0324834176967308,0.0540241658462378,3.62798910906544e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0353385134924764,0.00449685570437217,0.0265246763119069,0.0441523506730459,4.02282319730228e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,24111,0.0360808199062777,0.00459133231955149,0.0270818085599568,0.0450798312525986,4.05054134331651e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,-0.0113967485362708,0.00145177411709624,-0.0142422258057795,-0.00855127126676221,4.32418402937813e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,24845,0.0367587017364413,0.00468678927195489,0.0275725947634097,0.0459448087094729,4.5735715033516e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPARC,SPARC,29566,0.0379015158276842,0.00483312951618859,0.0284285819759546,0.0473744496794138,4.58208815623221e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,29491,0.0570886748136587,0.0072883623721011,0.0428034845643406,0.0713738650629769,4.92878057511838e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0312573667011228,0.00399289210956044,0.0234312981663843,0.0390834352358613,5.14867543414179e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,24867,0.025998099410743,0.00332275633086516,0.0194854970022473,0.0325107018192387,5.30898339665569e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,28797,0.0316804403504115,0.004051661427521,0.0237391839524703,0.0396216967483526,5.50031779266071e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,29786,0.0266264836028055,0.00341110085998798,0.019940725917229,0.0333122412883819,6.10409264709335e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,24793,0.0174786885373915,0.00223973307869834,0.0130888117031427,0.0218685653716402,6.23756790669945e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,28534,0.0410656956008459,0.00526589295163288,0.0307445454156455,0.0513868457860464,6.48132946699857e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,29566,0.0297553906450634,0.00382291323581724,0.0222624807028616,0.0372483005872652,7.2879100256989e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.0385332108804106,0.00495076106733368,0.0288297191884366,0.0482367025723846,7.34594260484117e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0226629483145824,0.00291187402791954,0.0169556752198601,0.0283702214093047,7.36612322720115e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,29218,0.0362863357053567,0.00466601681001184,0.0271409427577335,0.0454317286529799,7.68680868681641e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24845,0.0199111748097925,0.00256026053610334,0.01489306415903,0.0249292854605551,7.71324078790641e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.0419759932679435,0.00540102659971311,0.0313899811325058,0.0525620054033812,7.99159089498867e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,24805,0.0186681580081567,0.00240343892805174,0.0139574177091753,0.0233788983071381,8.32897825483561e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.027606820524997,0.00355567777798137,0.0206376920801535,0.0345759489698405,8.49137453118895e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,24326,0.0609099027474828,0.00785154670346204,0.0455208712086971,0.0762989342862684,8.98735169927321e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,29478,-0.0373851210757149,0.00482581029196247,-0.0468437092479614,-0.0279265329034685,9.71710948845048e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.043567355375199,0.00563654083664074,-0.0546149754150149,-0.0325197353353832,1.11434928690908e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,24951,0.0251992269180845,0.0032663363682115,0.01879720763639,0.031601246199779,1.256655922056e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,29349,0.0292648063810176,0.0037942356098917,0.0218281045856299,0.0367015081764054,1.26814159894534e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,24623,-0.0222504323443599,0.0028892432107428,-0.0279133490374158,-0.016587515651304,1.39935541420043e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BGN,Biglycan,28750,-0.063461334668633,0.00824760412007378,-0.0796266387439777,-0.0472960305932884,1.46570562612282e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PI3,Elafin,29014,0.0291630166548399,0.0037913153996858,0.0217320384714558,0.0365939948382241,1.49368447337987e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.0231577991599069,0.00301053369458723,0.0172571531185159,0.0290584452012979,1.50053099747675e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,24240,0.0480781137041664,0.00625045242870814,0.0358272269438984,0.0603290004644343,1.50423014875442e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,29349,0.0156918482491979,0.00204040479779834,0.0116926548455132,0.0196910416528827,1.51074428176442e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29391,0.0152404215580691,0.00198573429557707,0.011348382338738,0.0191324607774001,1.70598460429217e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,29349,-0.0405927870667597,0.00529246355899025,-0.0509660156423805,-0.0302195584911388,1.77420505161721e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.0445182295823042,0.00580808798810976,0.033134377125609,0.0559020820389993,1.85546490607684e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,29434,0.0440650209766767,0.00575444357529841,0.0327863115690918,0.0553437303842616,1.95296376246984e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0259064836491325,0.00338293625712294,0.0192759285851715,0.0325370387130934,1.95753228097132e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,29674,0.0272869758740805,0.00356693104572663,0.0202957910244563,0.0342781607237047,2.07081316925622e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,29434,0.0357482725003792,0.00467428266750073,0.0265866784720778,0.0449098665286806,2.10574156548676e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,29443,-0.0421129425822534,0.00551706255066576,-0.0529263851815583,-0.0312994999829485,2.3588670261016e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,24845,0.0243314087735444,0.00318778671281368,0.0180833468164295,0.0305794707306592,2.3814903724933e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,24822,0.0510848514919005,0.00671028144697637,0.0379326998558268,0.0642370031279741,2.77499209178315e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,29581,-0.033745218891174,0.00443911466560325,-0.0424458836357563,-0.0250445541465916,3.0070589657397e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,29544,0.0155688408080075,0.00204839161222765,0.0115539932480413,0.0195836883679737,3.03678623934314e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,28797,0.0150932439618835,0.00199036196567835,0.0111921345091539,0.0189943534146131,3.47381123636153e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,0.0146833330014769,0.00193652453818601,0.0108877449066323,0.0184789210963215,3.51277192580526e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,29443,0.0139516023970346,0.00184120226619179,0.0103428459552986,0.0175603588387705,3.62783367485993e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,24381,0.0173085536828408,0.00228473699927035,0.0128304691642709,0.0217866382014107,3.69796294384356e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,29566,0.0155753780262824,0.00205729206334774,0.0115430855821209,0.019607670470444,3.81694879607485e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,28591,0.0439047578925749,0.00580202312800374,0.0325327925616876,0.0552767232234622,3.92989313988893e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,24111,0.0205593013912103,0.00271769183076725,0.0152326254029065,0.0258859773795141,4.01763705854684e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28797,0.0477194142523078,0.00631077015330469,0.0353503047518306,0.060088523752785,4.10049504681049e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),24484,-0.0933296422045627,0.012346857575019,-0.1175294830516,-0.0691298013575254,4.20487447416008e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0190390911755368,0.00252138198565506,0.0140971824836528,0.0239809998674207,4.47061447664528e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,24761,0.0148037281593334,0.00196119741793316,0.0109597812201844,0.0186476750984824,4.56136685933409e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,28890,0.028777459813067,0.00382109430904811,0.0212881149673328,0.0362668046588013,5.1741008031678e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,29443,0.039261109142078,0.00521479457100783,0.0290401117829026,0.0494821065012534,5.26769080048066e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.0496735762033753,0.0066010105272114,0.036735595570041,0.0626115568367097,5.4165414860451e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0331922476017011,0.00441279196289841,0.0245431753544202,0.0418413198489819,5.55932936214512e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0228776644978774,0.003041762963269,0.0169158090898701,0.0288395199058847,5.58348747548851e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24867,0.0321866273508859,0.00429173544143735,0.0237748258856687,0.0405984288161031,6.61150605951952e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,29434,0.0343234745195054,0.00458024383773584,0.0253461965975432,0.0433007524414677,6.87826632542235e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,29725,0.0235813059825901,0.00314706373673298,0.0174130610585934,0.0297495509065867,6.9129045273471e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,28774,0.0268000294108478,0.00358540635657715,0.0197726329519566,0.033827425869739,7.95499886712657e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0276281215402937,0.00370419533885257,0.0203678986761426,0.0348883444044447,8.983225561264e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24732,0.0256269539423973,0.00343566823326477,0.0188930442051984,0.0323608636795962,8.99899592975228e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,29349,0.0167402264980018,0.0022460984586201,0.0123378735191064,0.0211425794768972,9.3739888097879e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0290970533477408,0.00390431122136135,0.0214446033538726,0.0367495033416091,9.40726400654758e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0176498402789225,0.00236882903568728,0.0130069353689754,0.0222927451888696,9.52796902168301e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.0393131912606578,0.00528160211391558,0.0289612511173832,0.0496651314039323,1.00793932738554e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,29434,-0.0135617676963165,0.00182579078061603,-0.0171403176263239,-0.00998321776630905,1.13339393293292e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24867,0.0310856884893714,0.00418877064801377,0.0228756980192645,0.0392956789594784,1.19789277296465e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.0217474263007929,0.00293206835430225,0.0160005723263605,0.0274942802752253,1.23003684110261e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,29434,0.024646117652836,0.00332351470624649,0.0181320288285929,0.0311602064770791,1.24264349146833e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29434,0.0124013983681346,0.00167265711873823,0.00912299041540768,0.0156798063208615,1.25665140318865e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0430384943288531,0.00580693978562922,0.0316568923490199,0.0544200963086864,1.28180715991287e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0199312164462404,0.0026921755769931,0.0146545523153339,0.0252078805771469,1.36273441409056e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.0340395634441645,0.00459839623375188,0.0250267068260108,0.0430524200623182,1.37975838068163e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,24951,0.0372190240035545,0.00502852344788671,0.0273631180456965,0.0470749299614125,1.38827950648736e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNC,Tenascin,29594,-0.0243224861068401,0.0032870915446767,-0.0307651855344065,-0.0178797866792738,1.40441886911957e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,24025,-0.0320663722757009,0.00433377241592638,-0.0405605662109166,-0.0235721783404852,1.41522402742346e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,24229,0.0215294885752774,0.00291013451628379,0.0158256249233611,0.0272333522271936,1.42630775378273e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,29632,0.0302021484059026,0.00408649209308772,0.0221926239034507,0.0382116729083546,1.49884534824388e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,24016,0.0259841212835209,0.00352184279657958,0.0190813094022249,0.0328869331648169,1.65912505153723e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,24240,0.0459830683482883,0.00623285662947945,0.0337666693545086,0.058199467342068,1.66439990964458e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.0745877761767063,0.0101195496870804,0.0547534587900287,0.0944220935633839,1.75094893027228e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,24867,0.0294251137098552,0.00399804812429964,0.0215889393862279,0.0372612880334824,1.89800765396035e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.043060165361183,0.00585717416758197,0.0315801039927223,0.0545402267296437,2.01928715807164e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,29313,0.0195619411010596,0.00266152604916551,0.0143453500446952,0.024778532157424,2.03541315421896e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0306855633962851,0.00417494231363806,0.0225026764615545,0.0388684503310157,2.04465847389511e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29409,-0.00889613437764614,0.00121445378804535,-0.011276463802215,-0.00651580495307726,2.44643810609776e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.0301238025679511,0.00411376341414723,0.0220608262762226,0.0381867788596797,2.49422796789393e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,29757,-0.0232359531854956,0.00317383200202123,-0.0294566639094572,-0.017015242461534,2.52168429542112e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.014200251342553,0.00194563103184002,0.0103868145201466,0.0180136881649595,2.99875604930023e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,29443,-0.0158813747269989,0.00217672750459579,-0.0201477606360066,-0.0116149888179911,3.03965106785762e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.0471585683669248,0.00647336029315523,0.0344707821923405,0.059846354541509,3.29755275558107e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,28669,-0.0451449565098475,0.00620256225877694,-0.0573019785370503,-0.0329879344826447,3.46388180933689e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0217676617580402,0.00299164394345558,0.0159040396288672,0.0276312838872131,3.53939299377985e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LXN,Latexin,29117,-0.0336754737796399,0.00462883143795439,-0.0427479833980305,-0.0246029641612493,3.54755550220668e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0148657527605717,0.00204753642255977,0.0108525813723545,0.0188789241487888,3.95837875585159e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,24528,0.0140795204237289,0.00193930744136467,0.0102784778386542,0.0178805630088037,3.98397292827143e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24867,0.0593275149535546,0.00817228121831329,0.0433098437656605,0.0753451861414486,3.99632413708874e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,24381,0.0336884547536585,0.00464290929814592,0.0245883525292925,0.0427885569780245,4.10952428440049e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,28916,0.0668520371552067,0.0092234681706891,0.0487740395406561,0.0849300347697573,4.33449205303505e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.0176205136342487,0.00243145257038264,0.0128548665962988,0.0223861606721987,4.37068281471451e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29725,-0.0292304914070029,0.00403495937461492,-0.0371390117812481,-0.0213219710327576,4.45218081714119e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28797,0.0225807668975236,0.00311801426069625,0.016469458946559,0.0286920748484883,4.53086374595557e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,29218,0.0401978423738316,0.00555419501588111,0.0293116201427047,0.0510840646049586,4.68695219753921e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,29694,-0.0115074892457027,0.00159202199977426,-0.0146278523652603,-0.00838712612614519,5.01162189944377e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29673,0.0151323022550295,0.00209506836854803,0.0110259682526753,0.0192386362573836,5.21459813655525e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29566,-0.0120543351297536,0.00167192794272492,-0.0153313138974944,-0.00877735636201275,5.73607919511923e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0239008563721064,0.00331759620345467,0.0173983678133352,0.0304033449308775,6.00622197787968e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,24951,-0.0298460471245344,0.00414359198511722,-0.0379674874153641,-0.0217246068337046,6.05996426752707e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.0123061448212632,0.0017127245436892,0.00894920471563237,0.015663084926894,6.87549526264038e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,29384,0.0562134858458904,0.00782575853949822,0.0408749991084739,0.0715519725833069,6.97508023182053e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.00962527718311926,0.00134018590363163,0.00699851281200127,0.0122520415542372,7.0308898178607e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.0245414828820836,0.00342209433003957,0.017834177995206,0.0312487877689612,7.63031305401527e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,24816,0.0319393922105575,0.00445578361253265,0.0232060563299935,0.0406727280911215,7.81880161969151e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24229,0.0436729537032614,0.00609423050304178,0.0317282619172995,0.0556176454892233,7.92712312603226e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24922,0.0446456764579379,0.00624790056976298,0.0323997913412025,0.0568915615746734,9.1996809342955e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.0528663375034045,0.00740126897646823,0.0383598503095268,0.0673728246972822,9.39102313076113e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,29296,0.0151564099168451,0.00212279732652965,0.010995727156847,0.0193170926768432,9.56235036054404e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,24805,0.0291419298965379,0.00408215834584824,0.0211408995386753,0.0371429602544004,9.67051090703417e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0173050798029626,0.00242577914972495,0.0125505526695017,0.0220596069364235,9.98704834876749e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0148216726591912,0.0020784061433682,0.0107479966181895,0.0188953487001928,1.02162865992267e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,29329,0.0384188090386436,0.00538895918708551,0.027856449031956,0.0489811690453312,1.03310756253883e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,29390,0.0138560613776174,0.00194420936378752,0.0100454110245939,0.0176667117306409,1.05069362593012e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29646,0.0111089177307422,0.00156171567626286,0.00804795500526696,0.0141698804562174,1.15888180760649e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28774,0.0188153471659051,0.00264769319310837,0.0136258685074127,0.0240048258243975,1.21954868209218e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,29349,0.0289704584349876,0.00408395656956963,0.0209659035586312,0.0369750133113441,1.33508899739906e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,29218,0.0642730271366993,0.00906510655894878,0.0465054182811597,0.0820406359922389,1.37003028762701e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLGN,Calmegin,24195,0.0220190745106165,0.00310605811842594,0.0159312005985017,0.0281069484227314,1.38722177633641e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29434,-0.0228397138097292,0.0032224532150941,-0.0291557221113137,-0.0165237055081448,1.39450553152697e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0178173187615263,0.00251430180616635,0.0128892872214403,0.0227453503016124,1.40823704063138e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.0113577488203242,0.00160332168742916,0.00821523831296308,0.0145002593276854,1.43288107259277e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,24111,0.0288676535801231,0.00407490838693918,0.0208808331417223,0.0368544740185239,1.43647523086321e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0139004555295243,0.00196635208692857,0.0100464054391443,0.0177545056199042,1.59985432612946e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0259421603474896,0.0036736592654692,0.01874178818717,0.0331425325078092,1.68849340072414e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0174978849158659,0.00247860927210898,0.0126398107425323,0.0223559590891995,1.71548199088647e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0312571376053185,0.00443183129018237,0.0225707482765611,0.039943526934076,1.79863245494298e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,24381,0.0263485543213204,0.00373677327607716,0.0190244787002092,0.0336726299424317,1.82178735593894e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.0369782801538226,0.00525030604388195,0.026687680307814,0.0472688799998313,1.92162744982683e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.0205584132684319,0.00291960032429778,0.0148359966328082,0.0262808299040555,1.95106492966854e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,28452,0.0292050756954237,0.00414849682692288,0.0210740219146548,0.0373361294761925,1.96717015025258e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24381,0.0336635281925484,0.00478189653812916,0.0242910109778153,0.0430360454072816,1.97640793432968e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,29566,0.0345157972757861,0.00490741977514933,0.0248972545164934,0.0441343400350788,2.05957285714261e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,29581,0.044671770598482,0.00635662628627755,0.032212783077378,0.057130758119586,2.14680703074467e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0248472895128319,0.00354049534027021,0.0179079186459022,0.0317866603797615,2.30819071258445e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0284726976736248,0.00405997354473261,0.0205151495259489,0.0364302458213007,2.39190006977815e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,28797,0.02103624796203,0.00300577896409779,0.0151449211923983,0.0269275747316617,2.64190771838193e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0321932457465801,0.00460216689576126,0.023172998630888,0.0412134928622722,2.71736684847228e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.027034211987342,0.00386916746939704,0.0194506437473238,0.0346177802273602,2.87920153162301e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0217145310643988,0.0031096190193013,-0.0278093843422294,-0.0156196777865683,2.95012632600337e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,28797,0.0257463717480862,0.00369182938583972,0.0185103861518404,0.0329823573443321,3.14975117287903e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0134704358023974,0.00193408997485654,0.00967961945167857,0.0172612521531162,3.37463989246096e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.0514536736349156,0.0073910969599156,0.036967123593481,0.0659402236763502,3.44856837078396e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,28774,0.0296410128143101,0.00426134047010301,0.0212887854929082,0.037993240135712,3.58075039876339e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,29311,0.0166733323615842,0.00240099687610905,0.0119673784844105,0.0213792862387579,3.8816965257636e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24915,0.0119252856332766,0.00171747946911627,0.00855902587380867,0.0152915453927444,3.91950895057937e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0205707612940651,0.0029709172947976,0.0147477633962618,0.0263937591918684,4.48097496446727e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,24951,-0.0125394484794833,0.0018111482284121,-0.016089299007171,-0.00898959795179555,4.51366555396935e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.0412543552189473,0.00596155254440742,0.0295697122319088,0.0529389982059859,4.62418143099768e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.025589086950133,0.00370275313249931,0.0183316908104344,0.0328464830898317,4.93708569354744e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,24195,0.0200261904759927,0.00289842821143771,0.0143452711815748,0.0257071097704106,4.99037566990023e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,29536,0.0411759304357499,0.00596532103090245,0.0294839012151811,0.0528679596563187,5.2108931705606e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.024431819287705,0.0035412530121331,0.0174909633839241,0.0313726751914859,5.35830795495629e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,29434,0.0319817851110886,0.00464007492235963,0.0228872382632637,0.0410763319589135,5.59195111085434e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,28931,0.038837822621981,0.0056360079350103,0.0277912470693608,0.0498843981746011,5.65304381052579e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0318970587171573,0.00463271399711359,0.0228169392828147,0.0409771781514999,5.90891184181205e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,24845,0.0336073377903306,0.00489329442017749,0.0240164807267827,0.0431981948538785,6.66256567613192e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.024613511381013,0.003585043814305,0.0175868255049752,0.0316401972570508,6.77706781019823e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29725,-0.0284003695030768,0.00414036430106342,-0.0365154835331611,-0.0202852554729925,7.05098444012218e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.028827484345097,0.00420269910320517,0.0205901941028149,0.0370647745873791,7.0577767664771e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.0400026332347513,0.00584219784785923,0.0285519254529472,0.0514533410165553,7.68272259857436e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0147291388420391,0.00215337878512703,-0.0189497612608881,-0.0105085164231901,8.09429281151506e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0282142368622894,0.00412639143315115,0.0201265096533131,0.0363019640712657,8.2191048198574e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0154197942153537,0.00225532628647913,0.0109993546938546,0.0198402337368528,8.24056883539935e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,24195,0.0231654028814321,0.00339203012081342,0.0165170238446378,0.0298137819182264,8.73136276057502e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,29566,-0.0129095311323555,0.00189232317440716,-0.0166184845541936,-0.0092005777105175,9.14770376520989e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,-0.0185948987860383,0.00272748778031936,-0.0239407748354643,-0.0132490227366124,9.43651122698765e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0490052757066204,0.00719687712480717,0.0348993965419983,0.0631111548712425,1.00013493733155e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0203073589502949,0.00298282944117605,0.0144610132455899,0.026153704655,1.00804659456189e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0187890243339871,0.00276464672985954,0.0133703167434624,0.0242077319245118,1.09855950419971e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,24195,0.0379494345857116,0.00558425652000375,0.0270042918065042,0.0488945773649189,1.1022336131873e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.0146471989093042,0.00215584681259381,0.0104217391566203,0.018872658661988,1.11015235049e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOC,Myocilin,29443,-0.0213551330467385,0.00314317006371571,-0.0275157463716213,-0.0151945197218557,1.1103594628272e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.048890075283539,0.00719718957223281,0.0347835837219627,0.0629965668451153,1.12400101482187e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,24867,0.0354499845447617,0.00521958037020473,0.0252196070191604,0.045680362070363,1.13294189200164e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0195899421227994,0.00288447095520317,0.0139363790506011,0.0252435051949976,1.1345236847154e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28797,-0.0176374475441897,0.0026013811816323,-0.022736154660189,-0.0125387404281903,1.22469272626227e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,29786,0.010983626543262,0.00162084202473822,0.00780677617477504,0.0141604769117489,1.25420123917764e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,29218,-0.015736805822641,0.00232468072502424,-0.0202931800436885,-0.0111804316015935,1.31719196476326e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEXN,Nexilin,24951,0.0322202205724673,0.00476217280374561,0.0228863618771259,0.0415540792678087,1.35447493860021e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.0113609201494302,0.00168063129625552,0.00806688280876934,0.014654957490091,1.40655932813088e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.0315151484451967,0.00466199695765971,0.0223776344081836,0.0406526624822097,1.41035533861658e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWC2,Brorin,29114,0.0185411315204751,0.00274299004300082,0.0131648710361935,0.0239173920047567,1.41120454870419e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,0.0159549791373803,0.00236424251833355,0.0113210638014465,0.020588894473314,1.52723102877654e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,24845,0.0329609468892418,0.00489073556359408,0.0233751051845974,0.0425467885938862,1.62448890512159e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",28774,0.0251260160984585,0.00373266471560312,0.0178099932558763,0.0324420389410406,1.71208081475398e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,29478,0.0591017784070835,0.00880005905854631,0.0418536626523327,0.0763498941618343,1.90087593071063e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,28722,0.0417930962304137,0.00622450945374211,0.0295930577010792,0.0539931347597483,1.9251847356281e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,0.0482324062041241,0.00719186804180858,0.0341363448421792,0.0623284675660689,2.02921190482558e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,29795,0.0156298378669002,0.00233072600936304,0.0110616148885487,0.0201980608452518,2.03611655956544e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,29566,0.0316442979450073,0.00472116909671404,0.0223908065154478,0.0408977893745669,2.08364928701859e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0259445913173189,0.00387050966907282,0.0183583923659362,0.0335307902687016,2.08398700682599e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0215092647728767,0.00321425531319859,0.0152093243590074,0.0278092051867459,2.24307816076214e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24922,0.0322394649686415,0.00482337383696878,0.0227856522481827,0.0416932776891003,2.37405045937849e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,24966,0.0245523956542592,0.00368484294788092,0.0173301034764126,0.0317746878321058,2.73734118657801e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,24240,0.0105216345143676,0.00157965553006886,0.00742550967543259,0.0136177593533025,2.78336170498885e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,24805,0.0356057523286369,0.00535306604252323,0.0251137428852914,0.0460977617719825,2.96221356093931e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24845,-0.0274999441976435,0.00414085549079808,-0.0356160209596077,-0.0193838674356793,3.17723590928791e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,29349,0.0409282362328982,0.00617766788452431,0.0288200071792306,0.0530364652865659,3.5279338173073e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,28931,0.0362374208087054,0.00547148807861644,0.0255133041746171,0.0469615374427936,3.58255934057686e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24845,0.0302993567833224,0.00457543980223312,0.0213314947709455,0.0392672187956993,3.6118219575269e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,29694,-0.0136872635376269,0.00206715452159628,-0.0177388863999557,-0.00963564067529824,3.62108053342335e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,29320,0.0190941752860163,0.00288786373421869,0.0134339623669477,0.0247543882050849,3.86015458657308e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,-0.0205625600094593,0.00311474983769605,-0.0266674696913435,-0.014457650327575,4.13423641638735e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,29023,0.0341191424992534,0.00517177784705112,0.0239824579190332,0.0442558270794736,4.2626202039068e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0257171821486404,0.0038994514544535,0.0180742572979115,0.0333601069993692,4.32169319097941e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29218,0.0359430116373243,0.00545290698467785,0.0252553139473557,0.0466307093272929,4.42721043418877e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,24606,-0.0141143892380083,0.00214309128561903,-0.0183148481578216,-0.009913930318195,4.60965037160588e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,28916,0.0226599529265091,0.00344437746932429,0.0159089730866335,0.0294109327663848,4.82279226254896e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,24381,0.0336035890648788,0.00510804912303781,0.0235918127837247,0.043615365346033,4.84668975495426e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,29694,0.0286246496246336,0.00436020238088432,0.0200786529581004,0.0371706462911669,5.28970008758865e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,24037,0.0249796705513392,0.00380576969691414,0.0175203619453875,0.0324389791572909,5.3583228139403e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0308096908731599,0.00469924096335345,-0.0400202031613326,-0.0215991785849871,5.62372814299833e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0231680158285999,0.00353440522390934,0.0162405815897376,0.0300954500674622,5.658408442948e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,24938,0.0378634854026008,0.00577902022558531,0.0265366057604536,0.049190365044748,5.79226743505815e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0277783477317635,0.00425658642856463,0.0194354383317768,0.0361212571317501,6.8861669652376e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,29732,0.0309450997365357,0.00474524027128792,0.0216444288048114,0.0402457706682601,7.08218157980493e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DMD,Dystrophin,24240,0.0232938993193638,0.00357214973561787,0.0162924858375527,0.0302953128011748,7.1227724569857e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,29443,0.0205730891518991,0.00315831919003497,0.0143827835394305,0.0267633947643676,7.43869061035039e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPART,Spartin,24381,0.0348171343936088,0.00534880457431391,0.0243334774279536,0.0453007913592641,7.69545459361516e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,24240,0.0234202562785252,0.00359940530860789,0.0163654218736538,0.0304750906833967,7.83189136338516e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,24445,0.0152588829493519,0.00234615796978554,0.0106604133285723,0.0198573525701316,7.98431459565399e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0245161000814221,0.00377197886334771,0.0171230215092606,0.0319091786535836,8.18616725779918e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,28931,0.0412782623347196,0.00635378518420307,0.0288248433736816,0.0537316812957576,8.34667461505929e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,29414,0.040616068169751,0.00625332381600022,0.0283595534903906,0.0528725828491114,8.42928073749407e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.0382959604612786,0.00589654269516071,0.0267387367787636,0.0498531841437936,8.48326259029973e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.0227003038833018,0.00350011928749783,0.0158400700798061,0.0295605376867976,9.00559874014464e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29349,-0.018248497862913,0.0028154295830092,-0.023766739845611,-0.012730255880215,9.21922782725267e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,28277,0.0102937674029683,0.00158820939282213,0.00718087699303689,0.0134066578128996,9.23919154836991e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29395,0.0130474446884907,0.00201358026049237,0.00910082737792565,0.0169940619990557,9.33438469504315e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29349,0.0145301154549945,0.00224327198990345,0.0101333023547838,0.0189269285552053,9.49199272606141e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,29396,0.0115683214398894,0.00178623986778819,0.0080672912990245,0.0150693515807542,9.5448672704626e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29820,0.0141979606893852,0.00219288529790892,0.00989990550548376,0.0184960158732867,9.65683306212637e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29545,0.0121835116126828,0.00188305238060083,0.00849272894670515,0.0158742942786604,9.94791502894611e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29581,0.057758213238083,0.00893320688794819,0.0402491277377045,0.0752672987384614,1.0249477918288e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.0426904206006486,0.00660498603443105,0.0297446479731637,0.0556361932281335,1.04017875496665e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,29379,0.0459027993932796,0.00710435984072639,0.0319782541054559,0.0598273446811033,1.05490618018688e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,29174,0.0259516475444618,0.00401674931830401,0.0180788188805859,0.0338244762083376,1.05751185410286e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.0342520466480591,0.0053022069758401,0.0238597209754126,0.0446443723207057,1.063644275013e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,24720,-0.0125559170857938,0.00194365861318717,-0.0163654879676407,-0.00874634620394698,1.06693969714758e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0175311737966376,0.00272132681918618,0.0121973732310327,0.0228649743622426,1.19954388732733e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,29328,0.0189962754331676,0.00295048665441336,0.0132133215905174,0.0247792292758178,1.22643608356787e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.0135051793924959,0.00209839752263512,0.00939232024813101,0.0176180385368607,1.2495606711048e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24240,0.0143567798330111,0.00223437861647238,0.00997739774472523,0.0187361619212969,1.33965941797436e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,24229,0.0180333260226835,0.00281214903937744,0.0125215139055037,0.0235451381398632,1.45650178148766e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,24381,0.0254186537695607,0.00397431610540569,0.0176289942029655,0.0332083133361558,1.62680403209943e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,24845,0.0602285339728037,0.00942165855617672,0.0417620832026973,0.07869498474291,1.66027207763972e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,24229,0.0253549695970687,0.00396942219001039,0.0175749021046483,0.033135037089489,1.71601717683074e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0181928123349377,0.00285384128058925,0.0125992834249827,0.0237863412448926,1.86458244443792e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,29694,0.0131770840067954,0.00206847453356341,0.00912287392101111,0.0172312940925797,1.91251883625787e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,29434,-0.0187212480834489,0.00294198663634475,-0.0244875418906846,-0.0129549542762132,2.00145267730511e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,24922,0.0120756528031615,0.00189861398223953,0.00835436939797204,0.015796936208351,2.0492692753263e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24793,0.0260392247089653,0.00409645080352284,0.0180101811340605,0.0340682682838701,2.09950789950106e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24867,-0.0196678082779437,0.00310226433270687,-0.0257482463700492,-0.0135873701858382,2.33980117383674e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,-0.0113142785049545,0.00178828377600695,-0.0148193147059282,-0.00780924230398093,2.54393873873724e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24209,0.0248196367061071,0.003930970408245,0.0171149347059469,0.0325243387062673,2.76868476586231e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,29786,0.0274528077690416,0.004355030871238,0.0189169472614151,0.035988668276668,2.94692911189759e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,24407,-0.0134665810096058,0.00213823050461825,-0.0176575127986576,-0.00927564922055407,3.06647787501631e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.0483755851696877,0.00768691654249921,0.0333092287463893,0.0634419415929862,3.15270889064146e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.0527888414389118,0.00839871855343127,0.0363273530741865,0.0692503298036371,3.31855362205808e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,24195,0.0296146242283088,0.00471910768063267,0.0203651731742688,0.0388640752823489,3.54490420328279e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,24101,0.0236345297334045,0.00377686054330586,0.016231883068525,0.031037176398284,3.97229759566191e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,29725,0.0122060783117361,0.00195206935965766,0.00838002236680708,0.0160321342566651,4.0839885004003e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,29456,-0.0275122330853356,0.00440012573495986,-0.0361364795258569,-0.0188879866448142,4.09207963097781e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24867,0.021041138239314,0.00336648770485819,0.0144428223377919,0.027639454140836,4.16651451877579e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,24445,0.0234476970814587,0.00375288059840682,0.0160920511085813,0.030803343054336,4.22818870156324e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.0134566535851783,0.00215530082799173,-0.017681043208042,-0.00923226396231448,4.33658783319067e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,24329,0.0443455307760695,0.00711475367308168,0.0304006135768294,0.0582904479753096,4.6540606494592e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,24845,0.0398424915234373,0.00640107780413438,0.0272963790273339,0.0523886040195407,4.91318451593533e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.0158609091714405,0.00255358080503384,0.0108558907935742,0.0208659275493068,5.34011588444929e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.0285319036041134,0.00459892881970233,0.0195180031174969,0.03754580409073,5.59300664810527e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,24229,-0.0113285215982355,0.00182649863160175,-0.0149084589161749,-0.00774858428029603,5.65382721320333e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,28774,0.0219725918224028,0.00354312710392136,0.0150280626987169,0.0289171209460886,5.66992925968673e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,29536,0.0244490194051993,0.00394498832850357,0.0167168422813323,0.0321811965290663,5.81292257932147e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,24966,0.0311162812952966,0.00502058307354878,0.021275938471141,0.0409566241194522,5.81751509496782e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0285546058594714,0.00460807155199881,0.0195227856175537,0.037586426101389,5.84407299450612e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,29443,0.0312300989596881,0.00504184257320568,0.021348087516205,0.0411121104031713,5.93627436066139e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,24793,0.0289267745945549,0.00467265292253594,0.0197683748663844,0.0380851743227253,6.08553680151983e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,28774,0.0142984211305034,0.00231120808499096,0.0097684532839211,0.0188283889770856,6.23206542455914e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.0375642708438824,0.00607836989756645,0.0256506658446522,0.0494778758431127,6.49482305689793e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,29279,0.0255955964912355,0.00415038397269808,0.0174608439047473,0.0337303490777238,7.04884355037131e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0225415927597222,0.00365717108616333,0.015373537430842,0.0297096480886023,7.21740110249914e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0241191721368928,0.00391912072599653,0.0164376955139396,0.031800648759846,7.64376316194367e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,24381,-0.0137499782401349,0.00223559902770467,-0.0181317523344361,-0.00936820414583379,7.84566528375866e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.0415509887910618,0.00676179011537801,0.0282978801649209,0.0548040974172027,8.10275854894293e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.0110420525057802,0.00179877398856636,-0.0145676495233703,-0.00751645548819012,8.44775434605355e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,29786,0.0114253239147993,0.00186137358095854,0.00777703169612053,0.015073616133478,8.45601063991165e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29223,0.0170196361176078,0.00278414435023832,0.0115627131911408,0.0224765590440749,9.89765683433937e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.0350309271852785,0.005732313722645,0.0237955922888943,0.0462662620816627,1.0040197190514e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0184370514349002,0.00301750624049764,0.0125227392035248,0.0243513636662756,1.00889639250405e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24845,0.0195687227773253,0.00320811164847066,0.0132808239463228,0.0258566216083278,1.07794630850811e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRN,Progranulin,29313,0.0103338040762951,0.00169717419153653,0.00700734266088352,0.0136602654917067,1.1515187738206e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,24273,-0.0144396244447243,0.00237374556969601,-0.0190921657613285,-0.00978708312812011,1.19678113728682e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,29566,0.023446423257958,0.00385956470537042,0.015881676435432,0.031011170080484,1.25588348097995e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,24805,0.0129228882487825,0.00212778125525051,0.00875243698849151,0.0170933395090735,1.27043693981801e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.0379691754069052,0.00625264422660197,0.0257139927227653,0.0502243580910451,1.27809663651312e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,28931,0.0275959560449182,0.00454540940011462,0.0186869536206936,0.0365049584691429,1.28561112469289e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0179397286919929,0.00295813996133996,0.0121417743677666,0.0237376830162192,1.33942651659226e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,29218,0.0419074397525058,0.00691094851248982,0.0283619806680258,0.0554528988369859,1.34472038240984e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGMN,Legumain,29581,0.014941850043738,0.00246643214958465,0.0101076430305521,0.0197760570569239,1.3941550296748e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24951,0.0112415135260074,0.00185945443144335,0.00759698284037842,0.0148860442116363,1.50971306435886e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0285358132528521,0.00472147289945148,0.0192817263699272,0.037789900135777,1.52640134692452e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0227862851820705,0.00377477749355416,0.0153877212947043,0.0301848490694366,1.59823809539913e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29349,0.0191183284874637,0.00316751941068638,0.0129099904425184,0.025326666532409,1.60130917478838e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALB2,Calretinin,28774,0.0126752578066981,0.00210449154844978,0.0085504543717365,0.0168000612416596,1.73337744520812e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,29383,0.0195973164590835,0.00325919657227754,0.0132092911774196,0.0259853417407475,1.84350400481743e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.0344282467605861,0.00573158956726038,0.0231943312087558,0.0456621623124165,1.91491146169333e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,24195,0.0283777468294525,0.0047244150418884,0.0191178933473513,0.0376376003115538,1.92141170878568e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.0203946684253,0.00340003983464057,0.0137305903494045,0.0270587465011955,2.01696669051812e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0140709845055617,0.00235235065739169,0.00946037721707399,0.0186815917940494,2.23889998366396e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24867,0.0470759100152723,0.00787418151938157,0.0316425142372844,0.0625093057932601,2.28253025509367e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,29291,0.0230808930127297,0.00386508260831624,0.0155053311004298,0.0306564549250295,2.37581466486842e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,29478,-0.0146608039886677,0.0024557051674358,-0.0194739861168419,-0.00984762186049356,2.39819841351321e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,28931,0.0199719792038421,0.00334581866291087,0.0134141746245368,0.0265297837831474,2.41143399243358e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.0159669858565939,0.0026802084017917,0.0107137773890822,0.0212201943241056,2.59252731763864e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0164963859750398,0.0027704191192668,0.0110663645012769,0.0219264074488028,2.64416606953652e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.0131587910619091,0.00221049954045479,0.00882621196261774,0.0174913701612005,2.66482187021513e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,24951,-0.0101011058971271,0.00169832160007102,-0.0134298162332663,-0.00677239556098786,2.75560702373579e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.0365143813104235,0.00614183890432352,0.0244763770579494,0.0485523855628976,2.79835807954678e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0283926968764827,0.0047811631876215,0.0190216170287445,0.0377637767242208,2.91673499782039e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0261301414777475,0.00440047364248806,0.0175052131384709,0.0347550698170241,2.91777033008892e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,24805,0.04214374444232,0.00709960722950499,0.0282285142724902,0.0560589746121498,2.95822939390414e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,-0.0105646257500956,0.00178207244067216,-0.014057487733813,-0.00707176376637811,3.09499126981739e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,24966,-0.00925085272014096,0.00156369266537936,-0.0123156903442845,-0.00618601509599741,3.3410529687546e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.0450946973567216,0.00764222418858107,0.0301159379471027,0.0600734567663405,3.6592755345228e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.0471054121954791,0.0080055502275035,0.0314145337495722,0.0627962906413859,4.04581910636893e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,-0.01653600977954,0.00281552585727297,-0.022054440459795,-0.011017579099285,4.32227236844137e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,28774,0.0188404024946343,0.00321469777907843,0.0125395948476406,0.0251412101416281,4.65921892496752e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0190734104076305,0.0032543359598468,0.0126949119263308,0.0254519088889302,4.66126694442948e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28931,0.0127554468469691,0.00217845466144293,0.00848567571054096,0.0170252179833973,4.81368893003544e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0127862852024339,0.00218762752998732,0.00849853524365877,0.0170740351612091,5.13617758885144e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.027915160207236,0.00477652988368403,0.0185531616352153,0.0372771587792567,5.14279583078283e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,24793,0.0170035137574587,0.00290936670628547,0.0113011550131391,0.0227058725017782,5.14750088600497e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,28722,0.028618379451462,0.00489833024076125,0.0190176521795699,0.038219106723354,5.19850360868058e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,24381,-0.00870203547896532,0.00149065591456038,-0.0116237210715037,-0.00578034988642698,5.35899460140201e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSPN,Persephin,29434,0.0376532474528835,0.00646850988192897,0.0249749680843027,0.0503315268214643,5.91004264199226e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,-0.0170716776557209,0.00293279291946874,-0.0228199517778796,-0.0113234035335622,5.91134475665684e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.0370275732194079,0.00636240312959121,0.0245572630854091,0.0494978833534066,5.96793079094703e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0248134934386704,0.00426621561720014,0.0164517108289581,0.0331752760483826,6.09328054896145e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.0439706368839989,0.00756259544012402,0.0291479498213558,0.058793323946642,6.15409143769935e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,24776,0.0378737994379853,0.00651950876321893,0.0250955622620762,0.0506520366138944,6.35011696043481e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.0140654562950423,0.00242300673958959,0.00931636308544673,0.0188145495046379,6.50535910751524e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,29725,0.00846364105933776,0.00145805341468005,0.00560585636656486,0.0113214257521107,6.51154115304661e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,24445,0.0212004308339617,0.00365642705707207,0.0140338338021005,0.028367027865823,6.78848306941296e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,24381,0.0223711330518749,0.00385958041891614,0.0148063554307993,0.0299359106729505,6.8645776854219e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.0117928091504231,0.00203524672372224,0.00780372557192749,0.0157818927289187,6.93093389630183e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,24229,0.0174364564473643,0.00301365799482188,0.0115296867775134,0.0233432261172152,7.30519851909102e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.0357711623714007,0.00618438141023916,0.0236497748073319,0.0478925499354694,7.37675391071063e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.0430376901433793,0.00744078360145063,0.0284537542845361,0.0576216260022225,7.38100815217441e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,28879,0.017011004054928,0.00294350321363422,0.0112417377562049,0.0227802703536511,7.58417858604122e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24867,0.0353050353353832,0.00611074908403913,0.0233279671306665,0.0472821035400999,7.6709750397677e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.0595632413946555,0.010325667435064,0.03932493322193,0.079801549567381,8.07980398122427e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29581,0.011208621957732,0.00194333204310847,0.00739969115323941,0.0150175527622246,8.114440059188e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLU,Clusterin,24966,-0.0126364889642377,0.00219348341354694,-0.0169357164547897,-0.00833726147368567,8.46382549121846e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,24938,-0.0198067180789706,0.00344438380456281,-0.0265577103359137,-0.0130557258220275,9.00518871259748e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,29531,-0.0111224875429193,0.00193485791803604,-0.0149148090622699,-0.00733016602356868,9.09368597489958e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28916,0.0137197748300851,0.00238814174161211,0.0090390170165254,0.0184005326436449,9.28657054833839e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,29786,0.024140210885488,0.00420477587310236,0.0158988501742074,0.0323815715967686,9.49538563906792e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,0.0112512212164243,0.00196086171764294,0.00740793224984417,0.0150945101830045,9.680308821051e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,24381,0.0273372227778199,0.00476814699194549,0.0179916546736067,0.036682790882033,9.96577854038775e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24111,0.0248350374048086,0.0043409071147667,0.0163268594598659,0.0333432153497514,1.07050477313197e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.0265960905103592,0.00465359265449382,0.0174750489075513,0.0357171321131671,1.10648367800818e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29354,0.0349514333898659,0.00613185855881709,0.0229329906145844,0.0469698761651474,1.20973730997276e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,29786,-0.0155158742877719,0.00272556596545549,-0.0208579835800646,-0.0101737649954791,1.26208422277982e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29478,0.0111042609811469,0.00195292087500997,0.00727653606612738,0.0149319858961665,1.31296675999459e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29623,0.0321950945537702,0.00566507349610151,0.0210915505014113,0.0432986386061292,1.3352770244473e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,24805,0.0132843905686711,0.00233782156428521,0.00870226030267214,0.0178665208346701,1.34322144428355e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,29386,0.0265651710024314,0.00467582378395406,0.0174005563858815,0.0357297856189814,1.34868015458017e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29349,0.0141842618311004,0.00249667937156531,0.00929077026283239,0.0190777533993684,1.34978012856745e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0149669719520782,0.00263515800910286,0.00980206225423659,0.0201318816499198,1.36443682451773e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCT,Secretin,24195,0.0184038943057322,0.00324353177224243,0.012046572032137,0.0247612165793273,1.41071247422097e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0191582896172661,0.00337781063017342,0.0125377807821262,0.025778798452406,1.42909263210443e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29443,0.0123912818865889,0.00218510346966314,0.00810847908604914,0.0166740846871287,1.4346390558114e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29786,0.0229732485086618,0.00405588508000702,0.015023713751848,0.0309227832654755,1.49093152089369e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24240,0.0316157097419134,0.00558191184514505,0.0206751625254291,0.0425562569583977,1.4959698792405e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.0312841570474396,0.00553240276397993,0.0204406476300389,0.0421276664648402,1.57863649785959e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.0353744574393955,0.00625835627324324,0.0231080791438388,0.0476408357349523,1.60001203559549e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.014104219912808,0.00249786276369176,0.00920840889597213,0.0190000309296438,1.65566162243792e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0179021849744621,0.00317496485437576,0.0116792538598856,0.0241251160890386,1.73401004010187e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,29443,0.0348478144782523,0.00618763382585881,0.022720052179569,0.0469755767769355,1.7991332685203e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,-0.0189973889705209,0.00337539369664994,-0.0256131606159548,-0.012381617325087,1.84106094040846e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24805,-0.0195838131953895,0.00347990576695156,-0.0264044284986146,-0.0127631978921644,1.84615881450021e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,24845,0.0325845715500018,0.00579614459931432,0.0212241281353457,0.0439450149646578,1.91043304985503e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0221529086874735,0.00394079019170507,0.0144289599117315,0.0298768574632154,1.91087570917038e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,24845,0.0226057886785424,0.00402360051937774,0.014719531660562,0.0304920456965228,1.94911977371646e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,24016,0.021776190950777,0.00387877129436886,0.014173799213814,0.02937858268774,1.99657256852244e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,29623,0.0228292827956719,0.0040667642360946,0.0148584248929264,0.0308001406984173,1.99905253544102e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,28797,0.0202800506521848,0.00361358144681859,0.0131974310164203,0.0273626702879492,2.01636056719322e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,24755,0.0340217353978748,0.00608460131850531,0.0220959168136044,0.0459475539821452,2.27558037349726e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.0271991681719574,0.00486954362601213,-0.0367434736789412,-0.0176548626649736,2.35379129906215e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0135757388286965,0.00243781549715801,0.00879762045426682,0.0183538572031262,2.58720095823119e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,29443,0.0220120279519023,0.00395871811702119,0.0142529404425408,0.0297711154612639,2.71501887358315e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24111,0.0454570817163606,0.00817876611871701,0.0294267001236753,0.061487463309046,2.75866975489183e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.0373767300380651,0.0067342141026925,0.0241776703967878,0.0505757896793424,2.88135227481549e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,24101,0.0245561033012091,0.00442455089859033,0.0158839835399721,0.0332282230624462,2.88733733152279e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,24845,-0.0142275748943234,0.00257932185129935,-0.0192830457228701,-0.00917210406577665,3.50231284857689e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.0113947238594489,0.00206763731026771,0.00734215473132417,0.0154472929875736,3.59881056095686e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.0401661858155393,0.00731338594935375,0.0258319493548059,0.0545004222762726,4.01033412231748e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,24922,0.0202844105131571,0.0036948263102999,0.0130425509449693,0.0275262700813449,4.05969903757424e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,21656,0.0398126070993456,0.00727707799734127,0.0255495342245567,0.0540756799741345,4.52563260227138e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,24966,0.00699877691855528,0.00127964328748313,0.00449067607508834,0.00950687776202221,4.5610363189268e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,24805,0.0135230038692336,0.00247406969815546,0.00867382726084893,0.0183721804776183,4.65015597410061e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.0369791159394029,0.00676759056953137,0.0237146384231215,0.0502435934556844,4.69590069136797e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,24867,0.0288386906539394,0.00528259685941225,0.0184848008094913,0.0391925804983873,4.82891134899532e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,28774,0.0184381712864247,0.00338588742639638,0.0118018319306878,0.0250745106421616,5.20549170575023e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,29434,0.0150194840012664,0.00275937238545546,0.00961111412577368,0.0204278538767591,5.27851878616308e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.0332339178638411,0.00611018158258265,0.0212579619619792,0.0452098737657031,5.40526926618733e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,29443,0.0243485537129954,0.00447981914057588,0.0155681081974667,0.0331289992285241,5.51803118567649e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,28884,0.0154246894881718,0.0028400715410048,0.00985814926780242,0.0209912297085412,5.64620252188277e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,29518,0.014181090455439,0.00261413679136443,0.00905738234436469,0.0193047985665133,5.84851239877996e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.0143937211698732,0.00265435286156694,0.00919118956120195,0.0195962527785444,5.92744578229704e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,24845,0.0372165120653558,0.00687475172729006,0.0237419986798673,0.0506910254508443,6.23749813255933e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24445,0.0282514341955514,0.00522018656650642,0.0180198685251988,0.0384829998659039,6.29254512097885e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",24966,0.00619168486976835,0.00114780319095987,0.003941990615487,0.0084413791240497,6.93864057766062e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.0252308666012073,0.00468007880171776,0.0160579121498404,0.0344038210525741,7.0668705073642e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,24920,0.0136955029868045,0.00254406254418586,0.00870914040020022,0.0186818655734088,7.37852222411918e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,29618,-0.0153143379062429,0.00285189422049095,-0.0209040505784052,-0.00972462523408064,7.93807269604845e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,24381,0.0401958578256595,0.00748701591167413,0.0255213066387782,0.0548704090125408,8.00125030266521e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,29349,-0.00560793352709263,0.00104466090533921,-0.00765546890155747,-0.00356039815262778,8.01360261817887e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.0336062694537106,0.00626639557666849,0.0213241341234404,0.0458884047839808,8.26307457046676e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,29725,0.0158408297402046,0.0029656625363067,0.0100281311690434,0.0216535283113657,9.29020518185892e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAX,Protein max,28774,0.0386914334149169,0.00724368979507543,0.0244938014165691,0.0528890654132648,9.29322033047922e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,29566,0.0117449086976872,0.00220065247616853,0.00743162984439687,0.0160581875509775,9.51863450008494e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,-0.0224190081011456,0.00420069446167658,-0.0306523692460317,-0.0141856469562595,9.52080354782279e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALB1,Calbindin,29349,0.0160463753097372,0.0030098156688936,0.0101471365987058,0.0219456140207687,9.82062604020523e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,28916,0.0163936948706175,0.00307625974085854,0.0103642257785347,0.0224231639627002,9.9439479061575e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,24966,0.01204339287868,0.00226234538924181,0.00760919591576605,0.016477589841594,1.02719240842561e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,24111,0.0145723154078128,0.00273871152002262,0.00920444082856846,0.0199401899870571,1.04196821833494e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24101,0.0280348806117562,0.0052775882993619,0.0176908075450069,0.0383789536785055,1.09353129132388e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24381,-0.0103523042171617,0.00194961603470229,-0.0141735516451782,-0.00653105678914524,1.10634218948318e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,29368,0.02504456034177,0.00472248631991596,0.0157884871547347,0.0343006335288053,1.14576879703152e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C3,Complement C3,23779,0.0170971222559937,0.00322565519237976,0.0107748380789294,0.0234194064330581,1.16607569086671e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,28931,0.0298612602500801,0.00566412245802442,0.0187595802323522,0.040962940267808,1.35912255887248e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,29787,-0.0156503018100957,0.00296864751638126,-0.021468850942203,-0.00983175267798843,1.35986910595379e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FST,Follistatin,29536,-0.0183329784464754,0.00347815173058575,-0.0251501558384235,-0.0115158010545273,1.36711965683758e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,28774,0.013431319528695,0.00255259258236921,0.00842823806725137,0.0184344009901387,1.43646243992342e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.0415595638036169,0.00789841425151611,-0.0570404557365884,-0.0260786718706453,1.4368842777547e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.0117374610413582,0.00223193869705672,0.007362861195127,0.0161120608875893,1.4614449188549e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0210651522794534,0.00400745505410344,0.0132105403734107,0.0289197641854962,1.47860854148654e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.00756613674840412,0.0014454188425529,0.00473311581700045,0.0103991576798078,1.66512685866843e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.014437812546285,0.00276167966528769,0.00902492040232112,0.0198507046902489,1.72826832740106e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,29443,0.0187565884324375,0.00358977996511831,0.0117206197008056,0.0257925571640694,1.75343853004806e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0127042357827288,0.00243301786096413,-0.0174729507902185,-0.00793552077523908,1.78851991072683e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRL,Prolactin,29694,0.0271407208670291,0.00521409662540716,0.0169210914812311,0.0373603502528272,1.95015329285986e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.0306272712308717,0.00589069103395999,0.0190815168043101,0.0421730256574333,2.01659808643876e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24805,0.0314519413732086,0.00605256240769472,0.0195889190541269,0.0433149636922902,2.04719293573228e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,24016,0.0129318383696072,0.00249177169248093,0.00804796585234454,0.0178157108868698,2.12213859322774e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,28797,0.0207342724334577,0.00400053787114664,0.0128932182060103,0.0285753266609051,2.199699020584e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.0302539003005363,0.00585236460765265,0.0187832656695372,0.0417245349315355,2.36232831582622e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,28353,-0.0112298493355658,0.00217258671398894,-0.0154881192949841,-0.0069715793761475,2.37092406627768e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,24938,0.0193968678410877,0.00375715291489316,0.0120328481278971,0.0267608875542783,2.453463488242e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,23862,0.0288197154314671,0.0055822805651589,0.0178784455237557,0.0397609853391786,2.45348546206477e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,-0.0165981198885079,0.00322307105814584,-0.0229153391624737,-0.0102809006145421,2.6277487687829e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,28774,0.0160888614841219,0.00312555421981271,0.00996277521328896,0.0222149477549548,2.65684339502498e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,0.010913831519593,0.0021232445499811,0.00675227220163003,0.015075390837556,2.7628029809482e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24867,0.0241694821689734,0.00470228121259185,0.0149530109922934,0.0333859533456534,2.76893916550209e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24845,-0.0109286285584555,0.00212751004824594,-0.0150985482530175,-0.00675870886389341,2.81543298884362e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.016895152190553,0.00329574207936444,0.0104354977149987,0.0233548066661073,2.97616162417755e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,28797,0.0170779819905219,0.00333163782356135,0.0105479718563416,0.0236079921247021,2.97872485596696e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLG,Plasminogen,24421,0.00785828027369531,0.00153307683111508,0.00485344968470976,0.0108631108626809,2.98499860614381e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,24793,0.0139719977178569,0.00272645640964235,0.0086281431549579,0.0193158522807559,3.00407767066301e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRNN,Cornulin,28580,-0.0235881355799329,0.00460323266264484,-0.0326104715987168,-0.014565799561149,3.00660227046258e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,24805,0.0157670903070379,0.00308293264469806,0.00972454232342972,0.0218096382906461,3.17223792872159e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0253420227341807,0.00495816177697187,0.0156240256513158,0.0350600198170456,3.22201381826772e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0153658090842059,0.00301185645143183,0.00946257043939953,0.0212690477290123,3.38966944308997e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,28774,-0.0260478848757395,0.00510604547179051,-0.0360557340004489,-0.0160400357510301,3.39324330551001e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.0277888424138018,0.00546896380854013,0.0170696733490632,0.0385080114785405,3.77793305046438e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPL,Periplakin,24229,0.0114747245532389,0.00226108713551914,0.00704299376762134,0.0159064553388564,3.90626903092642e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,24951,-0.0210803744061284,0.0041539338037824,-0.0292220846615419,-0.0129386641507149,3.90692841089532e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29566,0.0291768930282629,0.0057502452320076,0.017906412373528,0.0404473736829978,3.91843016311846e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,28916,0.0294847604460562,0.00581326990585465,0.0180907514305811,0.0408787694615313,3.96140217884912e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,29478,-0.0119031806178931,0.00234725334883483,-0.0165037971816094,-0.00730256405417684,3.97896632564645e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,24951,0.032011870087263,0.00631422896273399,0.0196359813203044,0.0443877588542217,4.01084542281698e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,24867,0.00894782426507616,0.00176651634620941,0.00548545222650572,0.0124101963036466,4.10808909534207e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,29039,0.0239722782090639,0.00473445055796567,0.0146927551154512,0.0332518013026766,4.14425224561801e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,24240,0.0149463107277905,0.00295280881300306,0.00915880545430449,0.0207338160012765,4.18516580686258e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0123830273660858,0.00244755058505077,0.00758582821938625,0.0171802265127853,4.23224351298231e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,29420,0.0331130939856826,0.00655263999551235,0.0202699195944784,0.0459562683768868,4.36617704340395e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24240,0.030408996938852,0.00601913356508589,0.0186114951512836,0.0422064987264203,4.40254991412848e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,24297,0.0229149783833201,0.00453954157403495,0.0140174768982116,0.0318124798684286,4.50009013069412e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,29820,0.0305325735869612,0.00605372502821488,0.01866727253166,0.0423978746422623,4.5952938032882e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,28931,0.0100555494707421,0.00199855447098692,0.00613838270760777,0.0139727162338765,4.89796966804688e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.00710775833789734,0.00141297739172673,-0.00987719402568173,-0.00433832265011296,4.93123710796762e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,29242,-0.0171891774945191,0.00341850473634595,-0.0238894467777572,-0.010488908211281,4.97839034704687e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,24793,0.017802486444687,0.0035532746349091,0.0108380681602651,0.0247669047291088,5.475773786786e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.0249087846518862,0.00497478932710291,0.0151581975707645,0.0346593717330079,5.56018651163548e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0146061673654197,0.00291961374083954,0.00888372443337422,0.0203286102974652,5.69063602584117e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.0129085696195353,0.0025898696359556,0.00783242513306229,0.0179847141060083,6.25539037083301e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,24111,0.020704850265678,0.00415808525071725,0.0125550031742721,0.0288546973570838,6.42156089699104e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,29566,0.0214478878761391,0.00430872122296392,0.0130027942791298,0.0298929814731484,6.46774612596074e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,29645,0.0168668772536183,0.00339468487211792,0.0102132949042671,0.0235204596029694,6.78085515781578e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,28674,0.015363187009072,0.00309213069341498,0.00930261084997866,0.0214237631681654,6.78682538141325e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,29478,0.0225599903988328,0.00454233007600146,0.0136570234498699,0.0314629573477956,6.85134586289772e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,29434,0.0126591064290136,0.00254898831728355,0.00766308932713785,0.0176551235308894,6.86150340196046e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24805,0.0171837674948842,0.00346035432169267,0.0104014730243666,0.0239660619654018,6.88378636964701e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,29497,0.00822978559776146,0.00165947715986872,0.00497721036441877,0.0114823608311042,7.11535659215949e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0165655487654497,0.00334252763278103,0.0100141946051989,0.0231169029257005,7.24473661828066e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24738,-0.00929679409575736,0.00187687553641625,-0.0129754701471332,-0.00561811804438151,7.34330378861454e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24111,0.012422877397753,0.00250976784032958,0.00750373243070706,0.017342022364799,7.47866112476167e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,-0.0202518385794846,0.00409352747131211,-0.0282751524232563,-0.0122285247357129,7.56763503703824e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.019209221243796,0.00388480866729927,0.0115949962558895,0.0268234462317026,7.6681164796847e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.0137092003827288,0.00277297000269569,0.0082741791774452,0.0191442215880123,7.70841200468084e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,24240,0.0401148053796902,0.00811827310438573,0.0242029900950942,0.0560266206642863,7.81215638630459e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,29192,0.0162287523892805,0.00328655057189288,0.00978711326837043,0.0226703915101905,7.93923515208553e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,24101,0.0149328808460815,0.00302966809179973,0.00899473138615408,0.020871030306009,8.32500112797577e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,29478,0.02316885146116,0.00470474660753325,0.0139475481103949,0.0323901548119252,8.50034432285971e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,29395,0.0136449152933385,0.00277449143225931,0.00820691208611028,0.0190829185005668,8.79099993619357e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,24229,-0.0145956338917077,0.00297018707417526,-0.0204172005570912,-0.00877406722632419,8.97985222234155e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.0249451517022573,0.00509025647073677,0.0149682490196132,0.0349220543849013,9.61713868884766e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24805,0.0197455471314936,0.00403298695532543,0.0118408926990558,0.0276502015639314,9.84165572663593e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,24229,0.0216184590055003,0.00441648049646379,0.0129621572324313,0.0302747607785693,9.89621698169023e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,28774,0.024544647097344,0.00501505165970822,0.0147151458443159,0.0343741483503722,9.92422088579878e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,24381,0.0289801482526723,0.00592472651449359,0.0173676842842649,0.0405926122210798,1.00764383747309e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,28604,-0.023501172282779,0.00481181253592605,-0.032932324853194,-0.0140700197123639,1.04485369479799e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.0397211219814821,0.00814051357399389,0.023765715376454,0.0556765285865101,1.07049255667398e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,29820,-0.00986862318345185,0.00202761309327267,-0.0138427448462663,-0.0058945015206374,1.13818424815493e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24381,0.0277663682348435,0.00571039658140149,0.0165739909352966,0.0389587455343904,1.16679215962606e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,29434,0.0226893652754555,0.00466856603534546,0.0135389758461784,0.0318397547047326,1.17972720143861e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24381,0.0398382560277212,0.00822171247497089,0.0237236995767782,0.0559528124786641,1.2707329475416e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,29478,0.0114119481039299,0.00236014171999555,0.00678607033273867,0.0160378258751212,1.33627684177378e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0250515764631434,0.00518909151060046,0.0148809571023665,0.0352221958239203,1.38926741403994e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00713642529139796,0.00148192837853139,0.00423184566947644,0.0100410049133195,1.47598274273924e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.031381852834834,0.00651669578360742,0.0186091290989635,0.0441545765707046,1.47618144462689e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,29683,0.0200143948283817,0.00416122210544387,0.0118583995017117,0.0281703901550517,1.51867939521191e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,28722,0.0203818472519401,0.00424415667289632,0.0120633001730633,0.0287003943308168,1.57618727199615e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24229,0.0285754682028728,0.00597049241549235,0.0168733030685078,0.0402776333372378,1.71042582622543e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,28671,0.0155965423478469,0.00326992589519464,0.00918748759326542,0.0220055971024284,1.85413857963196e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0229087700643494,0.00481694660834243,0.0134675547119982,0.0323499854167005,1.98720874856929e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0202484435514659,0.00425799391907013,0.0119027754700884,0.0285941116328434,1.99012777654746e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.0372673938123656,0.0078626589067528,0.0218565823551301,0.0526782052696011,2.149339608048e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,24240,0.00978207145329415,0.00206450731289535,0.00573563712001926,0.013828505786569,2.16835613766278e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28916,0.0169585277752342,0.00358209195174721,0.00993762754980969,0.0239794280006587,2.20905036788979e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28797,0.017239601190152,0.00364214590318837,0.0101009952199028,0.0243782071604012,2.21878581188548e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,29478,-0.0150871759379394,0.00319107054937055,-0.0213416742147057,-0.00883267766117308,2.2786228151638e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.00944357371981993,0.00200010197148602,-0.0133637735839325,-0.00552337385570734,2.35375271581944e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0158767950688741,0.00336338476331518,0.00928456093277638,0.0224690292049719,2.36572665943174e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29566,0.00823266308623893,0.00174508469092724,0.00481229709202153,0.0116530290804563,2.3969864142075e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,29163,0.0103516928408085,0.00219534884888457,0.00604880909699472,0.0146545765846222,2.42490026403173e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.0323068463064819,0.00686292931977133,0.0188555048397301,0.0457581877732337,2.52238811861376e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0156429772435623,0.0033266833173275,0.00912267794160043,0.0221632765455242,2.5847032307569e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0124426571634488,0.00264997107782193,0.00724871385091783,0.0176366004759798,2.67515192274845e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.00800654505783541,0.00170529252345093,0.00466417171187158,0.0113489184037992,2.67651560878263e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0202045388633582,0.00430955651673161,0.0117578080905642,0.0286512696361521,2.76692076466845e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24805,0.0173135965005497,0.0037085746692835,0.0100447901487541,0.0245824028523454,3.049482930954e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.0236729639235921,0.00507963795174964,0.0137168735381628,0.0336290543090214,3.17283106360128e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,24793,0.0227201349498514,0.00488270272513962,0.0131500376085778,0.0322902322911251,3.28531348260784e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29530,0.015759913140246,0.00338807993849435,0.00911927646079708,0.0224005498196949,3.3083430838991e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,29434,0.0187634167192643,0.00403415784591179,0.0108564673412772,0.0266703660972514,3.31546096298459e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,24381,0.00920946732439406,0.00198080444064397,0.00532709062073188,0.0130918440280562,3.34716242565372e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,28931,0.0161265137730829,0.00347568384435855,0.0093141734381401,0.0229388541080256,3.50256583786548e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,24805,0.0137203851488234,0.00295909985652453,0.00792054943003533,0.0195202208676115,3.55862706674757e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0941726614812009,0.0203401457051511,0.0543059758991047,0.134039347063297,3.67419023334775e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,29349,-0.00898099527314601,0.00194054683058831,-0.0127844670610991,-0.00517752348519291,3.70659396900009e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29349,0.0190397905114767,0.00411941501213781,0.0109657370876866,0.0271138439352668,3.81739924289321e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2,Complement C2,29545,0.00742883363478372,0.0016091818851197,0.00427483713994911,0.0105828301296183,3.91854476425281e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0232755282627222,0.00505000993996127,0.0133775087803981,0.0331735477450463,4.06334694103874e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24195,-0.0101496235492743,0.00220512350820643,-0.0144716656253589,-0.0058275814731897,4.19074932626596e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28916,0.029423923604585,0.00639356381528677,0.016892538526623,0.0419553086825471,4.19996026222995e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,24951,0.00834179921315739,0.00181301135504813,0.00478829695726305,0.0118953014690517,4.22386045305085e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.00980431831613464,0.00213094943634529,0.00562765742089788,0.0139809792113714,4.22768914968197e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24938,0.0192778518929825,0.00419059697179057,0.0110642818282729,0.027491421957692,4.24031577132635e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0142417399249336,0.00309647116293935,0.00817265644557252,0.0203108234042948,4.25590246244221e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0118369593927874,0.0025763734017626,0.00678726752533272,0.0168866512602421,4.36075940407741e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,24845,0.0144472266776806,0.00314487684863274,0.00828326805436045,0.0206111853010008,4.37189779789848e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,24951,0.0089932721577625,0.00196015193123589,0.00515137437254016,0.0128351699429848,4.49585889324019e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,29820,-0.00865987165256077,0.00189236815915111,-0.0123689132444969,-0.0049508300606246,4.753862780578e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28916,0.0137324174147002,0.00300280381374901,0.00784692193975214,0.0196179128896482,4.82326371909479e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0193204263943558,0.00422526544808636,0.0110389061161066,0.0276019466726051,4.84107890414786e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0133307769408673,0.00292107388059802,0.00760547213489516,0.0190560817468394,5.0478538481511e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.02082618842351,0.00457655032622341,0.0118561497841121,0.0297962270629078,5.3738537454285e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,24867,0.021644938496387,0.00476334741577328,0.0123087775614714,0.0309810994313026,5.54404820566458e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,24711,0.0151530741445415,0.00334036074356943,0.00860596708714537,0.0217001812019375,5.75030960360382e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,28916,0.0147003881588435,0.00324094643833269,0.00834813313971144,0.0210526431779756,5.76073727391937e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,29725,-0.0186698857676334,0.00411736494478547,-0.0267399210594129,-0.0105998504758539,5.7985849433958e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0209214851527078,0.00461663197722109,0.0118728864773544,0.0299700838280611,5.87753340550772e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,24793,0.0125104663658598,0.00276601914040825,0.00708906885065964,0.01793186388106,6.12768245347424e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,24445,0.0231833939890843,0.00512750621801235,0.0131334818017801,0.0332333061763885,6.172686621699e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,29443,-0.0126557909241579,0.00279942725278794,-0.0181426683396223,-0.00716891350869359,6.18317269627253e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,24195,-0.00975857976303436,0.00216165834627194,-0.0139954301217274,-0.00552172940434135,6.37972435394136e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,24951,-0.0450385294776269,0.00998859388408823,-0.0646161734904398,-0.025460885464814,6.54316682843449e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0209426543406263,0.00464827303268601,0.0118320391965617,0.0300532694846909,6.64865787584396e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,29640,0.0215579282930386,0.00479214079158271,0.0121653323415365,0.0309505242445407,6.86618971942078e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.0192416211729382,0.00428269856216508,0.0108475319910946,0.0276357103547817,7.05940691025547e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,24938,-0.00748498543851174,0.00166632308545179,-0.0107509786859972,-0.00421899219102622,7.09016991840021e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,29725,0.0186234317702125,0.00415325599306268,0.0104830500238097,0.0267638135166154,7.35113570983761e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0102446297938171,0.00229040337782448,0.00575543917328114,0.0147338204143531,7.74759607926855e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0122350802816752,0.00274236960770408,0.00686003585057522,0.0176101247127752,8.17460600580493e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,29123,-0.00789829994291427,0.00177271379550976,-0.0113728189821134,-0.00442378090371514,8.40154681284177e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,28916,0.0149855730726734,0.00336960181006216,0.00838115352495158,0.0215899926203953,8.72871472847372e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.0225643939572847,0.00507667278468545,0.0126141152993012,0.0325146726152681,8.83963573229295e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,24845,0.00827613970271788,0.00186697146466609,0.00461687563197234,0.0119354037734634,9.33625135448142e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0187425928930756,0.00423317667279616,0.0104455666143951,0.0270396191717561,9.57152066891356e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,29566,-0.00850494924191612,0.00192138263091925,-0.0122708591985179,-0.00473903928531438,9.61288945781062e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0143079963646312,0.00323621771028053,0.00796500965248139,0.0206509830767811,9.85099014371724e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24016,0.023404071613182,0.0053020908132981,0.0130119736191177,0.0337961696072462,1.01863317144684e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.0232089395199479,0.00526959830290756,0.012880526846249,0.0335373521936467,1.0656571208879e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29163,0.00714538417408328,0.00162359837260189,0.00396313136378357,0.010327636984383,1.08157656281905e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24867,0.0108699681942705,0.00246999274388806,0.00602878241624991,0.0157111539722911,1.08296521373345e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.0267033432038211,0.00607179228150121,0.0148026303320787,0.0386040560755635,1.09756820245961e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,24229,0.00802977302018243,0.00182588111427339,0.00445104603620658,0.0116085000041583,1.09843680612401e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0174997509878116,0.0039906656460295,0.00967804632159381,0.0253214556540294,1.16305524745684e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",24445,0.0138825785695202,0.00317004869318711,0.00766928313087348,0.0200958740081669,1.19558607795132e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29820,0.00914199226898816,0.00209142395704063,0.00504280131318852,0.0132411832247878,1.2399423204186e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,29349,0.0247762582334741,0.00567339933201724,0.0136563955427203,0.0358961209242279,1.26342583374143e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,28650,0.00917543076889333,0.00210171588613513,0.00505606763206848,0.0132947939057182,1.2716851298746e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,29478,0.0116721012879156,0.0026784098329131,0.00642241801540588,0.0169217845604252,1.31791971216098e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,24636,0.0298719754758347,0.00685971736136774,0.016426929447554,0.0433170215041155,1.33790170922441e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.00966768871031137,0.00222410776975793,0.00530843748158583,0.0140269399390369,1.3870438233533e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.035703037776589,0.00821528105197663,0.0196010869147148,0.0518049886384632,1.39149932694804e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,24069,0.0294524193154586,0.00679360220424519,0.016136958995138,0.0427678796357791,1.46141261812221e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0204606764044256,0.00472142371757564,0.0112066859179773,0.0297146668908739,1.47296456127498e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24867,0.00899610700908917,0.00208144208381401,0.00491648052481372,0.0130757334933646,1.55183181432808e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,24240,0.0218630840215196,0.00505879533731628,0.0119478451603797,0.0317783228826595,1.55380527653494e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.0174523960177063,0.0040429503444309,0.00952821334262177,0.0253765786927909,1.5897480875894e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24845,0.00664564984655012,0.00154017205071961,0.00362691262713968,0.00966438706596056,1.60310214289396e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,24922,0.0213557229696041,0.00495476575584852,0.011644382088141,0.0310670638510672,1.63778625574477e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29786,0.00755429801047285,0.00175299875393216,0.00411842045276582,0.0109901755681799,1.64254530217718e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,28931,0.0167470263020016,0.00388796264126245,0.00912661952512716,0.0243674330788759,1.65725927253973e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,29218,0.00983327872965632,0.00228339961785515,0.00535781547866024,0.0143087419806524,1.66458427619544e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,29454,0.0106233265029938,0.00247709494682083,0.00576822040722494,0.0154784325987626,1.80356410663116e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,28797,0.0198744567954131,0.00463499536481624,0.0107898658803733,0.0289590477104529,1.80946525255416e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,24111,-0.0106128500972067,0.00247859465633307,-0.0154708956236195,-0.00575480457079384,1.86103108518869e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0132764924156529,0.00310266029041481,0.0071952782464399,0.019357706584866,1.88401859096243e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24904,0.0141422737958034,0.00331005022693907,0.0076545753510028,0.020629972240604,1.93988895125399e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24111,0.0207200531083624,0.00485417660009928,0.0112058669721678,0.030234239244557,1.97543604506434e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,28706,0.0222455158955005,0.00521413139845464,0.0120258183545294,0.0324652134364716,1.9929782444333e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29628,-0.00593733866196759,0.00139566608947544,-0.00867284419733945,-0.00320183312659573,2.1051151195512e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,24195,0.0149283421754257,0.0035122305102244,0.00804437037538584,0.0218123139754655,2.14199966614781e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,28774,0.0208861116437937,0.00491596654087976,0.0112508172236694,0.030521406063918,2.15760212295203e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,28916,0.0223642175439804,0.00526682258390104,0.0120412452795344,0.0326871898084265,2.18061808258627e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,29373,0.0195010128356026,0.00459290081331014,0.0104989272415148,0.0285030984296905,2.18383335503492e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,29381,0.0119898407211843,0.00282680280477489,0.00644930722382553,0.0175303742185431,2.22725334730745e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.00820784012917711,0.00193679526166553,0.00441172141631268,0.0120039588420415,2.2635624098227e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.00787520861705612,0.00185990281118766,0.00422979910712831,0.0115206181269839,2.30059827804003e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,29688,0.0271489595307513,0.00643395367702313,0.014538410323786,0.0397595087377167,2.45420573007707e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.0176973431552367,0.00419716812689282,0.00947089362652681,0.0259237926839467,2.48873844124006e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.0137656935837857,0.00326697104599245,0.00736243033364054,0.020168956833931,2.52223697296825e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24240,0.0140116388548181,0.00332745108844968,0.00748983472145669,0.0205334429881794,2.55247635668046e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,29661,0.0124365305810179,0.00295583352707816,0.00664309686794473,0.0182299642940911,2.59024057299766e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,28774,0.0104110784172881,0.00247541478655689,0.00555926543563661,0.0152628913989396,2.60956989772579e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,24867,0.0181029297109884,0.00430804250674031,0.0096591663977774,0.0265466930241994,2.6534461644982e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29820,0.0178797017286283,0.00426639039683792,0.00951757655082596,0.0262418269064306,2.78740439198144e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,29443,0.00975913156578029,0.0023342348510353,0.0051840312577511,0.0143342318738095,2.91235545621246e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,29478,0.011581770444739,0.00277182663128437,0.00614899024742165,0.0170145506420564,2.94426441590705e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,24793,0.0111431677444281,0.00267730411198431,0.0058956516849388,0.0163906838039173,3.16418833508382e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.0242635478200342,0.00584009439560363,0.0128169628046511,0.0357101328354173,3.26725776972313e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,29434,0.0223194907642438,0.00537291835678159,0.0117885707849519,0.0328504107435357,3.2753136563423e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,24938,0.0238099635611194,0.00573359887683535,0.0125721097625221,0.0350478173597167,3.29656322172378e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,24421,0.0110033766363603,0.00265381266355582,0.0058019038157909,0.0162048494569297,3.39102722544082e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,29443,0.0345634710940422,0.00834338720856473,0.0182104321652553,0.0509165100228291,3.44320856677787e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.0283960773630295,0.0068683215004492,0.0149341672221491,0.0418579875039099,3.57120856609412e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,-0.00871167353199784,0.00210937106193767,-0.0128460408133957,-0.00457730625060001,3.63808053003397e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBN1,Drebrin,24229,0.0146443522644277,0.00354801169608495,0.00769024934010117,0.0215984551887542,3.67984989693487e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0117121743074613,0.00283904233642054,0.00614765132807707,0.0172766972868456,3.71137377219777e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29753,0.0148536422680736,0.00360548938505735,0.00778688307336124,0.0219204014627861,3.8034248050836e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,24938,0.0249003627610794,0.00606007768750277,0.013022610493574,0.0367781150285848,3.98787020427856e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,24111,0.0177657645387173,0.00432479521668223,0.00928916591402016,0.0262423631634145,4.00615802528664e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.0215683731762654,0.00525367249620848,0.0112711750836968,0.031865571268834,4.04746587563174e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,24867,0.00778801279558146,0.00189764847715925,0.00406862178034932,0.0115074038108136,4.07303696517509e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,28931,-0.0113098745223905,0.00275916067298363,-0.0167178294414385,-0.00590191960334262,4.16022219188703e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0142900934404274,0.00349169422955601,0.00744637275049759,0.0211338141303572,4.27707416706187e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28916,0.00944495139652721,0.00230819882756821,0.00492088169449351,0.0139690210985609,4.28987163254231e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29216,0.0164410400462841,0.00402240683744149,0.00855712264489878,0.0243249574476694,4.37468644175683e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,24381,0.0109193413449938,0.00268192115264855,0.00566277588580263,0.0161759068041849,4.68663412690156e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29218,0.01145213443441,0.00281632400584206,0.00593213938295951,0.0169721294858604,4.78821352528094e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24240,0.0158652431727232,0.00390613337250117,0.00820922176262093,0.0235212645828255,4.8885912741282e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,-0.00891493718548152,0.00219601038014622,-0.0132191175305681,-0.00461075684039492,4.92824314063868e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,28774,0.0171723039779277,0.0042309409742327,0.00887965966843159,0.0254649482874238,4.94678321029062e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,24229,0.0336268422125014,0.00829755795181544,0.0173636286269431,0.0498900557980596,5.08054649764485e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28797,0.0164575046113954,0.00406238357709849,0.00849523280028237,0.0244197764225085,5.10904774322762e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,24229,0.0138937852015112,0.00343411846105967,0.00716291301783422,0.0206246573851881,5.2304556868661e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,24229,0.011143442012501,0.00275744163230624,0.00573885641318079,0.0165480276118212,5.33368805085542e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,24343,0.0161231766972874,0.00399096039422839,0.00830089432459973,0.023945459069975,5.36326283375191e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,-0.00722865351484968,0.00179043399370602,-0.0107379041425135,-0.00371940288718588,5.42197158678996e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,29478,0.00796541645573227,0.00197526741330835,0.00409389232564789,0.0118369405858166,5.53075311209026e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,28774,0.0118773353476832,0.00294981510261838,0.00609569774655122,0.0176589729488153,5.67661371898534e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24111,0.0127182026670071,0.00315956958593947,0.00652544627856575,0.0189109590554485,5.70776257618973e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,24111,0.0341695091294423,0.00849262988999478,0.0175239545450526,0.0508150637138321,5.75314267992098e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,29443,-0.013577939177851,0.00337597594693642,-0.0201948520338464,-0.00696102632185559,5.7867172268184e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,28774,0.0123470042965197,0.00307657079426539,0.00631692553975956,0.0183770830532799,6.00436246279676e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0161639774185051,0.004031872610245,0.00826150710242491,0.0240664477345853,6.1144586858905e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,0.0327825442664331,0.00817848921624476,0.0167527054025934,0.0488123831302728,6.1285604114018e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.0196134268909851,0.00489389421596314,0.0100213942276974,0.0292054595542729,6.14823600646067e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,28774,0.0187376343885177,0.00468337606882999,0.00955821729361092,0.0279170514834245,6.32647556654235e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,24805,0.0166271383043114,0.0041599940841882,0.00847354989930257,0.0247807267093203,6.4359220317868e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,24016,0.0100766494321397,0.00252489168411226,0.00512786173127969,0.0150254371329998,6.60120240579677e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24445,0.00965590830257874,0.00242015998737351,0.00491239472732667,0.0143994218778308,6.63271151445623e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29820,-0.00435467525573759,0.00109197667920557,-0.0064949495469805,-0.00221440096449467,6.68244903369474e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0139986168187191,0.00351285741997098,0.00711341627557599,0.0208838173618622,6.7651869877417e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0102081501480719,0.00256331279324685,0.0051840570733081,0.0152322432228357,6.84193418625729e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,24111,-0.00869349946513988,0.00218371779677142,-0.0129735863468119,-0.0044134125834679,6.88113272905951e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,-0.00813760946282944,0.00204516400747336,-0.0121461309174772,-0.00412908800818165,6.94211996005933e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24111,0.0139952121567561,0.00351920349776131,0.00709757330114388,0.0208928510123682,7.004911373944e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,24845,-0.0207316772571604,0.00521361281309684,-0.0309503583708302,-0.0105129961434906,7.01494211593805e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.0306336618475726,0.00770816961838869,0.0155256493955307,0.0457416742996144,7.07940953876539e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.0223447035375283,0.00562403010685122,0.0113216045280999,0.0333678025469567,7.11191722344898e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0079681751336214,0.00200573641239099,0.00403693176533505,0.0118994185019077,7.12316250180072e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,24951,-0.013225537051645,0.00334571708209811,-0.0197831425325573,-0.00666793157073267,7.73982265345514e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFP,Properdin,24966,-0.00626551899213082,0.00159162190663771,-0.00938509792914074,-0.0031459400551209,8.28813438767254e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAT,Catalase,24587,0.0145527018227544,0.00370351600815455,0.00729381044677151,0.0218115931987373,8.53808813949783e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.00933605791664054,0.00237604452392813,-0.0139931051835397,-0.0046790106497414,8.54512375345198e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,29725,-0.0120228396901232,0.00307342682579285,-0.0180467562686772,-0.00599892311156926,9.17887183351799e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.0142626258673918,0.00366140823980634,0.00708626571737134,0.0214389860174122,9.83026795162287e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,0.00922764227538953,0.00237161258375635,0.0045792816112271,0.013876002939552,0.000100102771738599
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,0.0127646622255207,0.00328086598662879,0.00633416489172824,0.0191951595593131,0.000100206016384302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,24329,-0.00823093171090377,0.00211753362788913,-0.0123812976215665,-0.00408056580024108,0.000101744542360774
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00813893682776087,0.00209401088528608,-0.0122431981629216,-0.00403467549260015,0.00010186032021428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,29497,-0.00889761929464902,0.00229226680775184,-0.0133904622378426,-0.00440477635145542,0.00010400545601795
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,24867,0.00796355859165357,0.00205324819041925,0.00393919213843184,0.0119879250448753,0.000105365653215511
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,29566,0.00582263151034489,0.00150390303803694,0.00287498155579247,0.0087702814648973,0.000108320194710781
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,24281,0.0114543505845329,0.00296063697769385,0.00565150210825293,0.0172571990608128,0.000109621841631555
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,29301,0.0177338610998659,0.00458583939080165,0.00874561589389467,0.0267221063058371,0.000110379006039658
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24240,0.0206315645068281,0.00533514902063722,0.0101746724263792,0.0310884565872771,0.000110424147275744
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0148848655130932,0.00385068200094074,0.00733752879124933,0.022432202234937,0.000111146126851011
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,24793,0.0137509916635793,0.0035578443757537,0.00677761668710202,0.0207243666400565,0.000111382172601012
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,24111,0.010244191030436,0.00265843868075798,0.00503365121615036,0.0154547308447216,0.000116761388539551
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.013197691181046,0.00342801837686389,0.00647877516239282,0.0199166071996993,0.000118446565499206
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24111,-0.00733481921554979,0.00190706312405009,-0.011072662938688,-0.00359697549241161,0.000120305170276714
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.0082878999273151,0.00215877236136503,0.00405670609903963,0.0125190937555906,0.000123763487780845
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,28916,0.013906992675287,0.00362265414024209,0.00680659056041254,0.0210073947901615,0.000123851930368766
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,24381,0.0251967985811233,0.00656714850851596,0.012325187504432,0.0380684096578146,0.000124965001423259
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,29349,0.0197243762037221,0.00516000317221491,0.0096107699861809,0.0298379824212634,0.000132350749757922
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.0129788987241409,0.00339661180586758,-0.0196362578636414,-0.00632153958464046,0.000133113461866525
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,24229,-0.00900123675102456,0.00235689413120295,-0.0136207492481823,-0.00438172425386678,0.000134268217305374
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29725,-0.00864633612172471,0.0022646432279344,-0.0130850368484761,-0.00420763539497328,0.000134828247277609
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,28757,0.0287926948481408,0.00755995888220537,0.0139751754390183,0.0436102142572634,0.000140058608719753
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0178695374916011,0.00470768891279367,0.00864246722252557,0.0270966077606767,0.000147515542998422
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,29786,0.0202746542760921,0.00534767808516157,0.00979320522917545,0.0307561033230088,0.000150156114934841
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,24111,-0.0105147921826076,0.00278760668841441,-0.0159785012918999,-0.00505108307331541,0.000162345495257781
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,24833,0.00817027672405618,0.00216966123200885,0.00391774070931883,0.0124228127387935,0.000166471303086879
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,24922,0.0169781490327811,0.00451056123826268,0.00813744900578625,0.025818849059776,0.000167541655754272
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,0.00675339679740501,0.00179587295435761,0.00323348580686409,0.0102733077879459,0.000169955095648463
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0258399222965239,0.00687399202026404,0.0123668979368063,0.0393129466562414,0.000170938192077069
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,24951,-0.00584635106627129,0.00155804243375537,-0.00890011423643181,-0.00279258789611077,0.000175567768593271
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,24805,0.0158428926282859,0.00422537723886921,0.00756115324010224,0.0241246320164696,0.000177616774905238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.0244671990672295,0.00652737896233343,0.011673536301056,0.037260861833403,0.000178309279088743
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.00772795007841439,0.002063363870453,0.00368375689232651,0.0117721432645023,0.000180507307423475
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0162442896630631,0.00434200180127944,0.00773396613255543,0.0247546131935708,0.000183567258717711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,28845,0.0113722668949881,0.00304030954711813,0.00541326018263652,0.0173312736073396,0.000184012729529509
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24793,0.0142353111560717,0.00380647836862937,0.00677461355355809,0.0216960087585852,0.000184611523875924
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.0123033022774978,0.00330817363818504,-0.0187873226083405,-0.00581928194665512,0.000200417434551239
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24229,0.0052409866066537,0.00141090664415182,0.00247560958411613,0.00800636362919127,0.000203963723156501
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.0161827096740045,0.0043624767325237,-0.0247331640697509,-0.00763225527825803,0.000208114342142512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTG,Protogenin,29725,0.00633892477789113,0.00171621770253475,0.00297513808092302,0.00970271147485923,0.000221546820569904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.0222816512527738,0.00603612554686813,0.0104508451809123,0.0341124573246353,0.000223524171992886
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0058042460771295,0.00157284485119028,0.00272147016879656,0.00888702198546244,0.000224479604704212
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24445,0.0179900662154774,0.00488579125140977,0.00841391536271424,0.0275662170682405,0.000231801286142026
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C7,Complement component C7,24374,0.00825801659768314,0.00224677521218801,0.00385433718179464,0.0126616960135716,0.000237895694924579
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0153098364788366,0.00417599981741253,0.00712487683670802,0.0234947961209651,0.000246753836137622
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,28931,0.0126467385648109,0.00345559562394211,0.00587377114188432,0.0194197059877374,0.000252875410495552
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,29545,0.00651323279912205,0.00178120956315214,0.00302206205534386,0.0100044035429002,0.000255991650658674
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,24111,-0.00910577383904928,0.00249374523778276,-0.0139935145051035,-0.00421803317299507,0.000261320652668372
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,29434,0.0154110164252342,0.0042278678589257,0.00712439542173983,0.0236976374287286,0.000267744282882048
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,24229,0.00729244722805916,0.00200081707583006,0.00337084575943223,0.0112140486966861,0.000268227645659871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.00864853401206337,0.00237370176751897,-0.0133009894764006,-0.00399607854772617,0.000269436792519945
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,28722,0.00907629166262019,0.00249333569489048,0.00418935370063485,0.0139632296246055,0.000272882921839508
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,24793,-0.0280958837556628,0.007718687072152,-0.0432245104170807,-0.0129672570942449,0.000273211357626086
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,24101,0.0212501892456307,0.00586360756089791,0.0097575184262708,0.0327428600649906,0.000290587453168738
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28719,0.0165523111275186,0.00456790527149113,0.00759921679539596,0.0255054054596412,0.000291020027733214
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24016,0.0153688197848316,0.00424570920864587,0.00704722973588565,0.0236904098337775,0.000295382881873122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,0.00741338030692864,0.00205136415823516,0.00339270655678773,0.0114340540570695,0.000302246111568104
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,24445,-0.00921355714168935,0.00255287104496369,-0.0142171843898182,-0.00420992989356051,0.000307879545375758
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,29497,0.00816310087904246,0.00226273390324873,0.00372814242867495,0.01259805932941,0.000309520520910775
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,24845,-0.00984685367101536,0.002730257912376,-0.0151981591792723,-0.00449554816275839,0.000310884995174382
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,29132,-0.0168328604575851,0.00468213343724404,-0.0260098419945834,-0.00765587892058675,0.000324770008068564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.00946519843818554,0.00263300782785718,0.00430450309558547,0.0146258937807856,0.000325257136445203
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.00683027567591411,0.00190163524051394,0.0031030706045068,0.0105574807473214,0.000329045694768932
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24381,0.0311476086132703,0.00868474906338663,0.0141255004490325,0.0481697167775081,0.000335837918706767
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24240,0.0129791873290534,0.00362469833382452,0.00587477859475731,0.0200835960633494,0.000343261875744984
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,24229,0.0132804418739848,0.00371005774671896,0.00600872869041566,0.020552155057554,0.000344821924514526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.00945514696080967,0.00265109617590146,0.00425899845604281,0.0146512954655765,0.000362453936429204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29434,0.0137800572747358,0.0038658640430014,0.00620296375045304,0.0213571507990185,0.000365061156286054
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0142866480792964,0.00401346154438413,0.00642026345230346,0.0221530327062893,0.000371898841905575
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.008529297864551,0.00240193958590403,0.0038214962761791,0.0132370994529229,0.000384365117576899
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0215369196779247,0.0060759276526164,0.00962810147879658,0.0334457378770529,0.000393784136614253
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,29820,-0.00578240483109783,0.0016380486380918,-0.00899298016175776,-0.00257182950043791,0.000416096574075849
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,24789,0.0138815495775503,0.00394164048392133,0.00615593422906448,0.0216071649260361,0.00042944715341394
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.0228278021363988,0.00648422327356079,0.0101187245202197,0.035536879752578,0.00043136339362234
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29349,0.00527909067839031,0.00149967796725996,0.00233972186256078,0.00821845949421984,0.000431957202406244
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24381,0.00610370290598564,0.00173493024237582,0.00270323963092904,0.00950416618104225,0.000435397505728473
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29736,0.0112484992741016,0.00320262484576897,0.00497135457639441,0.0175256439718088,0.000444946961980749
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29581,0.0211466014925348,0.0060231073565696,0.00934131107365834,0.0329518919114112,0.000447236646451156
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLC,Galectin-10,29426,-0.0160256151508211,0.00457417085743802,-0.0249909900313997,-0.00706024027024263,0.000459865681404941
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,28443,0.00866348373979828,0.0024738158820081,0.0038148046110624,0.0135121628685342,0.000462361335821081
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,29283,0.00922378032379684,0.0026459501368503,0.00403771805557025,0.0144098425920234,0.000491020387518233
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,24793,0.0107443411410444,0.00309428416280732,0.00467954418194202,0.0168091381001467,0.000516862889103623
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,29443,0.00578276927205747,0.0016654745851214,0.00251843908521953,0.0090470994588954,0.000517058363162382
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24845,0.0253453319051281,0.007323615876488,0.0109910447872116,0.0396996190230446,0.000539542885484163
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29820,-0.0082726972858822,0.00239550669417431,-0.0129678904064638,-0.00357750416530056,0.000554289540035675
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.0196117063224073,0.00568111447816145,0.00847672194521086,0.0307466906996038,0.000557194094895442
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24016,0.0100968984875605,0.00292552789268496,0.00436286381789799,0.015830933157223,0.000558836061844826
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24925,0.00464831714257366,0.00134763035188623,0.00200696165287665,0.00728967263227068,0.000563071083803642
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,29478,0.0205638368713119,0.00596294208634639,0.00887647038207303,0.0322512033605509,0.000564276124986668
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.00727618523785981,0.00211646063295522,-0.011424448078452,-0.00312792239726757,0.000587233101710298
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,29400,0.0207879564886421,0.0060497518662155,0.00893044283085973,0.0326454701464245,0.00059082334007846
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29388,-0.0113724216665985,0.00331389401241028,-0.0178676539309226,-0.00487718940227434,0.000600548398234451
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24240,0.0226204733671276,0.00661903417446717,0.00964716638517193,0.0355937803490832,0.000633056315139623
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00641377019440723,0.00188004691387589,0.00272887824321048,0.010098662145604,0.000646961622199444
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.00973356874999214,0.00285635229729823,-0.0153320192526967,-0.00413511824728761,0.000656219121539061
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0153750720870426,0.00451909521413371,0.00651764546734049,0.0242324987067446,0.000669250323951471
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,29208,0.0106716183338493,0.00313772073872816,0.00452168568594214,0.0168215509817565,0.000672117305836167
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0185883387897965,0.00546751783612617,0.00787200383098917,0.0293046737486038,0.000675324481341352
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.00871004913273963,0.00256247876827678,0.00368759074691715,0.0137325075185621,0.00067721466400477
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0118469468704888,0.00348592269524819,0.00501453838780232,0.0186793553531752,0.00067845518153769
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,24016,-0.00823912210775511,0.0024278041360221,-0.0129976182143584,-0.00348062600115179,0.000690787682592674
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0130680384653142,0.0038551089065282,0.0055120250085189,0.0206240519221095,0.000700545161475454
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0170316089052818,0.00503363590343181,0.00716568253455545,0.0268975352760082,0.000716467522172246
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGN,Cingulin,24195,0.00933925416672161,0.00276329838972972,0.00392318932285135,0.0147553190105919,0.000726667641325904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,29594,-0.00703548547922572,0.00208221017544475,-0.0111166174230974,-0.00295435353535401,0.000728824021602325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,28797,0.00827603870531588,0.00244954761225716,0.00347492538529185,0.0130771520253399,0.000729528174435435
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.0077608921705494,0.00229814094245183,-0.012265248417755,-0.00325653592334383,0.000733887882892098
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,-0.00986697494269541,0.00292207217211237,-0.0155942364000356,-0.00413971348535517,0.000734721496991735
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,24845,-0.00979302093341309,0.00290200646438677,-0.0154809536036112,-0.00410508826321502,0.000740444970649474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,24793,0.0189361091521124,0.00561899476120309,0.00792287942015438,0.0299493388840705,0.000752781410139171
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,24922,0.0061809602430271,0.00183588248114597,0.00258263057998099,0.00977928990607321,0.00076174177955278
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,24240,0.00691906068499702,0.00205849894800197,0.00288440274691316,0.0109537186230809,0.0007771987312028
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0094008929334229,0.00280095630788675,0.00391101856996486,0.0148907672968809,0.000791098664760489
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.00992782558741168,0.00295941767220702,0.00412736694988592,0.0157282842249374,0.000795831131640471
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29378,0.00940740464963728,0.00280612123115459,0.00390740703657428,0.0149074022627003,0.000801983998589446
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,-0.00722915748700477,0.00215885361392035,-0.0114605105702886,-0.0029978044037209,0.000813219407783362
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.00941490498856332,0.00281409851437996,0.0038992719003786,0.014930538076748,0.000822234380932899
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,24101,-0.00650947988425914,0.00194837786241931,-0.010328300494601,-0.0026906592739173,0.000836118945441369
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,24445,0.00676092476717371,0.00202411072300157,0.00279366775009063,0.0107281817842568,0.000838448716713347
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,24101,-0.0098848603390112,0.00296690329418844,-0.0156999907956206,-0.00406972988240185,0.000864440840903701
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,24240,0.0140144528135715,0.00422461692739843,0.00573420363587056,0.0222947019912724,0.000910156191822404
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0148968598431559,0.00449230787963641,0.00609193639906852,0.0237017832872433,0.000914221800754508
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,28931,0.0135997331155648,0.00410235319164855,0.00555912085993362,0.021640345371196,0.000917212446555067
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,29166,0.0160494003502872,0.00484173176553432,0.00655960608983995,0.0255391946107345,0.000918186579997026
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24801,0.00877141249322803,0.00265299024410944,0.00357155161477354,0.0139712733716825,0.000946926595193006
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,24445,-0.00776894843070503,0.00235183033112026,-0.0123785358797007,-0.00315936098170932,0.000956700138403876
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,24111,-0.0126499149246294,0.00383582504348976,-0.0201681320098694,-0.0051316978393895,0.000975747034155467
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,24229,0.0143429466966656,0.00435492181819508,0.00580729993300329,0.022878593460328,0.000990892448608638
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0111147779730081,0.00337796686890079,0.00449396290996259,0.0177355930360537,0.00100171378399305
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,24016,-0.00592644092055481,0.00180185628197836,-0.00945807923323238,-0.00239480260787723,0.00100661797272708
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.0232391981653519,0.00706919028990346,0.00938358519714107,0.0370948111335626,0.00101263944638128
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.0270118764324312,0.00821836902880858,0.0109038731359664,0.043119879728896,0.00101462188384494
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,29163,0.0171035494554538,0.00520832341569909,0.00689523556068359,0.027311863350224,0.00102506305048955
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.0124417781665725,0.00378882461883931,0.00501568191364741,0.0198678744194975,0.0010255598334137
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,24101,-0.0205039569983169,0.00625585919908399,-0.0327654410285215,-0.00824247296811229,0.0010485650843774
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,23970,-0.00922303413282374,0.00282511621682597,-0.0147602619178026,-0.00368580634784484,0.00109750612575001
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0185125324688017,0.00567561214767013,0.00738833265936821,0.0296367322782351,0.00110845591143206
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.016617872277062,0.0051056870703468,0.00661072561918228,0.0266250189349417,0.00113632864326883
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,29218,-0.0125880913683143,0.0038685833156854,-0.0201705146670577,-0.00500566806957089,0.00113950515636122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29662,0.0142228366098781,0.00438766536334164,0.00562301249772853,0.0228226607220278,0.00119012819933771
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.00844012468835736,0.00260455488837377,-0.0135450522695699,-0.00333519710714478,0.00119471770862002
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,24903,-0.00801462180548133,0.00248766567845492,-0.012890446535253,-0.00313879707570969,0.00127576763993628
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,28797,-0.0181239172263697,0.00562886966731179,-0.0291565017743008,-0.00709133267843855,0.00128415772268019
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,29694,0.00595938963000149,0.0018531757720841,0.00232716511671666,0.00959161414328632,0.00130233716097774
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29218,-0.00800301328716261,0.00249404204444221,-0.0128913356942693,-0.00311469088005588,0.00133409664798092
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24845,0.0155420803753981,0.00484703698135402,0.00604188789194425,0.025042272858852,0.00134525021413875
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,29137,-0.0138142168199497,0.00431311132243159,-0.0222679150119156,-0.0053605186279838,0.0013622461815011
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.0129902904370923,0.00405629764355806,-0.0209406338184661,-0.00503994705571853,0.00136417589247918
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.012388328665432,0.00386841181313161,0.00480624151169401,0.0199704158191699,0.00136443875873209
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,29293,0.0123004545740851,0.00386180374311267,0.00473131923758425,0.0198695899105859,0.0014482665015886
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,24229,0.00859641747994479,0.00270026005865101,0.00330390776498882,0.0138889271949008,0.00145664113565752
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24846,0.00439578192569711,0.00138241844435757,0.00168624177475628,0.00710532207663793,0.00147569559432514
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24101,-0.0129619041260026,0.00408893888483773,-0.0209762243402846,-0.00494758391172065,0.00152633847780901
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28931,0.0105231224399557,0.00333589993203218,0.00398475857317262,0.0170614863067387,0.00160933663314597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.0137061871408902,0.0043509562325004,-0.022234061356591,-0.00517831292518945,0.00163383348656818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,28797,0.0165434683332238,0.0052524807086781,0.00624860614421469,0.0268383305222328,0.00163634157965767
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.0133895861211421,0.00425175815673309,-0.021723032108339,-0.00505614013394523,0.00163924785077583
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,24349,-0.0080046327356695,0.00254422151690329,-0.0129913069088,-0.00301795856253905,0.00165605486212647
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,-0.0069618804059344,0.0022130449221877,-0.0112994484534223,-0.00262431235844651,0.00165813329784358
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,29218,0.0092939576806785,0.00295495234809045,0.00350225107842122,0.0150856642829358,0.00166131774161627
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0109498015428477,0.00348335425487232,0.004122427203298,0.0177771758823975,0.00167156273644885
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,24938,-0.00723549280586298,0.00230208613959754,-0.0117475816394742,-0.0027234039722518,0.00167412874818689
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFB,Complement factor B,24538,0.00712957781385606,0.00227229152625924,0.00267588642238795,0.0115832692053242,0.00170529583451823
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0157026195852059,0.0050097213298365,0.00588356577872633,0.0255216733916854,0.00172392302466877
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRTN,Neurturin,28931,0.010679578946935,0.00340751795953777,0.00400084374624097,0.017358314147629,0.00172541154864215
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.0081180446121606,0.00259068212734796,0.00304030764255861,0.0131957815817626,0.00172908669816341
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,24938,0.00938879733677102,0.00300225804534934,0.00350437156788632,0.0152732231056557,0.0017665566292866
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F3,Tissue factor,29541,-0.00587868440789079,0.00188263164768294,-0.00956864243734934,-0.00218872637843223,0.00179441193699925
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,-0.0113124161383029,0.00363236402439125,-0.0184318496261098,-0.0041929826504961,0.00184573081022498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,29274,-0.0061665636444733,0.0019805964873631,-0.010048532759705,-0.00228459452924163,0.00185068236468194
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,29434,0.00669444874534894,0.00215107075369824,0.00247835006810039,0.0109105474225975,0.00185909729236429
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.00798998130472002,0.00256874754295337,-0.0130247264889086,-0.00295523612053142,0.00187015420008146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0150627094327499,0.00485133322951206,0.00555409630290631,0.0245713225625936,0.00190584079170232
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.0213492945595829,0.00687661372330239,0.00787113166191017,0.0348274574572556,0.00190702374350837
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23405,-0.023733919507726,0.0076684250017642,-0.0387640325111838,-0.00870380650426818,0.00197032701165882
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.0100254399189969,0.00324181267409373,-0.0163793927602206,-0.0036714870777732,0.0019867813700542
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24111,0.0085005081086569,0.00275278713968347,0.00310504531487729,0.0138959709024365,0.0020176171972251
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,-0.0148488034773501,0.00480953365910178,-0.0242754894491896,-0.00542211750551064,0.00202126147675408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.00874529489200588,0.00283257369683235,0.00319345044621447,0.0142971393377973,0.00202137244551667
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,29757,0.00634791220648067,0.0020669827054139,0.00229662610386944,0.0103991983090919,0.00213463543834126
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,24805,0.0145851270601527,0.00475213278022142,0.00527094681091877,0.0238993073093867,0.00214882619545269
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.0156078116876414,0.00509065535073413,0.00563012720020251,0.0255854961750803,0.00217164110690794
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,24195,0.0126325781262094,0.00412194508588233,0.00455356575788007,0.0207115904945388,0.00218119003286878
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29594,0.00969324527610624,0.00316657137531969,0.00348676538047965,0.0158997251717328,0.00220710604531123
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,24845,0.00809963010007934,0.00265086744970437,0.00290392989865878,0.0132953303014999,0.00224950897078371
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29116,0.00619554100279307,0.00202927092392767,0.00221816999189483,0.0101729120136913,0.00226704518974758
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0158269556075873,0.00520386882799323,0.00562737270472057,0.026026538510454,0.00235706307439048
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,24016,-0.00654782426862028,0.00215404116780923,-0.0107697449575264,-0.0023259035797142,0.00237001195461335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,24867,0.0093312915352516,0.00307815038325162,0.00329811678407844,0.0153644662864248,0.00243624257229749
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.0085926348453971,0.00283559289794967,-0.0141503969253785,-0.00303487276541575,0.00244584906045377
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.0106267629006832,0.00351454411998186,-0.0175152693758476,-0.00373825642551872,0.00250005163424451
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,0.0102226513019023,0.00338479463579948,0.00358845381573528,0.0168568487880692,0.00252849927050435
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29581,-0.00594315218260412,0.00196812831942714,-0.00980068368868131,-0.00208562067652694,0.00253243120481905
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.00971952688557348,0.0032215435830741,0.00340530146274825,0.0160337523083987,0.00255514335680546
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.00935954848893764,0.00310928142473738,0.00326535689645237,0.0154537400814229,0.00261341347546575
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,28797,0.00904703577734034,0.00301833564090599,0.0031310979211646,0.0149629736335161,0.00272561998704456
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.00477637600770038,0.00159488609453134,0.00165039926241895,0.00790235275298181,0.00274844049303536
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0180086323775906,0.00602385538703358,0.00620187581900474,0.0298153889361764,0.00279664459689749
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,24101,-0.0101630560271612,0.00341190262458238,-0.0168503851713426,-0.00347572688297971,0.00289756441608752
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,24111,-0.00824389918259955,0.00277469887925247,-0.0136823089859344,-0.00280548937926471,0.00297030933554573
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,29478,0.0137903378981677,0.00465529965017288,0.00466595058382881,0.0229147252125065,0.00305605838250973
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,24229,0.0157377118433592,0.00531490792647075,0.00532049230747651,0.0261549313792418,0.00306888794678636
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.0258751785420516,0.00874062322148766,0.00874355702793583,0.0430068000561675,0.00307594148373434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,29820,0.00398349444803926,0.00134809110654978,0.0013412358792017,0.00662575301687683,0.00312999892202913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29434,-0.00953501736427379,0.00322923484995923,-0.0158643176701939,-0.00320571705835369,0.0031523921475956
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28916,0.0170309814964852,0.00580611714169944,0.00565099189875425,0.0284109710942161,0.00335661939007824
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,0.00601734199391908,0.00205423224619175,0.00199104679138325,0.0100436371964549,0.00340098505254146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24845,0.0483927673540676,0.0165374715565214,0.0159793231032857,0.0808062116048496,0.00343386499964354
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,24445,-0.0057835726478647,0.00198040382862675,-0.00966516415197313,-0.00190198114375628,0.00349901169571733
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,-0.0114227405129255,0.00391779167363701,-0.019101612193254,-0.00374386883259694,0.00355266073023598
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,28751,0.017449719744261,0.00598629003827592,0.00571659126924023,0.0291828482192819,0.00356023226550605
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,24845,0.0103530359118919,0.003560961426721,0.00337355151551874,0.0173325203082651,0.00364803171567334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,24111,-0.0145028221738086,0.00499241188974682,-0.0242879494777123,-0.00471769486990482,0.00367618570259416
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,29694,0.00585194548914423,0.00201538615858133,0.00190178861832482,0.00980210235996365,0.00369129859449481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29038,-0.0343076572119225,0.0118355231911028,-0.0575052826664839,-0.011110031757361,0.00374991192898464
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24793,-0.0104058248855912,0.00359966023887533,-0.0174611589537869,-0.00335049081739557,0.0038462109316245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,29434,0.0127761535673157,0.00443298125505746,0.00408751030740313,0.0214647968272284,0.00395360249320489
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24805,-0.00866951851103213,0.00301217630625099,-0.0145733840712841,-0.0027656529507802,0.0040034684356585
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0126895809051892,0.00441184807593687,0.00404235867635292,0.0213368031340254,0.00402729635840993
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.00873853246946566,0.00304013803182216,0.00277986192709422,0.0146972030118371,0.0040516221976498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,-0.0127988727595125,0.00445755336505543,-0.0215356773550211,-0.00406206816400384,0.00409107212253258
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F2,Prothrombin,24966,-0.00293745615893391,0.00102344187829717,-0.00494340224039636,-0.000931510077471452,0.00410590874777459
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24805,0.0189855246130653,0.00661699181173383,0.00601622066206701,0.0319548285640636,0.00411848964408319
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0107466755107929,0.00374872602528423,0.00339917250123577,0.0180941785203499,0.00415054586065573
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,0.0152742684193516,0.00533378459178896,0.00482005061944521,0.0257284862192579,0.00419049371453953
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,24914,-0.00291487065652948,0.00102177937179952,-0.00491755822525654,-0.000912183087802422,0.00433798031907928
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24502,0.00840996460223792,0.00294897428813711,0.00262997499748919,0.0141899542069866,0.00435051132342236
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,24833,0.00509302681266806,0.00178639808682963,0.00159168656248198,0.00859436706285413,0.00436174567714738
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24845,0.00553018019852788,0.00194287704790891,0.00172214118462642,0.00933821921242934,0.00442546354853189
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,24867,0.00978745414695145,0.00344057969193969,0.00304391795074966,0.0165309903431532,0.00444880775653045
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28931,0.013100107184803,0.00461081808376138,0.00406290374063065,0.0221373106289753,0.0044980091560069
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,29725,-0.00896365728263281,0.0031571974127172,-0.0151517642115585,-0.0027755503537071,0.0045269060048377
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24515,-0.00266168781320312,0.00094121472619322,-0.00450646867654183,-0.00081690694986441,0.00468882908328335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,24922,0.0102657711509601,0.00364148806441489,0.00312845454470689,0.0174030877572133,0.00481943542919787
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0133476356311027,0.004741927109753,0.00405345849598679,0.0226418127662185,0.00488448439658262
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.00613799859016296,0.0021806302481555,-0.0104120338765477,-0.00186396330377818,0.00488499271007882
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,28867,0.0115912662959962,0.00412036141632296,0.00351535792000319,0.0196671746719892,0.00490892643089552
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,29590,0.00795766501811926,0.00283323783357498,0.00240451886431229,0.0135108111719262,0.00497773155020323
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0101683616948053,0.00362321662840924,0.00306685710312321,0.0172698662864874,0.00501303945419684
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,24647,0.00850802296599273,0.0030324451721223,0.00256443042863301,0.0144516155033524,0.00502523545524073
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,24111,-0.00811723820262731,0.00290133854126314,-0.0138038617435031,-0.00243061466175156,0.0051499747261722
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,29443,-0.00378842106423336,0.00135456035082237,-0.00644335935184521,-0.0011334827766215,0.00516465285815143
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,28931,0.00918003348760038,0.00328299950902108,0.00274535444991906,0.0156147125252817,0.0051736131330082
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,28797,0.0155314697227349,0.0055546686268298,0.00464431921414852,0.0264186202313213,0.00517559224731809
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.00545968184954021,0.00195630058450898,-0.00929403099517781,-0.00162533270390261,0.00526155541365968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,29327,0.0113752040743768,0.0040822769998371,0.00337394115469611,0.0193764669940575,0.00533173135854579
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.0070314908161088,0.00252450095525442,0.00208346894381013,0.0119795126884075,0.00535195099955277
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29478,0.0060973426327891,0.00219105203646841,0.00180288064131101,0.0103918046242672,0.00539200175322346
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24229,-0.00811716065688114,0.00292406001255305,-0.0138483182814851,-0.00238600303227718,0.00550761844363396
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,29349,0.00800159471411984,0.00288483826436092,0.00234731171597243,0.0136558777122672,0.0055462567937488
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,24111,-0.00652156181440373,0.00236050804098971,-0.0111481575747436,-0.00189496605406391,0.00573550277916339
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.00873853209362778,0.00316907015929966,0.00252715458140045,0.0149499096058551,0.00582991324003486
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,24914,-0.00430016395821278,0.00156176055987944,-0.00736121465557649,-0.00123911326084908,0.00590211002330869
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00642270535916501,0.00233488485831413,-0.0109990796814607,-0.00184633103686932,0.00594937192426481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0100998868980737,0.00368873483870678,0.0028699666142084,0.017329807181939,0.00618446734662717
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,29466,0.00750684460965332,0.00275195115137833,0.00211302035295179,0.0129006688663548,0.00637909551437805
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,0.0107653956526966,0.00394732023649723,0.00302864798916204,0.0185021433162312,0.00638991049729423
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,29453,0.0176304705062525,0.00647442508774647,0.00494059733426945,0.0303203436782356,0.00647116826649267
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.00537995893074952,0.00197807290281156,0.00150293604123887,0.00925698182026017,0.00653673099153573
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,29491,0.0120347404147967,0.00444696440927937,0.00331869017260911,0.0207507906569842,0.00680803623241742
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALLD,Palladin,24229,-0.00747229502398161,0.00276420161265779,-0.0128901301847909,-0.00205445986317235,0.00687154539314621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,24149,0.0127263289349081,0.00470861803768735,0.00349743758104087,0.0219552202887753,0.00688116530044381
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,24111,0.00939045573117341,0.00348332499423851,0.00256313874246593,0.0162177727198809,0.00702620112454711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.00623126944290067,0.00231199282884255,-0.0107627753874321,-0.00169976349836927,0.00703877203572526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29454,-0.00466863410600368,0.00173664240949741,-0.00807245322861861,-0.00126481498338876,0.00718549751569631
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0268897185696357,0.0100074153643381,0.00727518445553299,0.0465042526837384,0.0072142855044474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERVV_1,,24111,-0.00854559299324411,0.003193483251424,-0.0148048201660352,-0.00228636582045307,0.00745687343575529
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28797,0.00967755184663246,0.00362244766230227,0.00257755442852001,0.0167775492647449,0.00755441949455398
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,-0.0108738315597454,0.00408314922313446,-0.018876804037089,-0.00287085908240186,0.00774760511720909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24240,0.0156078926960353,0.00588266096616269,0.00407787720235641,0.0271379081897142,0.00797839505386539
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,24101,-0.0175371530104558,0.00661818616003145,-0.0305087978841174,-0.00456550813679415,0.00805818189697836
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0112336557006873,0.00425024606812134,0.00290317340716948,0.0195641379942051,0.00822133175786383
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,-0.00788437504900178,0.00298781550041108,-0.0137404934298075,-0.00202825666819606,0.00832412790848126
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,24016,-0.00862221133816548,0.00327036170606995,-0.0150321202820626,-0.00221230239426838,0.00838274663504355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24195,-0.0078671773331775,0.00298418128153166,-0.0137161726449796,-0.00201818202137545,0.00838707665202538
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,29218,-0.00220122901523079,0.00083785626750078,-0.00384342729953232,-0.000559030730929265,0.0086131753024965
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,-0.00664303532040051,0.00252964931710024,-0.011601147981917,-0.00168492265888404,0.00864213305716088
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,24445,-0.00709665007723063,0.00270264795415203,-0.0123938400673686,-0.00179946008709265,0.00864959863925523
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIM,Vimentin,28916,0.0210868401805781,0.00803716699239278,0.00533399287548824,0.0368396874856679,0.00870347897436031
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29786,0.0131766870519599,0.00505036680289854,0.0032779681182788,0.0230754059856411,0.00908379153274708
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.00944236922857556,0.00362539912790954,0.00233658693787285,0.0165481515192783,0.00920544275563403
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.00743570366304829,0.00285685345553014,-0.0130351364358874,-0.00183627089020921,0.00925333400510658
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.00713626332023697,0.00274672914239337,0.00175267420114598,0.012519852439328,0.00937902996715614
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,24101,-0.00830085344858054,0.00319564368521054,-0.0145643150715932,-0.00203739182556789,0.00939477731078059
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,29713,0.00378377733261571,0.0014611593639237,0.00091990497932526,0.00664764968590616,0.00961422220967383
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.0069048718608902,0.00266846573742474,0.00167467901553772,0.0121350647062427,0.00967100877538797
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,24445,-0.00614314953371575,0.00238126511800413,-0.0108104291650039,-0.00147586990242765,0.00989200019497673
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,29594,0.00828002976356653,0.0032119448905556,0.00198461777807754,0.0145754417490555,0.00994545310384922
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29434,0.0058650844209858,0.002288135783695,0.00138033828494361,0.010349830557028,0.0103743947643889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,24966,0.00458146006213308,0.0017890137593481,0.0010749930938108,0.00808792703045535,0.0104463931332354
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.0044929505883246,0.00176082251161719,-0.00794416271109429,-0.00104173846555491,0.0107284710148376
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29478,0.00696077353440352,0.00273080813679196,0.00160838958629128,0.0123131574825158,0.0108088936717492
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,0.00798537273388065,0.0031334197037413,0.00184387011454771,0.0141268753532136,0.0108251787507266
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,24706,-0.0126029631822393,0.00498015052574163,-0.0223640582126929,-0.00284186815178573,0.0113916539528855
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,29169,-0.0055784182411825,0.00221438233336529,-0.00991860761457847,-0.00123822886778653,0.0117682954023339
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,28797,0.012557430190491,0.00501599314603508,0.00272608362426223,0.0223887767567197,0.0123034131019596
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00665722594890052,0.00265983684399453,-0.0118705061631298,-0.00144394573467125,0.0123256431467537
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.00931642287623151,0.00373355443539117,0.00199865618286482,0.0166341895695982,0.0125897164079284
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29333,0.00447875880343605,0.00179635451973571,0.000957903944754054,0.00799961366211805,0.0126634805943211
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,28797,0.0127192462214792,0.00512535968947808,0.00267354123010212,0.0227649512128562,0.0130839634726258
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0066841027700953,0.00269724220682402,0.00139750804472023,0.0119706974954704,0.0132142678850708
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28931,0.00603896973736664,0.00244538970222288,0.00124600592100979,0.0108319335537235,0.013534698127401
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24805,0.0167519600880825,0.00678418804318468,0.0034549515234405,0.0300489686527244,0.0135457679286254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29395,0.0185983170372809,0.00754177187133351,0.00381644416946716,0.0333801899050945,0.0136672455019815
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.0203977824721005,0.0082778251782816,0.00417324512266861,0.0366223198215325,0.0137396317468265
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.00943596332784816,0.00383540687761049,-0.0169533608079647,-0.0019185658477316,0.0138907107192452
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00670343502517512,0.00272519512726925,0.00136205257572739,0.0120448174746229,0.0139084148895699
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,29478,0.0136597143685194,0.00556460251519256,0.00275309343874198,0.0245663352982968,0.0141039539438115
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,29497,0.00502123061129168,0.00204906406683518,0.00100506504029473,0.00903739618228862,0.0142715815888092
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,28774,-0.00553355537946012,0.00225922108977914,-0.00996162871542724,-0.001105482043493,0.0143185457176353
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,24111,-0.00784530361542531,0.00323069802234932,-0.01417747173923,-0.00151313549162065,0.0151744730692466
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,24922,-0.0177707773431569,0.00731989694735756,-0.0321177753599777,-0.00342377932633609,0.0152004354523929
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,24938,-0.00867563279117961,0.00357707238073793,-0.015686694657426,-0.00166457092493326,0.0153009212157903
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,29443,0.00735343246207254,0.00303441144519557,0.00140598602948922,0.0133008788946559,0.0153842117048498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,29349,0.0143249722938338,0.00592342729820085,0.00271505478936018,0.0259348897983075,0.0155967455285047
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,-0.00612787592749423,0.00253576400940893,-0.0110979733859357,-0.00115777846905272,0.0156742566924313
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,24111,0.0100212195376964,0.00415554761577862,0.00187634621077031,0.0181660928646225,0.015893259853847
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,24793,-0.00923724537503135,0.00383243176318963,-0.016748811630883,-0.00172567911917967,0.015947383882849
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24111,0.00731323186180823,0.00304745511439488,0.00134021983759428,0.0132862438860222,0.0164123221504845
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,24101,-0.00583806494415349,0.00243351513861502,-0.0106077546158389,-0.00106837527246806,0.0164463205006897
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,24101,-0.00786816324484348,0.00329214684538516,-0.0143207710617984,-0.00141555542788857,0.016856955325716
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,24229,0.00356406235069945,0.00150149509106504,0.00062113197221198,0.00650699272918693,0.0176197681883357
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0101985675090265,0.00430749200103094,0.00175588318700585,0.0186412518310471,0.0179097926696892
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,29343,0.0177276911817843,0.00748919571930227,0.00304886757195185,0.0324065147916167,0.0179344390385774
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,24229,-0.00891386149927886,0.00376844409577035,-0.0163000119269887,-0.00152771107156897,0.0180186493063984
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,24016,-0.00760513345684847,0.00321718223876229,-0.0139108106448226,-0.00129945626887438,0.0180910594609241
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.00329652219297967,0.00141019183832047,-0.00606049819608778,-0.000532546189871556,0.0194125159635147
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.00657855602631827,0.00281600416624876,0.0010591878604707,0.0120979241921658,0.019491216502388
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.00755689535612007,0.00323516961715187,0.00121596290650241,0.0138978278057377,0.0195054968262489
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24229,0.0104125815439218,0.00445850804929787,0.00167390576729799,0.0191512573205456,0.0195285277631342
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.010788397326594,0.00462095867863527,0.00173131831646884,0.0198454763367191,0.0195687950396582
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MB,Myoglobin,29820,0.00843493337965123,0.00361594483931046,0.00134768149460273,0.0155221852646997,0.0196702420553752
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,24307,0.0135364304472771,0.00580613768645071,0.00215640058183372,0.0249164603127205,0.0197404026033237
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.00763821987112553,0.00327877047627156,0.00121182973763328,0.0140646100046178,0.0198353558757597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.00595140493766812,0.00255610118250933,-0.0109613632553864,-0.000941446619949837,0.0199036639337654
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24111,0.00640865889818686,0.00275499124975228,0.0010088760486724,0.0118084417477013,0.0200161684361408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24111,-0.00602278947626278,0.0025958825281471,-0.0111107192314311,-0.000934859721094459,0.0203420607203233
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,24867,0.00599713197605356,0.00258800998739541,0.000924632400758564,0.0110696315513486,0.0204968159230365
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24805,-0.00745875997715754,0.00322000177385888,-0.0137699634539209,-0.00114755650039414,0.0205454340134159
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.00645385805520895,0.00278653170083528,-0.0119154601888461,-0.000992255921571793,0.0205616622702258
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,24381,0.0178950713076842,0.00775369007698813,0.00269783875678751,0.033092303858581,0.0210106654174229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,29199,-0.0202599309195113,0.00877990426065555,-0.0374685432703962,-0.00305131856862642,0.0210320092114356
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.00848791384409494,0.00368745589887289,0.00126050028230408,0.0157153274058858,0.0213527071637914
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,24381,0.00703399377771384,0.00306324560593753,0.00103003239007628,0.0130379551653514,0.021669736922428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,24195,0.00958826809163491,0.00418418350900424,0.00138726841398661,0.0177892677692832,0.0219401461646024
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,24195,0.0103396003284574,0.00451782850015508,0.00148465646815349,0.0191945441887614,0.0221099256393218
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,-0.00434176597162317,0.00189999816748905,-0.00806576237990171,-0.000617769563344621,0.0223115119898586
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,29349,0.0134018572854824,0.00589110632364823,0.00185528889113186,0.0249484256798329,0.0229172845870508
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,24919,-0.0171987918829021,0.00756781880758687,-0.0320317167457723,-0.00236586702003181,0.0230574485749093
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,24445,-0.0055734095924436,0.0024537532936192,-0.0103827660479372,-0.000764053136949966,0.0231325585059518
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28931,0.00614523564839256,0.00270697662539096,0.000839561462626278,0.0114509098341588,0.0232059735412098
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.00739223689292438,0.00326698355119472,0.000988949132582718,0.013795524653266,0.0236609811837791
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,24016,-0.0057864997080842,0.00256171904493658,-0.0108074690361599,-0.000765530380008494,0.0239026077712496
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,24938,-0.004876646969499,0.00216824537971437,-0.00912640791373915,-0.000626886025258841,0.0245134706653563
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,-0.00438069145246342,0.00195578611822418,-0.00821403224418281,-0.000547350660744019,0.0251072949441931
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',24111,0.00666061481453661,0.00297461689666838,0.000830365697066586,0.0124908639320066,0.0251552148681817
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,28847,0.0137500859050153,0.00614638641639807,0.00170316852887508,0.0257970032811555,0.0252873643501707
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,28931,-0.00724237934318736,0.00325043635642098,-0.0136132346017725,-0.000871524084602246,0.0258798233704906
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,28774,0.00595471465560952,0.00267275597958038,0.000716112935631971,0.0111933163755871,0.0258928509809473
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,24845,0.0148481580069899,0.00668374539594927,0.00174801703092934,0.0279482989830505,0.0263238931106435
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.00842577456291911,0.00379288491253298,0.000991720134354465,0.0158598289914838,0.0263282239248221
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28797,0.00508138447898508,0.00228772116484265,0.000597450995893486,0.00956531796207668,0.0263481809947495
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,24111,-0.00775333445459717,0.00350060269169451,-0.0146145157303184,-0.000892153178875927,0.0267791975581266
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,-0.00576724631301268,0.0026061406356533,-0.0108752819588932,-0.000659210667132205,0.026909379391816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,24016,-0.00629432405951099,0.00284541745224237,-0.011871342265906,-0.000717305853115944,0.026969716867283
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24966,-0.0025763464467968,0.00116484831465746,-0.00485944914352543,-0.000293243750068175,0.0269933747975764
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,24445,-0.00635531863635704,0.00288265949845929,-0.0120053312533373,-0.000705306019376827,0.0274864054137107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,29434,0.00527067216011681,0.00239074166549209,0.000584818495752319,0.00995652582448131,0.0274886208945521
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,-0.00770801683569855,0.00349673465868298,-0.0145616167667172,-0.000854416904679904,0.0275077142408698
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24229,-0.00661764965301144,0.00300576765405519,-0.0125089542549596,-0.000726345051063262,0.0276994066860808
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,24111,-0.00767298305701824,0.00348857254016575,-0.0145105852357431,-0.000835380878293362,0.0278545443616269
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24229,-0.00736024494982919,0.00334682508148123,-0.0139200221095324,-0.000800467790125974,0.0278750936810757
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,24229,-0.00885670203362566,0.00403201340709934,-0.0167594483115404,-0.000953955755710948,0.0280587995061421
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,24229,-0.0066750849936947,0.00304036602433775,-0.0126342024013967,-0.000715967585992707,0.0281381144780437
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,28774,-0.00778867463658367,0.0035639775810495,-0.0147740706954407,-0.000803278577726645,0.0288684321154138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,24938,-0.0134120885202458,0.0061402150984088,-0.025446910113127,-0.00137726692736453,0.0289492968681086
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00858998297980712,0.00393402583649971,-0.0163006736193466,-0.000879292340267681,0.029007956225214
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.00395547558031266,0.00181395807108886,-0.00751083339964683,-0.000400117760978486,0.0292243813882041
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,24111,-0.00780903449243469,0.00358281570574293,-0.0148313532756908,-0.000786715709178537,0.0292982353713319
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29478,0.00941128106858,0.00433384803166534,0.000916938926515939,0.0179056232106441,0.0298955981226807
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.00715082729638728,0.00330455021396801,0.000673908877009979,0.0136277457157646,0.0304776652667385
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,24805,0.0169008182710132,0.00783122234445214,0.00155162247588702,0.0322500140661394,0.0309270741685428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,24016,0.0107406914748647,0.0050034431226048,0.000933942954559272,0.0205474399951701,0.0318303457080894
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,24101,0.0065408567602897,0.00304856981083755,0.000565659931048111,0.0125160535895313,0.0319189210822832
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,24615,0.00953036009304877,0.00444345098129682,0.000821196169707003,0.0182395240163905,0.0319777691181564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,29536,-0.0122198804757197,0.00570323533770879,-0.0233982217376289,-0.00104153921381044,0.0321515736499222
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,0.0108503268293503,0.00507941335602548,0.000894676651540343,0.0208059770071602,0.032676414886033
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.00980441878085463,0.00459879171382313,0.00079078702176129,0.018818050539948,0.0330187068794058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,29478,0.011186543097617,0.00525739037017699,0.000882057972070065,0.0214910282231638,0.0333640322090501
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,24229,-0.00681404794857762,0.00320826505384977,-0.0131022474541232,-0.000525848443032062,0.0336882537774314
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24769,0.0128252329172385,0.00604436788987809,0.000978271853077396,0.0246721939813995,0.0338603672402116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,24111,0.0108045908875471,0.00510912339846913,0.000790709026547614,0.0208184727485466,0.0344602939206188
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,24938,0.00682894917605051,0.00322957903916625,0.000498974259284649,0.0131589240928164,0.0344823720064851
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.00461334423015498,0.00218209456651435,-0.00889024958052311,-0.000336438879786855,0.0345080392746245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.00785647404543659,0.00372040918634903,0.000564472040192489,0.0151484760506807,0.0347204355137504
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00484094795632354,0.00229488854704688,0.000342966404111654,0.00933892950853542,0.0349161644019761
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,24101,-0.00498299141166291,0.00236378276843653,-0.00961600563779852,-0.000349977185527312,0.0350362661628858
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.00715010424553373,0.00341219394493665,0.000462204113457893,0.0138380043776096,0.0361405467444043
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0102127731543067,0.00488108872720143,0.000645839248991871,0.0197797070596215,0.0364206768975857
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.00828296915511125,0.00397021075055796,0.000501356084017649,0.0160645822262048,0.0369621381419322
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,29434,0.00747236503858695,0.00358643036825231,0.000442961516812423,0.0145017685603615,0.0372133334941527
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,24111,-0.00777284537988798,0.00374020793971981,-0.0151036529417388,-0.000442037818037155,0.0377028486212418
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,24229,-0.00817840918306386,0.0039407592743915,-0.0159022973608712,-0.000454521005256533,0.0379657111747121
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,24229,0.00243302056242909,0.0011744302324388,0.000131137306849045,0.00473490381800914,0.0383076890373747
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,28852,0.0104439607482679,0.00505279237249347,0.000540487698180665,0.0203474337983551,0.0387460610253671
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,24922,0.0139326963269959,0.00676023425460466,0.000682637187970764,0.0271827554660211,0.039315464026848
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,24195,-0.00490703449982573,0.00239474080906298,-0.00960072648558918,-0.00021334251406228,0.0404642848355426
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.0170888777054427,0.00834881437328866,0.00072520153379697,0.0334525538770885,0.0406804213246302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29820,-0.00367939466979865,0.00179767190608898,-0.00720283160573304,-0.000155957733864254,0.0406908587657575
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,29594,-0.00822596612065268,0.00402428488575001,-0.0161135644967227,-0.000338367744582665,0.0409543368551302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0034063295107741,0.00166658280712196,0.00013982720881506,0.00667283181273314,0.0409722845247816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,28931,0.0040629980443437,0.00198899259890581,0.000164572550488317,0.00796142353819909,0.0410870666444043
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,29349,0.0265659809014332,0.0130318267038503,0.00102360056188664,0.0521083612409798,0.0415042864061498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,24966,-0.00273365751369224,0.00134111585237046,-0.00536224458433834,-0.000105070443046136,0.0415259099198803
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,24195,-0.00531271429768813,0.00260887362427319,-0.0104261066012636,-0.000199321994112675,0.0417209223130627
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24016,0.00789340486034504,0.00387675939707247,0.000294956442083004,0.0154918532786071,0.0417529530188149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00484457712349718,0.00238140989230746,0.000177013734574569,0.0095121405124198,0.0419270629282602
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,24111,-0.0048338381485789,0.00237946598877836,-0.00949759148658448,-0.000170084810573324,0.0422172524333645
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,0.0112168199898835,0.00552359844665962,0.000390567034430677,0.0220430729453364,0.0422955433600985
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.00804598052619103,0.00396400281135047,0.000276535015944121,0.015815426036438,0.0423899240843686
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0124717158414728,0.00615458625765062,0.00040872677647759,0.024534704906468,0.0427336457225688
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.00753718907641662,0.00371959072549309,0.000246791254450156,0.0148275868983831,0.0427382400402158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,-0.0136785604120718,0.00677353159238412,-0.0269546823331447,-0.000402438490998955,0.0434532799679591
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.00384816699798674,0.00190641434424068,0.000111594883275012,0.00758473911269847,0.0435446767635675
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,28114,0.00389660389426001,0.00193845179239333,9.72383811690871e-05,0.00769596940735094,0.0444234878959913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,28916,-0.00734535552709388,0.00367318321771997,-0.014544794633825,-0.000145916420362747,0.0455393324285034
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,24826,-0.00329621225777895,0.00164936447615576,-0.00652896663104424,-6.34578845136562e-05,0.0456761723237325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,-0.00578760591337265,0.00290052950075732,-0.011472643734857,-0.000102568091888305,0.0460143259550165
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,-0.00974914688211849,0.00489805153935246,-0.0193493278992493,-0.000148965864987669,0.0465545832978218
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,29392,-0.0107857188936242,0.0054299287443147,-0.021428379232481,-0.000143058554767343,0.0470041605628378
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,-0.00468996563566912,0.00236749797861069,-0.00933026167374607,-4.9669597592162e-05,0.0476028669764742
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.0133712823112658,0.00675077580746334,0.000139761728637607,0.0266028028938939,0.0476339579232576
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,28931,0.00738563433952757,0.00373033598172096,7.41758153544915e-05,0.0146970928637007,0.0477259751639532
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,24016,-0.00651878563344433,0.00330316319610557,-0.0129929854978112,-4.45857690774083e-05,0.0484503154682716
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28931,0.00856673997897961,0.00434747152305768,4.56957937865574e-05,0.0170877841641727,0.0487893723481951
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,24016,-0.0109320802836954,0.00555629528906359,-0.02182241905026,-4.17415171307441e-05,0.0491356564210184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,24229,0.00555290581702623,0.00282720189635893,1.15901001627311e-05,0.0110942215338897,0.0495299759195862
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24111,-0.00989335197399237,0.00504234135130066,-0.0197763410225417,-1.03629254430866e-05,0.0497675523656487
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.0154051454910399,0.00785734440156404,4.7504639743394e-06,0.0308055405181054,0.0499363475478238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPHS2,Podocin,24229,-0.0140131045995685,0.00715300724925826,-0.0280329988081147,6.78960897768782e-06,0.0501182956638496
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,28954,0.00557864662048711,0.00285679819674009,-2.06778451234679e-05,0.0111779710860977,0.0508574430819116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24101,-0.0123366468918607,0.00632359554921746,-0.024730894168327,5.76003846054704e-05,0.0510815687669021
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,24195,0.00657007320695668,0.00337413387191403,-4.32291819948121e-05,0.0131833755959082,0.0515237523557772
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.00596059101926895,0.00307130845638605,-0.0119803555937856,5.91735552477116e-05,0.0523022084684707
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24938,-0.00354219769321931,0.00182718834826805,-0.00712348685582469,3.9091469386065e-05,0.0525606475947045
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,24793,0.00560734127682355,0.00289666768284001,-7.01273815428725e-05,0.01128480993519,0.0529047466776823
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,24867,0.0040402986725928,0.00209874616981314,-7.3243820240947e-05,0.00815384116542655,0.0542281035733723
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.0067152825292519,0.00349432887931927,-0.0135641671327177,0.000133602074213874,0.0546468466207638
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,24867,-0.00686535374417337,0.0035800311950551,-0.0138822148864814,0.000151507398134632,0.0551630643873715
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,28916,-0.00509244806904646,0.00265681472008275,-0.0102998049204086,0.000114908782315728,0.0552796234047085
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,29478,-0.0154279660982854,0.00805493700824726,-0.0312156426344501,0.000359710437879213,0.0554584624187191
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,29581,0.00436006279024035,0.0023018279474933,-0.000151519986846515,0.00887164556732722,0.0582116600204384
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,29434,0.0072780292584005,0.00384338989406227,-0.000255014933961559,0.0148110734507626,0.0582814915487853
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0113175804183645,0.00598798930145291,-0.000418878612483192,0.0230540394492122,0.0587637296553769
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00562568195960844,0.00299975509725985,-0.0115052019502377,0.000253838031020864,0.0607524897474791
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENG,Endoglin,29820,-0.00221656663269083,0.0011862922983865,-0.00454169953752836,0.000108566272146698,0.0617046219625553
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,-0.00293201723171881,0.00156959339026302,-0.00600842027663433,0.00014438581319672,0.0617704884724253
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24101,-0.00726980679388177,0.00389888093978038,-0.0149116134358513,0.000371999848087769,0.062251322803484
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,-0.0100354896011171,0.0053829453642188,-0.020586062514986,0.000515083312751729,0.0622900110949512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,24793,-0.00742538621537466,0.00400119294253117,-0.0152677243827357,0.000416951951986436,0.0634949204159964
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29349,0.00292802847309856,0.00158232928953529,-0.000173336934390607,0.00602939388058772,0.064258106802291
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.00670863341758584,0.00362668124305983,-0.0138169286539831,0.000399661818811421,0.0643547496405007
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0111286216649824,0.0060178139308302,-0.000666293639444758,0.0229235369694096,0.064429601527002
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,-0.00451900561150206,0.00244718581358902,-0.00931548980613654,0.000277478583132425,0.064815414513564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.00842944708634248,0.00457734450999698,-0.000542148153251596,0.0174010423259366,0.0655520578179858
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTN,Titin,24111,0.00855462406902942,0.004646418819392,-0.000552356816978912,0.0176616049550377,0.065615962203364
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.010892999037184,0.00591800459445851,-0.000706289967954703,0.0224922880423227,0.0656845612830534
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.00567705039113717,0.0030852148592927,-0.000369970733076519,0.0117240715153509,0.0657683321876217
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24240,-0.00504287201132935,0.00274896995274931,-0.010430853118718,0.000345109096059299,0.0665981805301498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,24195,0.00798572368899112,0.00435538851062305,-0.000550837791830062,0.0165222851698123,0.0667364785141587
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00833954077515213,0.00456375312366428,-0.0172844968975341,0.000605415347229864,0.0676606746934651
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,24867,0.00869630797562856,0.00475930021546179,-0.000631920446676551,0.0180245363979337,0.0676780697695521
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,28774,0.00850122657293239,0.00465290151011382,-0.000618460386890701,0.0176209135327555,0.0676979938573255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,24195,0.00652881056024467,0.00357730534967271,-0.000482707925113847,0.0135403290456032,0.0680037297070517
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,29694,0.00821250055949017,0.00450476191211419,-0.000616832788253637,0.017041833907234,0.0683027008238626
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,24229,0.00575104154781888,0.00316404862989163,-0.000450493766768711,0.0119525768624065,0.0691344168746487
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,29581,0.00262112198591931,0.00144936489970446,-0.000219633217501439,0.00546187718934006,0.0705447121350486
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,24016,0.00910939760742282,0.00505072628587529,-0.000790025912892744,0.0190088211277384,0.0713094379093118
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0108506681142381,0.00605699352104629,-0.00102103918701262,0.0227223754154888,0.0732368235795368
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.00274626980448749,0.00153634610029167,-0.000264968552084183,0.00575750816105917,0.0738616290035524
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.00602384337235287,0.00337596085471944,-0.000593039902897238,0.012640726647603,0.0743815251313388
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29434,-0.0043311521758241,0.00242918260416879,-0.00909235007999492,0.000430045728346721,0.074601999039045
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00370064621433713,0.00208395445137891,-0.0077851969390398,0.000383904510365537,0.0757816828528663
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,29413,0.0156615041131132,0.00881958062234152,-0.00162487390667613,0.0329478821329026,0.0757819718915868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.00320176429832763,0.00180510538705189,-0.000336242260294072,0.00673977085694933,0.0761208647855664
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,28916,0.00594225988737865,0.00335537981356864,-0.000634284547215876,0.0125188043219732,0.0765770755957936
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.00510513418341149,0.00288366295049524,-0.0107571135663822,0.00054684519955918,0.076679038525408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24381,0.00647834321816201,0.00366491685239694,-0.000704893812535994,0.01366158024886,0.0771295300174914
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.00342074207502082,0.00194613767861774,-0.000393687775069952,0.00723517192511159,0.0788098070101423
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.0040345505191412,0.00229655674742348,-0.00046670070580882,0.00853580174409122,0.0789672268888907
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,24556,0.00745120827650393,0.00426433644417689,-0.000906891154082775,0.0158093077070906,0.0805924045564372
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,28931,0.00721355604885887,0.00413074287763339,-0.000882699991302585,0.0153098120890203,0.0807677822846974
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28916,0.00587650146599901,0.00336543617673912,-0.000719753440409671,0.0124727563724077,0.0807983493193402
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,24229,-0.0034259139716885,0.00196280326303719,-0.00727300836724139,0.000421180423864385,0.0809246563183442
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24922,0.00474014730238892,0.00272438610940217,-0.000599649472039341,0.0100799440768172,0.0818897094058455
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,23970,-0.00960356569642054,0.00552450638162095,-0.0204315982043976,0.00122446681155651,0.082160733402601
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,28931,-0.00586882296585445,0.00337658242500678,-0.0124869245188677,0.000749278587158832,0.082204619530666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24405,-0.00636915950449824,0.00366484151110003,-0.0135522488662543,0.000813929857257828,0.082239544408398
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00881288481560284,0.00507861485016037,-0.0187669699219172,0.00114120029071149,0.0827017102973016
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.00848179956938044,0.00489164136896931,-0.0180694166525603,0.00110581751379941,0.0829419932487089
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24229,0.012697448990345,0.00734102369277406,-0.00169095744749216,0.0270858554281821,0.0837044166874334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00840140206184574,0.00485920835244459,-0.0179254504326371,0.00112264630894565,0.0838281397557828
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24951,0.00867908449470812,0.00502270974262109,-0.00116542660082922,0.0185235955902455,0.0840062421743317
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,29820,0.00486473233495946,0.00282193740646728,-0.000666264981716409,0.0103957296516353,0.0847366225087512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,24793,0.00733647402030194,0.00426721132940847,-0.00102726018533865,0.0157002082259425,0.0855783229883424
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0041324181340778,0.00240979883332814,-0.000590787579245355,0.00885562384740095,0.0863850708877
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,-0.00666198168758986,0.00388708764651456,-0.0142806734747584,0.000956710099578683,0.0865645821198804
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24793,0.00440937040632762,0.00257360193373713,-0.000634889383797158,0.0094536301964524,0.0866685695790652
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,24101,-0.00632166223340842,0.00372094527507478,-0.013614714972555,0.000971390505738137,0.0893434298712701
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,-0.00372212856119713,0.00219197820423024,-0.0080184058414884,0.000574148719094145,0.0895056484201868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.00614085746019337,0.00361776906391854,-0.00094996990508697,0.0132316848254737,0.0896309930563154
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.00385275568652432,0.00227075209066144,-0.00830342978422074,0.00059791841117209,0.0897687610210775
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,0.00278091071916292,0.00164831522223326,-0.000449787116414274,0.00601160855474012,0.0915922296001653
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,29639,-0.00294014566126796,0.00175307818503378,-0.00637617890393417,0.000495887581398239,0.0935269838053581
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,-0.00390727012689612,0.00233149083701185,-0.00847699216743934,0.000662451913647105,0.0937766655722424
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,24195,0.00362463980257166,0.00216636415372193,-0.000621433938723326,0.00787071354386666,0.0943118304764307
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,29725,0.00724604472433083,0.00433377035643293,-0.00124814517427772,0.0157402346229394,0.0945357306615406
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,24229,-0.00305972541482014,0.00185143878166602,-0.00668854542688553,0.000569094597245252,0.0984211172493218
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,24195,0.00793753623572977,0.00480497535218955,-0.00148021545456175,0.0173552879260213,0.0985595438387254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28797,-0.00576020877564529,0.00349097654632904,-0.0126025228064502,0.00108210525515963,0.0989481366545749
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,29694,0.00339601286684899,0.00206023857682424,-0.000642054743726514,0.00743408047742449,0.0992896018508684
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,24195,0.00656884051797786,0.0040000219796623,-0.00127120256216026,0.014408883598116,0.100561336858526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESPL1,Separin,24016,-0.00626823242399609,0.00384050806841941,-0.0137956282380981,0.00125916339010597,0.102663905708639
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24229,-0.00331669975731677,0.00203235252726481,-0.00730011071075579,0.00066671119612225,0.102702810284188
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,29820,-0.00356238566579775,0.00219005693089723,-0.00785489725035633,0.000730125918760825,0.103828859826114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,-0.00289233043670816,0.0017878314727574,-0.00639648012331265,0.000611819249896336,0.105721681099839
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24805,-0.0164492184169098,0.0101842747218136,-0.0364103968716644,0.00351196003784481,0.106289089199558
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,29439,-0.0065446619685793,0.00406758296473332,-0.0145171245794566,0.00142780064229801,0.107631317427185
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,29566,0.00875646585004666,0.00546021916065067,-0.00194556370482865,0.019458495404922,0.108794421275833
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,24101,-0.0104174748949092,0.00652534515581826,-0.023207151400313,0.00237220161049456,0.110398483140967
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.00404102677001593,0.00253141818868681,-0.000920552879810218,0.00900260641984207,0.110423955909615
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28774,-0.00603378639154358,0.00379552593212428,-0.0134730172185072,0.00140544443542001,0.111911129029424
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,28797,-0.00951773604411649,0.00599527325625807,-0.0212684716263823,0.00223299953814932,0.11240138162157
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29478,0.0049171727898282,0.00310225410387295,-0.00116324525376278,0.0109975908334192,0.112969739864355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.00843265484424648,0.00533743403698094,-0.0188940255567291,0.00202871586823616,0.114141062891359
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24195,0.00848686749554411,0.00537572171974727,-0.00204954707516054,0.0190232820662488,0.114408761135919
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29288,-0.00243523845387523,0.00155045347799634,-0.00547412727074805,0.000603650362997601,0.116271973962735
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,24445,0.00474447146046031,0.0030287019312932,-0.00119178432487436,0.010680727245795,0.117243796487858
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.00382153673739134,0.00244301353453607,-0.00860984326508203,0.000966769790299358,0.117766925650575
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,24111,-0.00480695108757273,0.00308234183763729,-0.0108483410893418,0.00123443891419635,0.118888225186021
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,24016,-0.00653051085174168,0.00419402880122844,-0.0147508073021494,0.00168978559866606,0.119460574523219
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,24111,-0.00653757942995764,0.00419865188700258,-0.0147669371284827,0.00169177826856741,0.119467873658017
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,24845,-0.00242599622392064,0.00155976318680499,-0.00548313207005842,0.000631139622217132,0.119872648666715
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,24195,-0.00310725829922291,0.00200494490523685,-0.00703695031348714,0.000822433715041331,0.121203250378379
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,24101,-0.00975127768142737,0.00630664794393087,-0.0221123076515319,0.00260975228867713,0.122071760407155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,-0.00317360766151949,0.00205807081544554,-0.00720742645979276,0.000860211136753778,0.123078913828272
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,24101,-0.0079126938287121,0.00513243158791926,-0.0179722597410339,0.00214687208360965,0.123158509277132
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,0.00682956818106668,0.00443701953320607,-0.00186699010401723,0.0155261264661506,0.123762537779104
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,24381,-0.00552119934919379,0.00359023939771045,-0.0125580685687063,0.00151566987031869,0.124101706393027
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,24016,-0.00472127080975855,0.00307174660239847,-0.0107418941504595,0.00129935253094245,0.12430678734326
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,24016,-0.00669772967922076,0.00438309265059079,-0.0152885912743787,0.0018931319159372,0.126505091432408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,0.00517925986206966,0.00339263672116445,-0.00147030811141266,0.011828827835552,0.126869138537516
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00755808956118379,0.00495506740462761,-0.0172700216742539,0.00215384255188632,0.127190930547138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,28774,-0.00370130552477073,0.00243341014826204,-0.00847078941536433,0.00106817836582287,0.128261685030631
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,-0.0037041446303333,0.00244352408251839,-0.00849345183206934,0.00108516257140275,0.129554951828834
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,24805,-0.0119220825506294,0.00789993074396843,-0.0274059468088075,0.00356178170754873,0.131276365555645
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,-0.00908909839698571,0.0060415377886796,-0.0209305124627977,0.0027523156688263,0.132480261848744
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,28931,0.00403903208127327,0.00268636583160182,-0.0012262449486663,0.00930430911121285,0.132713303129801
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24951,0.00333841082820119,0.00222590960725039,-0.00102437200200958,0.00770119365841196,0.133679854797601
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29566,0.00379531671121885,0.0025420720382822,-0.00118714448381428,0.00877777790625197,0.135447537322706
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLPS,Colipase,29400,-0.00728044799466009,0.00488243798280051,-0.0168500264409491,0.00228913045162891,0.135932819321934
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24101,-0.00486994223240553,0.00327539748844763,-0.0112897213097629,0.00154983684495182,0.137074177441058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FN1,Fibronectin,24966,0.00274011520004914,0.0018492604502206,-0.000884435282383233,0.00636466568248151,0.138423265889814
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,24793,0.00811784938897292,0.00547960434828104,-0.00262217513365791,0.0188578739116038,0.138495064170362
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,24016,0.00636066277982707,0.00430816748780804,-0.00208334549627669,0.0148046710559308,0.139844411862105
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,24195,-0.00342853701343918,0.00232240307635183,-0.00798044704308877,0.00112337301621042,0.139879474788532
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,24229,-0.00340294412949769,0.0023102162288491,-0.00793096793804193,0.00112507967904655,0.140764544170757
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,24111,0.00917777100971423,0.006248756180825,-0.00306979110470277,0.0214253331241312,0.141917555874595
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,24867,-0.00359930921534318,0.00245469103392071,-0.00841050364182778,0.00121188521114141,0.142579698766956
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,24240,0.00182578965423553,0.00124622112723928,-0.000616803755153468,0.00426838306362452,0.142917322284182
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,0.00460509532234102,0.0031566317498134,-0.00158190290729324,0.0107920935519753,0.144615678686462
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24111,0.00993658040494524,0.00681719415069521,-0.00342512013041738,0.0232982809403079,0.144970406591747
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,24966,0.00256429538798484,0.00176306768850689,-0.000891317281488665,0.00601990805745835,0.145833915077374
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,24240,0.00863835816079341,0.0059481349126573,-0.0030199862680149,0.0202967025896017,0.146436679993205
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,24111,-0.00461816066695293,0.00319277510051494,-0.0108759998639622,0.00163967853005635,0.14806656830355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,24195,0.00753270840969578,0.00521752845418734,-0.00269364736051139,0.017759064179903,0.148827567725137
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00571849283878531,0.00397054037348094,-0.013500751970808,0.00206376629323733,0.14981523015189
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,0.00590996290217391,0.00411656252648262,-0.00215849964973202,0.0139784254540798,0.151113562573027
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24445,0.00452067180128662,0.00315215804957681,-0.00165755797588393,0.0106989015784572,0.151541868453465
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,-0.00337204153604366,0.00235620458954988,-0.00799020253156141,0.0012461194594741,0.152405194442436
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24111,-0.00323145608096742,0.00225921220834459,-0.00765951200932282,0.00119659984738799,0.152630585776595
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,24016,-0.00304771761156313,0.00213145004064382,-0.00722535969122501,0.00112992446809875,0.152764502501267
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,28797,-0.00545561241342505,0.00381608799051455,-0.0129351448748336,0.00202392004798346,0.152832698996022
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.00565899035013679,0.00396593753014466,-0.00211424720894675,0.0134322279092203,0.153619636456424
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00617481617396979,0.00433083667471927,-0.0146632560564196,0.00231362370847997,0.153945085291702
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.00395265866254639,0.00277734799361851,-0.00939626073003868,0.00149094340494589,0.154697705968119
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,29114,0.0102383960376237,0.00719923952751337,-0.00387211343630249,0.0243489055115499,0.154993527322217
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.00362242648104549,0.00255421583385659,-0.00138383655331343,0.00862868951540441,0.156140875522233
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24951,0.00255778070160198,0.00180505361008409,-0.000980124374162844,0.00609568577736681,0.156492223500929
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.00764945883523716,0.00541617278699804,-0.00296623982727899,0.0182651574977533,0.157861706950861
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,29761,0.00582025908211322,0.00413557039077903,-0.00228545888381369,0.0139259770480401,0.159329485085303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00306558786388247,0.002196544226168,-0.00737081454717175,0.00123963881940682,0.162835350485738
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00358207103970598,0.00256668778553707,-0.00144863701994668,0.00861277909935865,0.162845514526454
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,24966,-0.00201443387890183,0.00144541123251425,-0.00484743989462977,0.000818572136826106,0.16342810190036
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24867,0.00729579898322717,0.00523908750991915,-0.00297281253621436,0.0175644105026687,0.163762151271083
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.00434288208255482,0.00312280040571117,-0.00177780671263908,0.0104635708777487,0.164326773608455
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24867,-0.00344148836533089,0.0024814202975861,-0.00830507214859965,0.00142209541793786,0.165483890657499
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24016,-0.0039140044612509,0.00282449473181835,-0.00945001413561486,0.00162200521311307,0.165840359874297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFD,Complement factor D,24966,0.00186159520469852,0.00135246220920327,-0.000789230725339896,0.00451242113473693,0.168695029384181
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,29443,-0.00228181937164449,0.00165781432513518,-0.00553113544890944,0.000967496705620451,0.168707603091282
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.00431519536592006,0.00314149887266268,-0.0018421424244988,0.0104725331563389,0.169575392461795
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,0.00822963379565224,0.00600757780648029,-0.00354521870504913,0.0200044862963536,0.170738173735123
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.00359663192402765,0.00262609927489646,-0.00874378650282472,0.00155052265476941,0.170833326178682
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,-0.0047242027210655,0.0034516094038046,-0.0114893571525225,0.00204095171039151,0.171107194663472
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00616124793735224,0.00450312217943565,-0.0149873674090461,0.00266487153434163,0.171256950771774
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,24867,0.00733196513321275,0.00536068453789151,-0.0031749765610546,0.0178389068274801,0.171409202504993
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,24229,-0.00389906241209922,0.00285132725573708,-0.00948766383334389,0.00168953900914546,0.171495348019746
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,24195,0.00569712926495257,0.00417060284154249,-0.0024772523044707,0.0138715108343758,0.171945211476682
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,29820,-0.00247298090159838,0.00181496194722461,-0.00603030631815862,0.00108434451496186,0.173033888935125
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,23801,-0.00368255567173053,0.00271160884746361,-0.00899730901275921,0.00163219766929816,0.174454232137502
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,29434,0.006096750025215,0.00449137261543585,-0.00270634030103927,0.0148998403514693,0.174653188699641
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,24195,-0.00556378480864393,0.00410036192476758,-0.0136004941811884,0.00247292456390052,0.174825365148436
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNLY,Granulysin,29443,0.00487061476129524,0.00359347351434113,-0.00217259332681338,0.0119138228494039,0.175298712155535
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,28797,-0.0154096642838294,0.011412619456853,-0.0377783984192612,0.00695906985160252,0.176952747239037
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,-0.00364837952470599,0.00270410406051932,-0.00894842348332384,0.00165166443391187,0.177283079989903
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.0063230291361885,0.00469429696542128,-0.00287779291603722,0.0155238511884142,0.178003804574184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,24195,0.00853712563637401,0.0063550074845542,-0.00391868903335222,0.0209929403061002,0.179164841820214
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,24016,-0.00408239288122855,0.00303994269181132,-0.0100406805571787,0.00187589479472163,0.179311319502057
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29169,0.00369714330879163,0.00275909835864338,-0.00171068947414939,0.00910497609173265,0.180261502011054
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.00628544883855109,0.00469807943516061,-0.0029227868543637,0.0154936845314659,0.180947362824685
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,29434,-0.00455028507494177,0.00340377894925893,-0.0112216918154893,0.00212112166560575,0.1812873910515
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,24016,-0.00637324329331985,0.00479065676399404,-0.0157629305507482,0.00301644396410846,0.183416096503463
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24111,0.00435663343304873,0.0032793594720394,-0.00207091113214849,0.010784177998246,0.184025124035656
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.00459187501718757,0.00346361328004157,-0.0113805570460691,0.00219680701169391,0.184936076588719
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,24793,0.00482956846413863,0.00364943521686142,-0.00232332456090976,0.011982461489187,0.185723172555391
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,24229,-0.00255101355261815,0.00193412175219323,-0.00634189218691688,0.00123986508168058,0.18719766734597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24111,-0.00308338619737395,0.00233817290588413,-0.00766620509290685,0.00149943269815895,0.18727658302073
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,24101,-0.0044984222464361,0.00341993641829172,-0.0112014976262879,0.00220465313341568,0.188403949739699
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,24229,0.00303048409891798,0.00230724824184989,-0.00149172245510781,0.00755269065294377,0.189039585815334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,29121,0.00517853252184856,0.00394423200373426,-0.00255216220547058,0.0129092272491677,0.189214153914431
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,0.00642506747094365,0.00490172830719948,-0.00318232001116733,0.0160324549530546,0.189943640775028
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRELP,Prolargin,29454,0.00209645851504575,0.00160308347765701,-0.001045585101162,0.00523850213125349,0.190962806640627
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28916,0.00309059990359614,0.00236354519093486,-0.00154194867063617,0.00772314847782846,0.191015367471279
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.00827148239034152,0.00633088792737577,-0.004137057947315,0.020680022727998,0.191385463991434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,-0.00269734816312086,0.00206555549785733,-0.00674583693892123,0.00135114061267951,0.191606959865788
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,28774,-0.00588117377852913,0.00451550228095642,-0.0147315582492037,0.00296921069214545,0.192776219653854
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,24445,-0.00511113177770795,0.00393544965066139,-0.0128246130930043,0.00260234953758837,0.194044915043788
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.00432642313101359,0.00334114879795227,-0.00222222851297286,0.010875074775,0.195370279162602
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BSND,Barttin,24016,-0.00303135231867589,0.00234690028966303,-0.00763127688641543,0.00156857224906366,0.196493982988443
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCIN,Adseverin,24101,0.00655977557727265,0.00508985249977183,-0.00341633532228014,0.0165358864768254,0.197481802255688
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.00222166183816416,0.00172621284736783,-0.00560503901900511,0.0011617153426768,0.198101354522207
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.00745359009299164,0.00580797765341037,-0.00393004610769269,0.018837226293676,0.199384527973294
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,24016,-0.00473393120751184,0.00370737476413128,-0.0120003857452092,0.00253252333018547,0.201651395436428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24111,0.00405015050920382,0.00317289746257225,-0.00216872851743779,0.0102690295358454,0.201797040911801
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,24381,0.00673966713866301,0.00530500009289161,-0.00365813304340455,0.0171374673207306,0.203941225294745
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28774,-0.00447468620096165,0.00352363457560145,-0.0113810099691405,0.00243163756721718,0.204128237255463
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,28931,-0.00248798811724855,0.00197077379533125,-0.00635070475609779,0.00137472852160069,0.206799872834487
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,24016,-0.00447791526583288,0.0035480274114786,-0.0114320489923309,0.00247621846066518,0.206930152176721
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24793,0.00532469587730083,0.00422135976466556,-0.00294916926144367,0.0135985610160453,0.207187505066191
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24445,0.00464997432147806,0.00370108565100046,-0.00260415355448283,0.011904102197439,0.20898981837451
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24922,0.00263575129811576,0.00209903187355077,-0.00147835117404375,0.00674985377027526,0.209237060944448
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.00235619315722977,0.00187680968064485,-0.00603474013129368,0.00132235381683415,0.209334483516661
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.00277473377122408,0.00222546761221182,-0.00158718274871109,0.00713665029115926,0.212479544391149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,24111,-0.00572281780619962,0.0046069548763861,-0.0147524493639164,0.00330681375151714,0.21417018813474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,0.00349800990311644,0.00282297304760473,-0.00203501727018884,0.00903103707642172,0.21531214113286
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,29349,-0.00179818824035554,0.00145134942941922,-0.00464283312201721,0.00104645664130613,0.215364010980102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00417645180745936,0.00337766886182656,-0.0107966827766394,0.0024437791617207,0.216286785914448
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,29694,-0.00247101050986086,0.00200774478561376,-0.00640619028966382,0.0014641692699421,0.218430119472354
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,24845,0.00586520004245969,0.00478062840073957,-0.00350483162298988,0.0152352317079093,0.219883837082002
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24195,-0.00307995101189248,0.00251138208341858,-0.0080022598953929,0.00184235787160793,0.220061322420543
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,24845,-0.00224652368577891,0.00183331872157543,-0.00583982838006676,0.00134678100850893,0.220441320547742
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,24867,0.00504276015383065,0.00412503185559869,-0.00304230228314278,0.0131278225908041,0.221538560873295
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00514884254809161,0.00422064314716102,-0.0134213031165272,0.003123618020344,0.222507541161089
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,24229,-0.00253583875851703,0.0020788261547461,-0.00661033802181937,0.00153866050478532,0.222536783545254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0060025097545571,0.0049325648577559,-0.00366531736664447,0.0156703368757587,0.223648299357669
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,29443,-0.00282786114651906,0.00232405612014961,-0.00738301114201229,0.00172728884897418,0.223698321510788
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,24016,0.00658568904583885,0.00543400483696561,-0.00406496043461374,0.0172363385262914,0.225547193019391
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,29157,-0.00234222874139456,0.00194092461700436,-0.00614644099072309,0.00146198350793398,0.227534667604335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.00249227631219368,0.00207042583834769,-0.00156575833096779,0.00655031095535515,0.228695780316093
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,24229,-0.00574319634592703,0.0047986806015829,-0.0151486103250295,0.00366221763317545,0.23138523485142
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,28774,0.00474118211977767,0.00396817312028398,-0.00303643719597893,0.0125188014355343,0.232174159114345
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,-0.00337620945869644,0.00283426528446269,-0.0089313694162433,0.00217895049885043,0.233580043691504
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00306990467230592,0.0025801608841558,-0.00812702000525129,0.00198721066063944,0.23413227499241
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,29820,0.00592997910244621,0.00499888524354996,-0.00386783597491172,0.0157277941798041,0.235528975702533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.00288006624117901,0.00243009396236694,-0.0018829179250602,0.00764305040741822,0.235962941991393
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.0024021925551341,0.00203080186838344,-0.00157817910689745,0.00638256421716565,0.236868886102772
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,28830,0.00393476230689917,0.00336354332242065,-0.00265778260504531,0.0105273072188436,0.242080449215544
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24793,-0.00329341212046088,0.00282286782638408,-0.00882623306017367,0.00223940881925192,0.243346745342019
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,29434,-0.00449830809238747,0.00385752855988341,-0.012059064069759,0.00306244788498403,0.243578854533835
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24101,0.0035331593715278,0.00303746089636116,-0.00242026398534007,0.00948658272839566,0.244761911826635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.00204122572663055,0.00176752200204233,-0.00550556885063352,0.00142311739737242,0.248162500752274
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,24805,0.0207128145222577,0.0179361629530564,-0.0144420648657328,0.0558676939102483,0.248180418342434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,-0.00550308000674345,0.0047662259817805,-0.0148448829310332,0.00383872291754632,0.248265947781445
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.00301874139126601,0.0026240610192926,-0.00212441820654749,0.00816190098907952,0.249985149835684
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.0047408167248167,0.00412285339278424,-0.0033399759250404,0.0128216093746738,0.250201651628341
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24229,0.0059891813722585,0.00521664091985418,-0.0042354348306557,0.0162137975751727,0.250942112802932
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24195,0.00428300686715451,0.00373185573365816,-0.00303143037081549,0.0115974441051245,0.251108649955058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.002325173848688,0.00203635941649277,-0.00166609060763783,0.00631643830501384,0.253536475306893
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,24229,0.00233414343505808,0.00204642262513165,-0.00167684491019996,0.00634513178031611,0.254048961483352
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,24016,-0.00331882334213689,0.00291115119485892,-0.00902467968406037,0.00238703299978658,0.254281795170873
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00404588139011473,0.00354940021567741,-0.0110027058128424,0.00291094303261298,0.254348676364701
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.00816967956965436,0.00716790861502343,-0.00587942131579157,0.0222187804551003,0.254398519605374
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,28916,-0.00256690357301612,0.00225979547089798,-0.00699610269597616,0.00186229554994392,0.256007485656278
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,24101,0.00869884976916389,0.00767837537910453,-0.00635076597388099,0.0237484655122088,0.257266525529538
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.00383326936541617,0.00338788848329727,-0.00280699206184648,0.0104735307926788,0.257871609843911
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,24101,-0.00376857231566104,0.00333302043524619,-0.0103012923687436,0.00276414773742151,0.258201973510925
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,24016,-0.00527560927395624,0.00468081178727601,-0.0144500003770172,0.00389878182910474,0.259723545360893
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,24016,-0.00728172571845464,0.00646319006581165,-0.0199495782474455,0.0053861268105362,0.259903545014095
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24240,-0.00446850314975842,0.0039669679492716,-0.0122437603303308,0.00330675403081392,0.259995624793396
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,-0.00706988140083672,0.00628142891734598,-0.0193814820788348,0.00524171927716139,0.260379394766098
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00372803611606614,0.00331309587255225,-0.0102217040262685,0.00276563179413627,0.26049751679986
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,24938,-0.00687914280875955,0.00611485006653685,-0.0188642489391718,0.00510596332165267,0.260604269380931
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEB,Nebulin,24111,0.00294667341316065,0.00262333673969742,-0.00219506659664629,0.00808841342296759,0.261340836620182
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00538801232414927,0.00480013166880504,-0.0147962703950071,0.00402024574670861,0.26167308484358
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24240,0.0032487706227827,0.00290604378530262,-0.00244707519641045,0.00894461644197584,0.263605464351648
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,24229,-0.00425296679702291,0.00381093472002739,-0.0117223988482766,0.00321646525423077,0.264437291673397
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,24195,0.00637983039653628,0.00572634334566235,-0.00484380256096192,0.0176034633540345,0.265239026808621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,24229,0.00380949173945525,0.0034193787133897,-0.00289249053878856,0.0105114740176991,0.265252124197908
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28797,-0.00443092745053319,0.00398310409134583,-0.012237811469571,0.00337595656850463,0.265962282618393
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.00380371092252104,0.0034225502200849,-0.0105119093538875,0.00290448750884536,0.266421347876735
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.00710486949327497,0.00640662821741647,-0.0054521218128613,0.0196618607994112,0.267446761138551
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,24111,0.00851256931171139,0.00768143227884082,-0.00654303795481661,0.0235681765782394,0.2677861709908
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,29434,0.00294980495574047,0.00267561739436788,-0.00229440513722057,0.00819401504870151,0.270263643962609
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,28774,0.00364822954588636,0.00331601830294283,-0.00285116632788158,0.0101476254196543,0.271261265408076
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24016,-0.00316384186883061,0.00287622174013989,-0.0088012364795048,0.00247355274184359,0.271343463986801
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,29518,0.00341218006991458,0.00311961713664738,-0.00270226951791429,0.00952662965774344,0.274059671004254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,29725,-0.0023911744742698,0.00218650086985385,-0.00667671617918335,0.00189436723064375,0.274135879478133
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,28931,0.00240986873428855,0.00220625494897621,-0.00191439096570481,0.00673412843428192,0.274715049882599
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29594,-0.00208015059101334,0.00190460115448466,-0.00581316885380328,0.0016528676717766,0.274766739442573
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00378922044789023,0.00347092476956416,-0.00301379210045552,0.010592232996236,0.274974682431269
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,24445,0.00542171634807778,0.00497601288932042,-0.00433126891499023,0.0151747016111458,0.275913175230925
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,-0.00258810830758408,0.00238353427327262,-0.00725983548319841,0.00208361886803026,0.277565971500121
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29120,-0.00323394238525362,0.00298141881121511,-0.00907752325523524,0.00260963848472799,0.278063918486307
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28774,0.00298550794653346,0.00275787521585596,-0.00241992747654422,0.00839094336961113,0.279022096308583
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,24922,-0.00259073503927507,0.00239533639120269,-0.00728559436603234,0.00210412428748219,0.279452059631471
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.0062850745965927,0.00581378099596777,-0.00510993615550412,0.0176800853486895,0.279679024806636
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,-0.00367034321390471,0.00340258960175785,-0.0103394188333501,0.00299873240554068,0.280736244008347
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAG,S-arrestin,24101,-0.00393433428197765,0.00365807258463747,-0.0111041565478671,0.00323548798391178,0.282152259505275
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.00314093331959088,0.00292700730528145,-0.00259600099876077,0.00887786763794253,0.28324106380574
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,24793,-0.00255022506814819,0.00238044275414577,-0.00721589286627391,0.00211544272997753,0.284034279172453
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.00223103469076338,0.00208374651526156,-0.00185310847914928,0.00631517786067605,0.284320387008896
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.00267815680818581,0.00250235002301943,-0.00222644923693227,0.00758276285330389,0.284514155472338
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24805,0.00592563651164077,0.00554521662790665,-0.00494298807905625,0.0167942611023378,0.285258888254443
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.0031823172533456,0.0029784015625143,-0.00901998431587362,0.00265534980918243,0.285321604462084
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,24111,0.00376889643592209,0.00352904055929194,-0.00314802306029012,0.0106858159321343,0.285546406159953
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28797,0.00340560222186454,0.00319718639036853,-0.00286088310325778,0.00967208754698685,0.286800131357852
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,-0.00283831853508285,0.00266589731352026,-0.00806347726958256,0.00238684019941686,0.287032935421826
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24867,0.00166972965107956,0.00156830835004992,-0.00140415471501828,0.0047436140171774,0.287035980366981
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,29349,0.0020761858845827,0.00195764045408607,-0.001760789405426,0.00591316117459141,0.28890079481923
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARTN,Artemin,28931,0.00327110368928596,0.00308568889193755,-0.00277684653891164,0.00931905391748356,0.289113137207029
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00241421743426074,0.00231625092401478,-0.00695406924532971,0.00212563437680822,0.297283436807146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,24195,0.00362866800005694,0.00350708238530284,-0.00324521347513664,0.0105025494752505,0.30083405501557
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,28931,-0.00216581369974333,0.00209460412701578,-0.00627123778869425,0.0019396103892076,0.301146365442814
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24240,0.0188936249777813,0.0182736480221806,-0.0169227251456926,0.0547099751012553,0.301180435861309
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,29632,0.00434844243909641,0.00423684854267425,-0.00395578070454512,0.0126526655827379,0.304740252966318
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,24195,-0.00492618592819261,0.00480376722129114,-0.0143415696819232,0.00448919782553803,0.305145178109484
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,24381,-0.00660339461430148,0.00646390770189392,-0.0192726537100136,0.0060658644814106,0.306990178467267
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24195,0.00354555101509102,0.003479698348158,-0.00327465774729866,0.0103657597774807,0.308248853222344
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,0.00526297727181399,0.00516586201911724,-0.0048621122856558,0.0153880668292838,0.308308429822412
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,29566,-0.00192546452633633,0.00189867439190165,-0.00564686633446356,0.0017959372817909,0.31053860999371
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,-0.00248560141744272,0.00245554358436423,-0.0072984668427966,0.00232726400791117,0.311432954357336
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.00808417855082344,0.00799116736589814,-0.00757850948633692,0.0237468665879838,0.311720421122871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.00590610324051228,0.00584287312624431,-0.00554592808692658,0.0173581345679511,0.312111865263968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28797,0.0032751250592335,0.00327029709302692,-0.00313465724309926,0.00968490736156626,0.316605007587855
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24101,-0.00536040926142098,0.00535253773786581,-0.015851383227638,0.00513056470479599,0.316609399861965
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,24195,0.00231515571840682,0.00232145828970501,-0.00223490252941499,0.00686521396622864,0.318636132566263
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00193587167354772,0.00194431167412344,-0.00187497920773423,0.00574672255482967,0.319425742371432
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCN,Decorin,28916,-0.0015705846455109,0.00157789640252761,-0.00466326159446501,0.00152209230344321,0.319566555522255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,0.00586608079236151,0.00589927602548738,-0.00569650021759375,0.0174286618023168,0.320049755439595
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,28931,-0.00447420232573668,0.00450140254606683,-0.0132969513160277,0.0043485466645543,0.320251929370749
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,-0.00592623619030999,0.00597295522213201,-0.0176332284256887,0.00578075604506875,0.32112054869438
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24195,-0.00291467455846098,0.00293843381575691,-0.00867400483734453,0.00284465572042258,0.321249251924714
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,29443,0.00187792006490751,0.00189702273923871,-0.00184024450400037,0.0055960846338154,0.3222163849586
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24445,0.0036267322434568,0.00367804887486564,-0.00358224355127985,0.0108357080381934,0.324119389897006
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,28931,0.00231223985770617,0.00235309190839814,-0.00229982028275418,0.00692429999816652,0.325793368515474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_A,,24867,0.00221700721723191,0.00226228913573321,-0.00221707948880518,0.006651093923269,0.327103542553205
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00199934426730026,0.0020579778308896,-0.00203429228124335,0.00603298081584387,0.331304522725008
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,24016,0.00399888150741654,0.00412339912454083,-0.00408298077668348,0.0120807437915166,0.332154872612069
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.00178052249882366,0.00183986746418398,-0.00182561773097694,0.00538666272862426,0.333179687289204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,-0.00180004898767775,0.00186433981398043,-0.0054541550230794,0.0018540570477239,0.334296070986579
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24445,-0.00291883702918411,0.00304076595160234,-0.00887873829432471,0.00304106423595648,0.337114086909702
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,24111,-0.00324598018087954,0.00338317303502626,-0.00987699932953102,0.00338503896777194,0.337342495333911
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28797,0.00304468558655345,0.00318153727354564,-0.00319112746959601,0.0092804986427029,0.338582524526181
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24101,-0.00407057362503832,0.00427032372456153,-0.0124404081251789,0.00429926087510227,0.340486324650708
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,28745,0.00368388023882698,0.0038799809570129,-0.00392088243691831,0.0112886429145723,0.342395542091825
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24111,-0.00289842605187366,0.00305290445130557,-0.00888211877643259,0.00308526667268526,0.342426970555711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.00406887854921785,0.00428748561908773,-0.00433459326419411,0.0124723503626298,0.342623594654485
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,29536,0.00205835274124535,0.00217101903984874,-0.00219684457685817,0.00631355005934887,0.343084060427046
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,29579,0.00994413413328805,0.0104987732091611,-0.0106334613566677,0.0305217296232438,0.343559361721825
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,24922,-0.00193463852503581,0.00204738094036595,-0.00594750516815308,0.00207822811808145,0.34470207130421
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,24101,0.00398679523683359,0.00428961252254094,-0.00442084530734665,0.0123944357810138,0.352687596050668
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.00260006666353875,0.00279921381469218,-0.00288639241325793,0.00808652574033543,0.35297300074385
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24229,0.00359598995322952,0.00388354192075236,-0.0040157522114451,0.0112077321179041,0.354477939651264
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,24938,-0.00302907219018326,0.00327452846158746,-0.00944714797489467,0.00338900359452816,0.354953678731796
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,0.00241499836636754,0.00261750430077752,-0.0027153100631564,0.00754530679589148,0.356206946899533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.00365758392262896,0.00396853957414223,-0.00412075364268982,0.0114359214879477,0.356723137810265
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.00496107103411937,0.00538520641608553,-0.00559393354140826,0.015516075609647,0.3569324914266
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.00378466773760454,0.0041090049115991,-0.00426898188912969,0.0118383173643388,0.357024843709514
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.00239054624224497,0.00260764298015565,-0.00750152648335003,0.0027204339988601,0.359284903855882
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28733,-0.00181155334825651,0.00197796108839618,-0.00568835708151303,0.002065250385,0.359743270349912
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.00366551350274657,0.0040030865602082,-0.00418053615526151,0.0115115631607546,0.359846554558543
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.00401490476611499,0.00439163476985201,-0.00459269938279494,0.0126225089150249,0.36061216600798
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24845,-0.00253393191901426,0.00277508770099058,-0.0079731038129558,0.00290523997492727,0.36119894086714
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00167541706858235,0.00183658721163202,-0.00192429386621641,0.00527512800338111,0.361649046167062
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,24445,0.00261811220904391,0.00287627776447539,-0.00301939220932785,0.00825561662741568,0.362703258570259
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,24111,-0.00269837418350597,0.00296513667913453,-0.00851004207460964,0.00311329370759771,0.362813861071655
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,-0.00227825789810834,0.0025099022956075,-0.00719766639749903,0.00264115060128236,0.364040184537567
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24548,-0.000509595237096211,0.000562223520137686,-0.00161155333656608,0.000592362862373653,0.364736990811782
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00585351363856015,0.00647733380102644,-0.018549087888572,0.00684206061145167,0.366167901870981
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,28916,0.00376923565456323,0.00417095745484694,-0.00440584095693677,0.0119443122660632,0.366169482572823
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,-0.00435874877245471,0.00483035741957006,-0.013826249314812,0.00510875176990261,0.366871615824876
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24016,-0.00208667960319401,0.00231653475536168,-0.00662708772370291,0.00245372851731489,0.367716309526637
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,-0.00552255972861649,0.00613817952759983,-0.0175533916027122,0.00650827214547917,0.368283827087519
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,24845,-0.0018944798106711,0.00210834719867763,-0.00602684032007925,0.00223788069873705,0.368894938443621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,24445,-0.00278224177448513,0.00309653989266653,-0.00885145996411152,0.00328697641514127,0.368927782857798
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29662,0.0025184121972529,0.00280494766700416,-0.00297928523007526,0.00801610962458106,0.369274728412305
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,24101,-0.0048001194812155,0.00534747386697076,-0.0152811682604782,0.0056809292980472,0.369385178217987
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCLN,Nicalin,28931,0.00322759585418753,0.00360685042761269,-0.00384183098393334,0.0102970226923084,0.370873873921634
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,-0.00366231150116082,0.0041051362174643,-0.0117083784873909,0.00438375548506921,0.372331047985908
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,0.00174950698057802,0.00196826306777086,-0.00210828863225287,0.00560730259340891,0.374086555462758
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24922,0.00168894527575658,0.00190262838242417,-0.0020402063537948,0.00541809690530795,0.374715790531437
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRN1,Neuritin,24867,0.00218947854805012,0.00247266520540407,-0.00265694525454186,0.0070359023506421,0.375910083532165
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,24938,0.00558729299663674,0.00631782427191682,-0.00679564257632022,0.0179702285695937,0.376505150117507
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,24845,-0.00578446385485003,0.00654766313641405,-0.0186178836022216,0.00704895589252151,0.377007442291304
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24229,0.00564473158371064,0.0064052258568397,-0.00690951109569517,0.0181989742631164,0.378180599134389
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29349,-0.00157521097993051,0.00179979243743973,-0.00510280415731237,0.00195238219745135,0.381462393538099
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24922,-0.00214103159578086,0.00245086232916104,-0.0069447217609365,0.00266265856937477,0.382353825103243
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24922,0.00159769768877989,0.00183736413871548,-0.00200353602310245,0.00519893140066224,0.38454948437042
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,28774,0.00225398321367756,0.0026354353402945,-0.00291147005329965,0.00741943648065478,0.392414186349407
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,-0.00328121573640662,0.00383795869663875,-0.0108036147818186,0.00424118330900532,0.392592698819173
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24016,-0.00328801769656739,0.00385771343363109,-0.0108491360264843,0.00427310063334953,0.394043375578963
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00256244210162977,0.0030247323393746,-0.00336603328354444,0.00849091748680399,0.396912428727174
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00148297205376468,0.00175487870918165,-0.00492253432376071,0.00195659021623135,0.398087280593144
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,24867,0.00922602927000876,0.0109643268712596,-0.01226405139766,0.0307161099376776,0.400099055982134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.00675786076412709,0.00813327698252055,-0.00918336212161319,0.0226990836498674,0.406042477122953
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.00354564467041822,0.00427672037559582,-0.00483672726574958,0.011928016606586,0.407080408327344
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.00389185470913907,0.00471749579981371,-0.0053544370584958,0.0131381464767739,0.40938905533178
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,23970,0.00201351661763836,0.00245777678660969,-0.00280372588411662,0.00683075911939335,0.412655892025389
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.00370567668443846,0.00454257935591404,-0.00519777885315306,0.01260913222203,0.41464264970984
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,28984,0.0019144839837531,0.00234892554520091,-0.00268941008484067,0.00651837805234688,0.415052286823098
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,24195,-0.003857834269174,0.00473911027635465,-0.0131464904108291,0.00543082187248112,0.415628971744549
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,29676,-0.00241939585079479,0.00298778272930637,-0.00827545000023527,0.00343665829864568,0.418082908151245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,24101,0.00208113591864445,0.00260348212964203,-0.00302168905545392,0.00718396089274283,0.424085918484903
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,24111,0.00202783713986226,0.00254771132642302,-0.00296567705992686,0.00702135133965137,0.426072061900989
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,29218,-0.00191195819908635,0.00241480179954064,-0.00664496972618601,0.0028210533280133,0.428503504034323
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00184016897390878,0.00232968449658886,-0.00640635058722295,0.00272601263940538,0.4296061805888
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,24546,-0.00186577572858876,0.00236710022282733,-0.00650529216533032,0.00277374070815279,0.4305805921699
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,28931,0.00497147552696594,0.00632917919853902,-0.00743371570217054,0.0173766667561024,0.432175678316062
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.0034011111459641,0.00433429306828769,-0.011896325559808,0.00509410326787977,0.43263836699679
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,28774,-0.00286316103134258,0.00365102544401004,-0.0100191709016023,0.00429284883891711,0.432924904841474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.00141091229093952,0.00180025889045924,-0.00211759513436058,0.00493941971623963,0.433207545565744
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24016,0.00343817459344627,0.0043898135198227,-0.00516585990540622,0.0120422090922988,0.433507686508768
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00240007753737235,0.00306484854073686,-0.0084071806772166,0.0036070256024719,0.433577143571692
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NENF,Neudesin,24793,0.0059495300049859,0.00759992382175389,-0.00894632068565173,0.0208453806956235,0.433728120491944
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,0.00776888351813038,0.00994474628121069,-0.0117228191930426,0.0272605862293033,0.434689756769355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,28797,-0.00490623054523963,0.00630100851275795,-0.0172562072302452,0.00744374613976594,0.436196968776105
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,29478,0.00243789611574132,0.00313181776144313,-0.00370046669668722,0.00857625892816987,0.436322710030369
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.00522659520461269,0.00671710834663823,-0.00793893715479825,0.0183921275640236,0.436516333708829
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,24195,0.0018928658309397,0.00244330548005534,-0.00289601290996878,0.00668174457184817,0.438515557479827
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,28931,0.00328723483587527,0.00424579632974972,-0.00503452597043418,0.0116089956421847,0.438799457117571
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,24793,0.00195866045902484,0.00254696764683521,-0.00303339612877217,0.00695071704682185,0.441890772030604
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.00233638050954624,0.00304297577437707,-0.00362785200823282,0.00830061302732531,0.442616682130621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,24445,0.00122386264515016,0.00159491936659194,-0.00190217931337004,0.00434990460367035,0.442880390466772
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,-0.0023663275604355,0.00308542701521382,-0.00841376451025459,0.0036811093893836,0.443126391942485
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,0.00138753893931291,0.00180990547665294,-0.00215987579492685,0.00493495367355266,0.443305355094919
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,24111,-0.00267169343308186,0.00351714311903703,-0.00956529394639444,0.00422190708023072,0.447488991641613
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00401990938233423,0.00530032008454842,-0.0144085367480491,0.00636871798338067,0.448202215110139
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,28774,0.00156472318124437,0.00206361234740052,-0.00247995701966064,0.00560940338214938,0.448310702915449
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,28774,0.00169454334066944,0.00224499140024496,-0.00270563980381068,0.00609472648514956,0.450368804183174
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.00116047862981953,0.00154054715460508,-0.00185899379320643,0.00417995105284549,0.451281834008303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00258090263371765,0.0034360251103458,-0.00931551184999541,0.00415370658256011,0.452581566369744
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29478,0.00146780005897974,0.00196455820994229,-0.00238273403250716,0.00531833415046663,0.454985007659737
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEO1,Neogenin,24867,0.00112891350564697,0.00151687071032425,-0.00184415308658856,0.00410198009788249,0.456739267070855
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,24229,0.00449099397129442,0.00605168802324359,-0.00737031455426301,0.0163523024968519,0.458030314801782
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,24016,0.00376599811541357,0.00507936567241164,-0.00618955860251324,0.0137215548333404,0.458439533988771
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,28872,-0.0028374611039629,0.00387706367361996,-0.010436505904258,0.00476158369633221,0.464261023340993
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24134,-0.0019913717343444,0.00273522668343725,-0.00735241603388141,0.0033696725651926,0.466592296692401
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00208834617815771,0.00287059077891715,-0.00771470410483532,0.0035380117485199,0.466928596286191
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.00925302831620474,0.0127872266452289,-0.0158099359084439,0.0343159925408533,0.469307933891505
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,24951,-0.00264210636674992,0.00365288573761837,-0.00980176241248193,0.0045175496789821,0.469506729851836
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,24229,0.00311371308550174,0.00432676337973224,-0.00536674313877344,0.0115941693097769,0.471753467748315
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,-0.00448145368923862,0.006311830941102,-0.0168526423337985,0.0078897349553213,0.477704485697073
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,24195,0.00205354616073155,0.00289574499600165,-0.0036221140314317,0.00772920635289479,0.478232107165825
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,28797,0.00505060660078596,0.00713547642449815,-0.0089349271912304,0.0190361403928023,0.479065067078946
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,29313,0.00337172045642987,0.00479231004502793,-0.00602120723182486,0.0127646481446846,0.481706856259594
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.0040240019528344,0.0057788436897136,-0.0153505355846731,0.00730253167900426,0.486226676940238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.00292114239544868,0.00420463853284485,-0.0111622339198246,0.00531994912892722,0.487223159129287
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C5,Complement C5,24966,0.000727490093638281,0.00104789445442714,-0.00132638303703891,0.00278136322431547,0.487538266053629
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24229,0.00196059677738639,0.00282677246140214,-0.00357987724696182,0.00750107080173459,0.487951419630552
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,24101,0.00359968227643536,0.00519106254926077,-0.00657480032011574,0.0137741648729865,0.488041137149303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,24381,0.00163294231742585,0.00237450510129211,-0.00302108768110668,0.00628697231595838,0.491649549803725
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24195,-0.00174302521871172,0.00253737844452649,-0.00671628696998363,0.0032302365325602,0.492127506592183
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,23902,0.00208449459200516,0.00303976412637603,-0.00387344309569186,0.00804243227970218,0.492882334416638
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24016,-0.00191432911938697,0.00280316939567025,-0.00740854113490066,0.00357988289612671,0.494666539477732
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,29216,0.00243284633553229,0.00356460038636032,-0.00455377042173394,0.00941946309279852,0.494927091125487
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.00296811215191794,0.00436505357816517,-0.0115236171651217,0.0055873928612858,0.496528931951538
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,-0.000875060648330804,0.0012916352715597,-0.00340666578058781,0.0016565444839262,0.4981059765099
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23037,0.00247769224316009,0.0036784625161287,-0.00473209428845217,0.00968747877477235,0.500593179295407
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,29694,-0.00145483703227689,0.00216644993880517,-0.00570107891233502,0.00279140484778125,0.501887915161376
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,24754,0.00240260798121975,0.0035779368530847,-0.00461014825082626,0.00941536421326577,0.501904167135533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,28931,-0.00656751778790154,0.00979956455271102,-0.0257746643112151,0.0126396287354121,0.502745436527161
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,28931,-0.00189820276568529,0.00283724312708872,-0.00745919929477918,0.0036627937634086,0.503481233296061
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,24111,0.00153386035555296,0.0023160255630382,-0.0030055497480019,0.00607327045910782,0.507797310710744
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,24195,0.00190110762172345,0.00288307882434975,-0.00374972687400206,0.00755194211744896,0.509644009256369
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,-0.00335616982209004,0.00510552895604413,-0.0133630065759365,0.00665066693175645,0.510955833462905
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.00236850385316215,0.00362239563951329,-0.0047313916002839,0.00946839930660819,0.513214521170734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00319727336674319,0.00490644791446618,-0.0128139112790969,0.00641936454561053,0.514634966403944
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,28797,0.00619660142950037,0.00955779198110714,-0.0125366708534696,0.0249298737124704,0.516776831286446
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,29434,-0.00396479466785638,0.00613610486883262,-0.0159915602107683,0.00806197087505555,0.518192480044538
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,24229,-0.00212562395595462,0.00329955935788427,-0.00859276029740778,0.00434151238549854,0.519442456541675
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_DRA,,29322,0.00159811910668385,0.00248995005677396,-0.0032821830045931,0.00647842121796081,0.520990032600398
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,24016,-0.00352716680903789,0.00549949557323534,-0.0143061781325791,0.00725184451450337,0.521293719207749
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,24867,0.00200286524699221,0.00312706384215097,-0.00412617988362368,0.00813191037760811,0.521857472981975
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,23913,-0.00153352939974993,0.00239543003837079,-0.00622857227495667,0.00316151347545682,0.522055480144389
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,-0.00452320718017436,0.00709832354206695,-0.0184359213226256,0.00938950696227685,0.523986202107578
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00172561779463804,0.00271089619831031,-0.00358773875405017,0.00703897434332624,0.524424813346703
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,-0.0022095645965375,0.00347915319955938,-0.00902870486767389,0.00460957567459888,0.525377777410966
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.00295260337625869,0.00467166722756633,-0.00620386438977132,0.0121090711422887,0.52737638799018
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,0.00599382716424444,0.00952284053622659,-0.0126709402867597,0.0246585946152486,0.5290825860331
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.00334277886747173,0.00532685545006602,-0.00709785781465767,0.0137834155496011,0.530315678947363
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00245813549300703,0.00392470000615463,-0.0101505475050701,0.00523427651905605,0.531108098541727
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24016,-0.00274254921859163,0.00438839886638925,-0.0113438109967146,0.0058587125595313,0.532006922104085
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,29694,-0.00551964991275252,0.00883548932699883,-0.0228372089936702,0.0117979091681652,0.532163879931927
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,24111,-0.00280938457139397,0.00451501918673662,-0.0116588221773977,0.0060400530346098,0.533795920460796
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24111,0.00242399938719148,0.00390083208406802,-0.00522163149758184,0.0100696302719648,0.534338584780907
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,-0.0014046398801889,0.00228438595989952,-0.00588203636159196,0.00307275660121417,0.538634935783154
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24421,0.00427331653626179,0.00695905388475052,-0.00936642907784923,0.0179130621503728,0.539177613385465
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,24016,-0.00172410239299744,0.00283240957190996,-0.00727562515394096,0.00382742036794608,0.542725630054062
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,28334,0.00198969397317785,0.00330333485829893,-0.00448484234908804,0.00846423029544375,0.546960065492312
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,24016,0.0022019926396881,0.00367430604264645,-0.00499964720389894,0.00940363248327515,0.548981946959944
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24101,0.00445363223412352,0.00749674031034594,-0.0102399787741545,0.0191472432424016,0.55246697407673
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,28774,0.00244079595912031,0.00411368005496351,-0.00562201694860817,0.0105036088668488,0.552960734307056
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,24229,0.00132607923805674,0.00223957461166502,-0.0030634870008067,0.00571564547692017,0.553781049680397
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,29693,0.00130346119090321,0.00221747519373832,-0.0030427901888239,0.00564971257063032,0.556662154852967
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,29169,-0.00185136245299078,0.00318540333438565,-0.00809475298838666,0.00439202808240511,0.561108883858793
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.00196390917003375,0.00338216090639218,-0.00859294454656243,0.00466512620649493,0.561470369792917
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,-0.00143159705434777,0.002476026966115,-0.00628460990793316,0.00342141579923762,0.56314490226466
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,0.00195789554369153,0.00341257505862877,-0.00473075157122085,0.00864654265860391,0.566156087018024
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,28626,-0.00264989380569935,0.00462860451586074,-0.0117219586567864,0.0064221710453877,0.56698519128732
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00214871689477929,0.00376647861458359,-0.00953101497936313,0.00523358118980456,0.568354526787804
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,-0.00202569166343065,0.00355564263222787,-0.00899475122259728,0.00494336789573598,0.568878477322994
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,24016,-0.00457646839625679,0.00808029362017864,-0.0204138438918069,0.0112609070992933,0.571144846038184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,24195,-0.00235712500404946,0.00416774080989054,-0.0105258969914349,0.005811646983336,0.57169531651019
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,0.00125325405026535,0.00221807401857071,-0.00309417102613324,0.00560067912666394,0.572065218015183
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.0019121671665205,0.00339547406118771,-0.00856729632644841,0.00474296199340742,0.573336814215694
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24195,-0.00160542687821453,0.0028517694810546,-0.00719489506108154,0.00398404130465248,0.573468599504888
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29349,0.00282735624681459,0.00502261061731343,-0.00701696056311972,0.0126716730567489,0.573489828754742
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,24111,0.00184387369119202,0.00329230923582454,-0.00460905241102407,0.00829679979340811,0.575447244973976
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.00105152090872826,0.00188317059580289,-0.00263949345904542,0.00474253527650193,0.57659056704297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24867,-0.00295045544751012,0.00529335544368143,-0.0133254321171257,0.00742452122210548,0.577267041225051
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,24229,0.00115737188019019,0.00209021586326352,-0.00293945121180631,0.0052541949721867,0.579782949068668
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24445,-0.0025677222777187,0.00464451126868203,-0.0116709643643355,0.00653551980889808,0.580370563104581
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,-0.00183935616962866,0.00336359784148847,-0.00843200793894606,0.00475329559968873,0.584492431128953
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,29341,0.002705432937513,0.0049656837195029,-0.00702730715271269,0.0124381730277387,0.585877429226967
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,-0.00134412493636734,0.0024704429231254,-0.00618619306569313,0.00349794319295845,0.586389670213524
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24445,0.00145511684474516,0.00268750990615934,-0.00381240257132715,0.00672263626081746,0.588211464391762
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,24195,-0.00181190404656346,0.00334648415022808,-0.0083710129810105,0.00474720488788357,0.588212694106818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,27585,0.00182439032689636,0.00337701502206471,-0.00479455911635047,0.00844333977014319,0.589037582506842
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,24101,-0.00129517445492104,0.0024041758081664,-0.00600735903892718,0.00341701012908509,0.590085950240235
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,24111,-0.00311296023768423,0.0057908506404676,-0.0144630274930007,0.00823710701763227,0.590882170684617
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24445,0.00257503704956484,0.0048256638221616,-0.0068832640418719,0.0120333381410016,0.593614152298841
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00173583055769742,0.00326459676391773,-0.00466277909958133,0.00813444021497617,0.594929236071486
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28916,-0.00122240730738243,0.00230192976826738,-0.0057341896531865,0.00328937503842164,0.59539799417272
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.00270015031680303,0.00509158250169922,-0.0126796520201335,0.00727935138652744,0.5958973140463
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24845,0.000978566423170691,0.00186959145148561,-0.00268583282174111,0.00464296566808249,0.600692312140503
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,28916,-0.00256160697328764,0.00492130842347698,-0.0122073714833025,0.00708415753672725,0.602709778939939
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,-0.00198993659962274,0.00383211716191012,-0.00950088623696657,0.0055210130377211,0.603570437144255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.00178834765500652,0.00348482501450109,-0.00861860468342865,0.00504190937341561,0.607829084922122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.00221939815007959,0.0043580056471653,-0.0107610892185236,0.0063222929183644,0.610567434816507
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24016,0.00130126153623489,0.00255893958722246,-0.00371426005472112,0.0063167831271909,0.611096246206335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.0019045298597859,0.0037648942406829,-0.00928372257152438,0.00547466285195258,0.612955748569006
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,29565,-0.00134151804755629,0.00266118546751779,-0.00655744156389116,0.00387440546877857,0.614191048787654
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.00185427570334623,0.00370610587962864,-0.00540969182072591,0.00911824322741837,0.616846606557015
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.0016359224092599,0.00327828614037199,-0.008061363244389,0.00478951842586919,0.617771540382482
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,24445,-0.00581314782775364,0.011668144414335,-0.0286827108798502,0.0170564152243429,0.618342838991712
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,24229,-0.00129520834927894,0.00261859703269343,-0.00642765853335806,0.00383724183480018,0.620873439342173
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0012630524103707,0.00255381424020226,-0.00374242350042573,0.00626852832116714,0.620904711665935
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,24101,-0.00218352778089354,0.00449190025268257,-0.0109876522761514,0.00662059671436429,0.626898310844872
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24852,-0.00216905757420409,0.00448246784407302,-0.0109546945485872,0.00661657940017902,0.628462470696593
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,-0.00136732369305757,0.0028450304655158,-0.00694358340546855,0.0042089360193534,0.630804606335227
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24101,-0.00281616598182538,0.00586822174248585,-0.0143178805970977,0.00868554863344689,0.631302087248147
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24016,0.00289301826363804,0.00604453571713384,-0.00895427174194428,0.0147403082692204,0.632215397993821
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,28931,-0.0015698944487663,0.00332123466698589,-0.00807951439605865,0.00493972549852605,0.636442219039937
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,24381,0.00118279274097504,0.00250311314618926,-0.0037233090255559,0.00608889450750598,0.636553710369816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.00350918254729338,0.00748965785902158,-0.0111705468563889,0.0181889119509757,0.639404874709616
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00159486158996037,0.00340484651224998,-0.00507863757404959,0.00826836075397033,0.639496195402255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.00125581681094066,0.0026905723272697,-0.00401770495050795,0.00652933857238927,0.640684299081892
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,23603,-0.00224007477341509,0.00484469600572995,-0.0117356789446458,0.00725552939781562,0.643815437028481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSC1,Hamartin,24229,-0.00239891799889398,0.00519598639179731,-0.0125830513268167,0.00778521532902876,0.644310131457947
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,24445,0.00268659389525965,0.00593197668803259,-0.00894008041328423,0.0143132682038035,0.650624572113238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,28774,0.00172339742793291,0.0038368763705222,-0.00579688025829059,0.00924367511415642,0.653314729873707
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,29165,-0.00146834194100873,0.0033128235430629,-0.00796147608541202,0.00502479220339455,0.657602853767751
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",24793,-0.00132177499409731,0.00299733214468782,-0.00719654599768543,0.00455299600949082,0.659228554262995
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,24101,-0.00293294934126976,0.00669682782229634,-0.0160587318729706,0.0101928331904311,0.661418489657648
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,24195,0.00200669252117743,0.00462890025912353,-0.00706595198670469,0.0110793370290595,0.664645350277701
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,-0.00373703685401491,0.00862536032432247,-0.020642743089687,0.0131686693816571,0.664828025733695
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,24445,0.00179555607752018,0.00416833136026394,-0.00637437338859715,0.00996548554363751,0.666645699503332
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,24726,0.00103048436958468,0.00239797105822749,-0.00366953890454121,0.00573050764371056,0.66739451029509
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,-0.00144605139763493,0.00337077294934163,-0.00805276637834452,0.00516066358307466,0.667929261379374
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,28931,0.00128372005541167,0.00300340938246072,-0.00460296233421135,0.00717040244503469,0.669075942226393
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.00108433689711902,0.00259625031667566,-0.00617298751780332,0.00400431372356529,0.676202487021614
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,24793,-0.00127401857822835,0.00307089395401034,-0.00729297072808861,0.00474493357163191,0.678241426174187
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24445,0.0024365515345923,0.00589869116315187,-0.00912488314518537,0.01399798621437,0.679561539957239
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.00107133097972553,0.0026061676077881,-0.00403675753153914,0.00617941949099021,0.681020978551772
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.00127635966816875,0.00310530696977925,-0.00481004199259859,0.00736276132893609,0.681057552020705
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,29478,0.00108396979203995,0.00264613361621027,-0.00410245209573219,0.00627039167981208,0.682070915782385
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,24016,-0.00167769514452932,0.00418583397283104,-0.00988192973127815,0.00652653944221951,0.688568679402313
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,0.0014217343653755,0.0035525953540981,-0.00554135252865678,0.00838482125940779,0.689015713364303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24751,0.00111256448468824,0.00279014043305829,-0.004356110764106,0.00658123973348248,0.690081923784376
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,-0.00337277967520557,0.00850685256025029,-0.0200462106932961,0.013300651342885,0.69175539221372
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,28774,-0.00121051733703273,0.00308657806295893,-0.00726021034043222,0.00483917566636677,0.694922584831752
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,28797,0.00106150998004216,0.00272124266789432,-0.00427212564903071,0.00639514560911502,0.696478201892351
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,-0.00207829568624529,0.00534319754284736,-0.0125509628702261,0.00839437149773554,0.697308383693108
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,24229,0.00114218480794593,0.00297679453601302,-0.00469233248263958,0.00697670209853144,0.701206984063661
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,24229,-0.000928237636812909,0.00243255899161678,-0.0056960532603818,0.00383957798675599,0.70276962827323
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23975,-0.00126219577547796,0.00335492282436026,-0.00783784451122406,0.00531345296026815,0.706755192077459
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,24793,-0.000702098573346212,0.00187677097824305,-0.0043805696907026,0.00297637254401017,0.708333694265124
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.000661368407197528,0.00177591054381645,-0.00414215307307778,0.00281941625868272,0.709590133321139
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,24793,0.000965828429295689,0.00262360072990398,-0.00417642900131611,0.00610808585990749,0.712778795476836
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,28797,-0.00218523423642053,0.00599400855932892,-0.0139334910127052,0.00956302253986415,0.715435272884093
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00199371727967066,0.00551404357156453,-0.0128012426799371,0.00881380812059581,0.717675897171158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,29523,0.00137565884938242,0.00381011724553161,-0.00609217095185953,0.00884348865062437,0.718061511817758
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,24922,-0.00122786315265809,0.0034027479828062,-0.00789724919895824,0.00544152289364207,0.718218698047677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,-0.000681829535934847,0.00189101150277529,-0.00438821208137441,0.00302455300950472,0.718428409304561
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29374,-0.000815049491481865,0.00226108051179632,-0.00524676729460265,0.00361666831163892,0.718499008195084
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,24445,-0.0018602269766378,0.00516619767328205,-0.0119859744162706,0.00826552046299502,0.71879295175765
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,29599,-0.00277807825789947,0.00772898388634074,-0.0179268866751273,0.0123707301593284,0.719271202620004
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,24867,-0.000914934988482617,0.00258540387643745,-0.00598232658630001,0.00415245660933478,0.723428262824236
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.000925931215966034,0.0026173683651517,-0.00605597321166337,0.0042041107797313,0.723518692048968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24101,0.00289312909876593,0.00820182272598404,-0.0131824434441628,0.0189687016416946,0.724284796102007
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,29589,-0.000830237080489704,0.00235519199024095,-0.00544641338136196,0.00378593922038255,0.724455673211293
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,-0.00152996302666704,0.00437178132443832,-0.0100986544225661,0.00703872836923207,0.726369255938667
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,0.00413515808385033,0.0119272522842251,-0.0192422563932308,0.0275125725609315,0.728820930519817
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,28916,-0.00145441596671884,0.00419868514347013,-0.0096838388479203,0.00677500691448262,0.729046179956778
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00145812722303062,0.00431123197675032,-0.00699188745140001,0.00990814189746124,0.735203356619347
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,24938,-0.00102465430431425,0.00303688796130637,-0.00697695470847473,0.00492764609984624,0.735816164371349
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,28931,0.000766988449235707,0.00228190711566604,-0.00370554949746974,0.00523952639594115,0.73678485492997
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,28490,0.000605693457276718,0.00181473286144796,-0.00295118295116127,0.00416256986571471,0.738559709999199
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.000898152796545844,0.0027052981391065,-0.00440423155610289,0.00620053714919458,0.739893787706504
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,24016,0.000934797877509027,0.0028377890638249,-0.00462726868758777,0.00649686444260583,0.741848210104969
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24445,-0.00176219379520882,0.00541446391854351,-0.0123745430755541,0.00885015548513645,0.744835407632426
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,-0.00110786170300659,0.00341796442601021,-0.0078070719779866,0.00559134857197342,0.745843078026977
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,24240,0.00156096055736423,0.00488981298378579,-0.00802307289085592,0.0111449940055844,0.749557101214874
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29820,-0.000499901033206558,0.00156710205352693,-0.00357142105811934,0.00257161899170622,0.749730936243685
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24195,0.00227492141604632,0.00714266216788842,-0.011724696433015,0.0162745392651076,0.750110195705579
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,28916,-0.00234761018074648,0.00739956969046059,-0.0168507667740492,0.0121555464125563,0.751046290184718
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24229,-0.00196776849308073,0.00627567779373289,-0.0142680969687972,0.0103325599826357,0.753861943144008
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,24445,-0.00114373044030234,0.00365315734232142,-0.00830391883125232,0.00601645795064765,0.75422256858245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,24111,0.00103165572724359,0.00331292375148174,-0.00546167482566063,0.00752498628014781,0.755496661730314
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.00185976547145907,0.00598915862371574,-0.00987898543102378,0.0135985163739419,0.756166686517344
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,24229,-0.00046050002558822,0.00151605289546036,-0.00343196370069053,0.00251096364951409,0.761321495218336
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00146931183997496,0.00493756927222029,-0.00820832393357681,0.0111469476135267,0.76602784712852
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,24203,0.00142414400310085,0.00482915602260425,-0.00804100180120348,0.0108892898074052,0.768068706933105
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,24229,-0.00201696645853271,0.0070498760653792,-0.0158347235466759,0.0118007906296105,0.774804313967652
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,24195,-0.000921896747617275,0.00328604856942266,-0.00736255194368568,0.00551875844845113,0.779058945986565
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.000630940012034359,0.00225233937732561,-0.00378364516752384,0.00504552519159256,0.779382836492596
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.000754518802981169,0.00274144850763107,-0.00612775787793806,0.00461872027197572,0.78314464328214
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27986,-0.000549352552891885,0.00201392350187611,-0.00449664261656905,0.00339793751078528,0.785026447442962
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,29786,0.000778111444731799,0.0028797796520293,-0.00486625667324562,0.00642247956270922,0.787009605812051
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,24195,0.000503853667476576,0.00189124207462463,-0.00320298079878769,0.00421068813374084,0.789922533143941
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24445,0.000994836272257685,0.00374295459490398,-0.00634135473375411,0.00833102727826948,0.790403934729629
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,24229,0.00112205706704256,0.00424792642536048,-0.00720387872666397,0.00944799286074909,0.791672516207557
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.000762843936970463,0.00288971719755154,-0.00490100177023056,0.00642668964417149,0.791793208771796
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,24016,-0.00114595901876521,0.00440171689624016,-0.00977332413539593,0.00748140609786551,0.794600942783057
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,24240,0.0011072661726618,0.00433905468041697,-0.00739728100095546,0.00961181334627905,0.798581580478412
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29218,-0.000814030282048433,0.00326471727810317,-0.00721287614713064,0.00558481558303377,0.803098201482111
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24195,-0.000624656965419436,0.00251127476839121,-0.0055467555114662,0.00429744158062733,0.803563254170904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,0.00033405398338762,0.00134443257038472,-0.00230103385456643,0.00296914182134167,0.80377119954427
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24805,-0.000950623932230787,0.00384002451074535,-0.00847707197329168,0.00657582410883011,0.80447943900783
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,29434,0.00101891899102419,0.00415826567892618,-0.00713128173967113,0.00916911972171951,0.806431345517319
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,29725,-0.000495538585808558,0.00202855264695237,-0.00447150177383521,0.00348042460221809,0.807014229062187
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28722,0.000900755455514541,0.00370173238402155,-0.0063546400171677,0.00815615092819678,0.807748802191323
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,-0.000762217158456255,0.00324256595347315,-0.00711764642726363,0.00559321211035112,0.81415946891114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.000798699958457136,0.00345570165735617,-0.00597447528996096,0.00757187520687523,0.81721913258506
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,24229,-0.000416451194560781,0.00181327995614666,-0.00397047990860823,0.00313757751948667,0.81835221082562
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,24229,-0.000911482723439508,0.00398789109469623,-0.00872774926904413,0.00690478382216511,0.819210832580098
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24229,0.000492612240213094,0.0022017394511321,-0.00382279708400583,0.00480802156443202,0.822963254364883
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,29443,0.00054806418298806,0.00247507128210649,-0.00430307552994065,0.00539920389591677,0.824756293923536
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,28931,-0.000945699084492351,0.00430311194494395,-0.00937979849658249,0.00748840032759778,0.826051081071285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,24195,-0.000994096645754234,0.00453127435134364,-0.00987539437438778,0.00788720108287931,0.826351485916895
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,29566,-0.000554269253119692,0.00259576186465725,-0.0056419625078479,0.00453342400160852,0.830916200108423
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,28931,0.000713175273055255,0.00336024012598617,-0.00587289537387763,0.00729924591998814,0.831921783437252
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.000630921648087017,0.00306085472250083,-0.0053683536080146,0.00663019690418864,0.836694211199241
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29594,-0.000422834655183827,0.00205246617854578,-0.00444566836513355,0.0035999990547659,0.836782197073467
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29478,-0.000245939738456568,0.00121553901791463,-0.00262839621356925,0.00213651673665611,0.839660319594198
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,-0.000966237681407954,0.00482576748220478,-0.0104247419465293,0.00849226658371342,0.841306243244041
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24101,-0.00105283139296373,0.00529975132112324,-0.0114403439823653,0.00933468119643782,0.842532931855622
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.000884099517456173,0.00459021447316404,-0.00988091988485769,0.00811272084994535,0.84726971493793
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24195,-0.000657513816690302,0.00347638291171126,-0.00747122432364438,0.00615619669026378,0.849986763905829
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,-0.000752239497961381,0.00400544507669705,-0.0086029118482876,0.00709843285236483,0.851031707636396
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,-0.000608315985613738,0.00327748936984281,-0.00703219515050565,0.00581556317927818,0.852756422363803
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,24229,0.000848230611509243,0.00460236038981411,-0.00817239575252642,0.0098688569755449,0.853776999734991
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24240,-0.000481719832311596,0.00263320690526924,-0.0056428053666393,0.00467936570201611,0.854846341493447
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,0.000829313300806169,0.00455472873382685,-0.00809795501749446,0.0097565816191068,0.855523492713343
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,24229,-0.000588808907363194,0.00324144609798593,-0.00694204325941561,0.00576442544468923,0.855858873495166
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,0.00068400234564328,0.00377025993315848,-0.00670570712334734,0.0080737118146339,0.856039067724901
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,29349,-0.000235005705424351,0.00131729076791871,-0.00281689561054502,0.00234688419969632,0.858409465759707
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,28931,0.000938823683117259,0.00528405374389145,-0.00941792165490998,0.0112955690211445,0.858982521191378
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,24111,0.000700858198306647,0.00409787984816683,-0.00733098630410035,0.00873270270071364,0.864202033164175
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,24229,0.00032128432270838,0.00188577788539171,-0.00337484033265938,0.00401740897807614,0.864718775452867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.000958992287572183,0.00581190859940326,-0.0123503331424026,0.0104323485672582,0.868941665135804
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.000616598393471342,0.00376194488620211,-0.00675681358348479,0.00799001037042748,0.869807972208707
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24111,0.00044971772473178,0.0027451642369864,-0.00493080417976156,0.00583023962922512,0.869872809798886
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24805,0.000285040275575749,0.00177137123148816,-0.00318684733814105,0.00375692788929255,0.872161626306204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29473,0.000429367248553528,0.0026875755950941,-0.00483828091783091,0.00569701541493797,0.873071179691513
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIT,Vitrin,24922,-0.000402656334156503,0.0026016444867018,-0.00550187952809203,0.00469656685977903,0.877003952207624
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.00038876990392545,0.00252794033360927,-0.00534353295779962,0.00456599314994872,0.877777203829782
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,24421,-0.00104820129265836,0.0068314022771035,-0.0144377497557812,0.0123413471704645,0.87805361867873
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.000625898854397805,0.00412651428641768,-0.00871386685577645,0.00746206914698084,0.879442673181809
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24016,-0.000436068773311595,0.0028872999541282,-0.00609517668340287,0.00522303913677968,0.879953357879558
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28774,0.000870937845754239,0.00587528821856853,-0.0106446270626401,0.0123865027541486,0.882156402976751
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.000686386575211202,0.0046369158151435,-0.00977474157289247,0.00840196842247006,0.882323066584461
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,29519,0.000312042735388413,0.00210850279981485,-0.0038206227522487,0.00444470822302553,0.88234964803954
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.000930905326953225,0.00632719684352503,-0.0114704004863558,0.0133322111402623,0.883032493631832
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,24445,-0.000598952210445711,0.00411479111925638,-0.00866394280418821,0.00746603838329679,0.884269330930556
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24101,-0.000404778752000413,0.00278225584453995,-0.00585800020729872,0.0050484427032979,0.884328533944125
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,29478,-0.000736611826326499,0.00530438778399398,-0.0111332118829547,0.0096599882303017,0.889555093905607
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,28797,0.000296592582551957,0.00214681163732072,-0.00391115822659666,0.00450434339170058,0.890118951178
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,24445,0.000498715519880786,0.00371103958826142,-0.00677492207311159,0.00777235311287316,0.893097658773255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,-0.000627281030969531,0.00481440917218982,-0.0100635230084616,0.00880896094652251,0.896336159221053
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24867,0.000308010465305521,0.0024390077403714,-0.00447244470582243,0.00508846563643347,0.899507230020865
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,0.000563594734477506,0.00447315401101401,-0.00820378712710996,0.00933097659606497,0.899736973225502
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24111,-0.000527332433954543,0.00421998255988048,-0.00879849825132028,0.00774383338341119,0.900555619477864
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,24756,-0.000502520140544401,0.00406478591509563,-0.00846950053413183,0.00746446025304303,0.901611062178965
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,24101,-0.00062436307126386,0.00507385454329915,-0.0105691179761302,0.00932039183360246,0.902064587382887
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,24101,0.000480713397826847,0.0039903264187801,-0.00734032638298214,0.00830175317863583,0.904112091212148
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,24101,0.000525417959741606,0.00438830694664671,-0.00807566365568595,0.00912649957516916,0.904696955750526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,-0.000241415739409659,0.00201776778271611,-0.00419624059353324,0.00371340911471392,0.904765397581334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24016,0.000254705696643486,0.00220856068097294,-0.00407407323806347,0.00458348463135044,0.908187255033772
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.000182574741734685,0.00161556936613022,-0.00298394121588054,0.00334909069934991,0.910023933141771
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,29478,0.000199052437263297,0.00181449514141632,-0.00335735803991269,0.00375546291443928,0.912647033361277
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.000422786152722907,0.00391312295518837,-0.0080925071448921,0.00724693483944629,0.913962359160913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,-0.000427552157773629,0.00397547804677069,-0.00821948912944419,0.00736438481389693,0.914355656396381
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24793,-0.000405655823394154,0.00385299891486367,-0.00795753369652694,0.00714622204973864,0.916151993292679
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSPN,Claspin,28719,0.000251649211882094,0.00239562046752703,-0.00444376690447088,0.00494706532823507,0.916340418029704
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24016,0.000389201156027998,0.00374478806306526,-0.00695058344757991,0.0077289857596359,0.91722463773689
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,24101,-0.000340202930226638,0.00330513726927313,-0.00681827197800198,0.00613786611754871,0.918018147528191
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,-0.000387421335838111,0.00376888948579206,-0.00777444472799055,0.00699960205631432,0.918126875400356
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,28931,0.000433255823677959,0.00449459234704299,-0.0083761451765263,0.00924265682388222,0.923207602728993
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,24657,0.000199052799140147,0.00206540321196481,-0.00384913749631089,0.00424724309459118,0.923223697911815
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,29461,-0.00116028860864437,0.0129184891173578,-0.0264805272786656,0.0241599500613768,0.928433946447099
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,24454,-0.00015419145949033,0.00173775910781883,-0.00356019931081525,0.00325181639183459,0.929297174101761
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",29725,0.000444091917157192,0.00504684129050249,-0.00944771701222769,0.0103359008465421,0.929882012061276
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,24833,0.00027975238637982,0.00327039344330407,-0.00613021876249616,0.0066897235352558,0.931832074050661
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.000310210885707472,0.00369052270103897,-0.00754363537974386,0.00692321360832892,0.933012539544176
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.000318272836403117,0.00381229101749779,-0.00779036323069878,0.00715381755789255,0.93346582421125
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,28774,0.000272042574904436,0.00326904525812221,-0.00613528613101511,0.00667937128082398,0.933678982315883
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,24111,-0.000258538084164383,0.00331095431922521,-0.0067480085498458,0.00623093238151704,0.93776055493623
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,24229,0.000257249550648797,0.00331361039365443,-0.00623742682091388,0.00675192592221147,0.938119664156447
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29434,-0.00021435521960702,0.00285113502995937,-0.00580257987832738,0.00537386943911334,0.94007008601181
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,-0.000238608775990996,0.00323660473246133,-0.00658235405161521,0.00610513649963322,0.941232138457786
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,29218,0.000296344581183523,0.00419701288425931,-0.00792980067196472,0.00852248983433176,0.94370986725508
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTTG1,Securin,24445,-0.000199840425541838,0.0028676981413403,-0.00582052878256883,0.00542084793148515,0.944443596730554
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,28931,0.000146195600034391,0.00217686942680231,-0.00412046847649814,0.00441285967656692,0.946455871941885
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28797,-0.000121610021115414,0.00219933218034116,-0.00443230109458408,0.00418908105235325,0.955904572499914
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29361,-0.000127206001842486,0.00233735371595589,-0.00470841928511604,0.00445400728143107,0.95659845675301
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,24195,8.34644704252775e-05,0.0015833945859375,-0.00301998891801223,0.00318691785886279,0.957961523781225
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,24445,0.000217552186924895,0.0041626370388006,-0.00794121640912428,0.00837632078297407,0.958319507012029
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,24059,0.000301077964763551,0.00589792670990756,-0.0112588583866553,0.0118610143161824,0.95928761459871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.000210521753904947,0.00421106850780415,-0.00804317252139118,0.00846421602920107,0.960128727183964
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24111,-0.000136984662800355,0.00276434607692787,-0.00555510297357898,0.00528113364797827,0.960478140771558
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24793,0.000151485421535753,0.00314099443910834,-0.0060048636791166,0.00630783452218811,0.961534532882841
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24101,-0.000191013174574712,0.00415921465817639,-0.00834307390460044,0.00796104755545102,0.963370170903029
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,-0.000156855684599969,0.00399549017379977,-0.00798801642524753,0.00767430505604759,0.968684872499996
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.000110933200286517,0.00290564328305106,-0.00558412763449356,0.00580599403506659,0.969545643523232
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,24445,7.75693892848869e-05,0.00212591775818963,-0.00408922941676679,0.00424436819533656,0.970893956829644
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.000138662365213972,0.00385254648718984,-0.00768965348010605,0.00741232874967811,0.971288722042053
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24867,8.34030071087756e-05,0.00234104310451079,-0.00450504147773237,0.00467184749194992,0.971580520124136
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,24381,0.000196470984704806,0.00582159259190094,-0.011213850495421,0.0116067924648307,0.973077847524692
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,-9.84387606370634e-05,0.00292531663803779,-0.00583205937119113,0.005635181849917,0.973155978233529
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,24793,7.65793092058684e-05,0.0024137314256562,-0.00465433428508029,0.00480749290349203,0.974690397566735
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.000110807822062698,0.00353741543526044,-0.00682252643104777,0.00704414207517317,0.975011000488178
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,28916,5.72589327220224e-05,0.00189261895936591,-0.00365227422763516,0.0037667920930792,0.975864843575796
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24111,0.000235777808847757,0.00784259654936748,-0.0151357114279125,0.015607267045608,0.976016465344075
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24445,8.34271977767822e-05,0.00278209317552035,-0.00536947542624311,0.00553632982179667,0.976077502632098
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24111,0.000202406139681812,0.00679202664454892,-0.0131099660836341,0.0135147783629977,0.976226365737439
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPGN,Epigen,24793,-9.43721250942024e-05,0.00331861827075652,-0.00659886393577698,0.00641011968558857,0.977313704653981
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24195,0.000121844516794819,0.00455746781001104,-0.00881079239082682,0.00905448142441646,0.978671210144924
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,-0.000115814049119666,0.00441930076449823,-0.00877764354753621,0.00854601544929687,0.979092913596868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,28931,9.06238189160625e-05,0.00383643890109459,-0.00742879642722934,0.00761004406506146,0.981154399016536
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29349,1.90513406145919e-05,0.00140034601237515,-0.0027256268436407,0.00276372952486988,0.989145416956999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24101,-6.65855965540319e-05,0.00581724013978557,-0.0114683762705337,0.0113352050774257,0.990867506470307
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,24111,3.16150385103239e-05,0.00277083679895503,-0.00539922508744153,0.00546245516446218,0.990896489432964
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24229,-4.25094428703916e-05,0.00400035492107773,-0.00788320508818273,0.00779818620244195,0.991521592380952
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,3.48112537872792e-05,0.00386289210755159,-0.00753645727701384,0.0076060797845884,0.992809868618082
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,-2.82393104607977e-06,0.00541524762044353,-0.0106167092671154,0.0106110614050232,0.999583925289569
